Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,39288,0.444181938818101,0.011215845108935,0.422198882404588,0.466164995231613,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,39668,0.176819786873825,0.00396687837611101,0.169044705256647,0.184594868491003,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,37268,0.297259138449656,0.00756519335977314,0.2824313594645,0.312086917434811,1.11253692925868e-308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37267,0.139404201577388,0.00369733170093879,0.132157431443548,0.146650971711228,8.83745600219233e-296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39721,-0.107604060804554,0.00294268295018669,-0.11337171938692,-0.101836402222188,3.94256958944464e-281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,39617,0.120059041067011,0.00372992278555172,0.11274839240733,0.127369689726692,3.27301803554092e-220
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37203,0.167486529875262,0.00518825628417027,0.157317547558288,0.177655512192235,3.29659334095242e-220
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39668,-0.0895516360846872,0.00283002345767093,-0.0950984820617223,-0.0840047901076522,3.91042807465464e-213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,39836,0.190890984791278,0.00616466611885397,0.178808239198325,0.202973730384232,1.66008608982697e-204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,36855,0.267625512933565,0.00862485474890677,0.250720797625708,0.284530228241422,5.38859528601452e-204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,39594,0.255841101878231,0.00832972468753885,0.239514841490655,0.272167362265807,3.04792393780393e-201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,39663,0.225450626610031,0.00745368137065579,0.210841411123546,0.240059842096517,2.03443919231806e-195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,37277,-0.14932593846541,0.00497469080235294,-0.159076332438021,-0.139575544492798,1.18050820638545e-191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,39865,0.144043163636024,0.00498814902575148,0.134266391545551,0.153819935726497,8.61799949936444e-179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39826,-0.323198717204651,0.0115550195822507,-0.345846555585862,-0.30055087882344,4.09476090976282e-168
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39743,-0.07384344646442,0.00264686123481804,-0.0790312944846634,-0.0686555984441766,2.92025369126733e-167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39817,0.357448449800039,0.0130144363782994,0.331940154498572,0.382956745101506,2.63281687524391e-162
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39693,0.131769981055086,0.00489656140088051,0.12217272070936,0.141367241400812,5.20346339773703e-156
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39557,0.0730442431840983,0.00273571793122002,0.0676822360389071,0.0784062503292896,1.23685742507353e-153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39452,-0.134772956897048,0.00506870771694314,-0.144707624022257,-0.12483828977184,2.21247703133781e-152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,39763,0.0854228018312026,0.00324475211559592,0.0790630876846346,0.0917825159777706,1.50184912497985e-149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,39817,0.294692516717923,0.0112123574377472,0.272716296139938,0.316668737295907,4.4092253900943e-149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,39680,0.151422326365371,0.0058186301686215,0.140017811234873,0.162826841495869,3.1357696860637e-146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39673,0.129041293100443,0.00498123453481422,0.119278073412207,0.138804512788679,6.00007691547939e-145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,39668,0.0981821522754016,0.00388984817103037,0.0905580498601821,0.105806254690621,7.59826352515947e-138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FURIN,Furin,39721,0.079718457967211,0.00319228616681803,0.0734615770802477,0.0859753388541743,4.90832857957141e-135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,39756,-0.065140500100805,0.00261530387698805,-0.0702664956997016,-0.0600145045019084,2.29988220096845e-134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,37277,-0.0593255447715566,0.00244731617800975,-0.0641222844804557,-0.0545288050626575,4.35739812664511e-127
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,39564,0.166811931280607,0.00719238657091215,0.152714853601619,0.180909008959594,4.94000435659279e-117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,36958,0.0631547852917805,0.00272508346073756,0.0578136217087349,0.0684959488748261,1.75175481278689e-116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,39706,0.065206736527819,0.00283247949375852,0.0596550767200523,0.0707583963355856,2.22423169383058e-115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39401,0.139780617037198,0.00607589330316382,0.127871866162997,0.151689367911399,3.40155903413043e-115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36880,0.0946793663922064,0.0041440030578202,0.0865571203988789,0.102801612385534,2.5894650940992e-113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39820,-0.132956134206847,0.00588243093429398,-0.144485698838063,-0.121426569575631,2.29108835430856e-111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,39634,0.213571980068431,0.00948869130118582,0.194974145118107,0.232169815018755,1.88688214101911e-110
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,39680,-0.0983906488553125,0.00446776226139559,-0.107147462887648,-0.0896338348229771,6.81983618597974e-106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,39836,-0.0728364865870514,0.00333124243370095,-0.0793657217571052,-0.0663072514169975,1.90736757102578e-104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39817,0.0884334324010914,0.00404841093222344,0.0804985469739334,0.0963683178282493,2.97265023130309e-104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,38538,0.0808540542921161,0.00372745789783484,0.0735482368123598,0.0881598717718724,1.0066939409917e-102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36673,0.0652687754773044,0.00304042433399011,0.0593095437826838,0.071228007171925,1.84515355545504e-100
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37088,0.051890307736539,0.00242897340939501,0.0471295198541248,0.0566510956189532,1.4066104469441e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,39401,0.159693499581657,0.00751558995455005,0.144962943270739,0.174424055892575,8.65230300743786e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39836,0.0750260921413317,0.00354024061372918,0.0680872205384225,0.0819649637442409,2.52362920969814e-98
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,36877,0.159929161030121,0.00760800412395236,0.145017472947174,0.174840849113067,1.67178426383439e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,39668,-0.0527808352797425,0.00252671484791702,-0.0577331963816598,-0.0478284741778251,1.31162956350356e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39756,0.0935378193456996,0.00448390492576529,0.0847493656911996,0.1023262730002,2.29752861107352e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,39715,0.0357499035736585,0.00172945373742364,0.0323601742483082,0.0391396328990088,1.07854909967816e-93
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,37268,0.181276742243736,0.00877870780049081,0.164070474954774,0.198483009532698,2.76587167680679e-93
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39401,0.165413342463276,0.00801929326883176,0.149695527656366,0.181131157270186,2.78479854509513e-93
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,39727,0.114820632367223,0.00557641591414376,0.103890857175501,0.125750407558944,5.47918180178489e-93
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39738,-0.0750597226650735,0.00365445449517778,-0.082222453475622,-0.0678969918545251,1.52752220143744e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39401,0.0971395190269194,0.0047386069999921,0.0878518493069349,0.106427188746904,3.58418736413029e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39653,0.165077091024806,0.00807172209257553,0.149256515723358,0.180897666326254,9.01071938345866e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37200,0.164124223459396,0.00805245612589289,0.148341409452646,0.179907037466146,5.84557038871571e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,37285,-0.127539511895407,0.00626470470028798,-0.139818333107972,-0.115260690682843,9.1211760537534e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,37267,-0.111154629482677,0.00552992673200491,-0.121993285877407,-0.100315973087947,1.4640550771196e-88
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,39594,0.150158498011073,0.00749470843625378,0.135468869476016,0.164848126546131,3.40697942907895e-88
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFM,Afamin,37285,0.0359926571563261,0.00180810689885887,0.0324487676345627,0.0395365466780895,6.41177726538388e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,39680,0.117672533753045,0.00593914030223691,0.106031818760661,0.12931324874543,2.552134554066e-86
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,39860,0.0969461282046775,0.00494388187356175,0.0872561197324965,0.106636136676859,1.26616137845301e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39358,0.139477389501349,0.00712683195787227,0.125508798863919,0.153445980138779,2.85221360876648e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,37215,0.131815464597401,0.00682486755673239,0.118438724186205,0.145192205008596,5.35793531847501e-82
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39594,0.145787773341068,0.00756882407967981,0.130952878144896,0.160622668537241,9.83022252029574e-82
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,37277,-0.0940506768727909,0.00490960033963398,-0.103673493538473,-0.0844278602071083,1.01831762266038e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36958,-0.0540586755522274,0.00286854923686514,-0.0596810320564831,-0.0484363190479717,3.46319740521821e-78
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39288,0.105347375808281,0.0056360080984355,0.0943007999353475,0.116393951681215,4.0947920508564e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,39302,0.0899371879298839,0.00482930800991105,0.0804717442304582,0.0994026316293095,1.43526691514151e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36958,0.0661482782332348,0.00355240943272757,0.0591855557450888,0.0731110007213809,2.10996879144558e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39288,0.135155345092794,0.00727944678882595,0.120887629386695,0.149423060798893,4.0292732605843e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,37244,0.0787040164709435,0.00423847745944352,0.0703966006504342,0.0870114322914528,5.15340713998245e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37268,0.0501274619514558,0.00270011951202707,0.0448352277078827,0.0554196961950288,5.52327894272946e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39594,0.117296242150988,0.00633844539056968,0.104872889185471,0.129719595116504,1.18233610936706e-75
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,39756,0.0545233253417961,0.00296276225327222,0.0487163113253825,0.0603303393582096,7.45580349677374e-75
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39716,0.0582609476164216,0.00316913116579753,0.0520494505314584,0.0644724447013847,1.05518816924829e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,37142,0.0441316169694355,0.00239857491304676,0.0394304101398638,0.0488328237990071,1.12807703998465e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37220,0.134417100568467,0.00732977781362801,0.120050736053756,0.148783465083178,3.31097644956695e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39836,0.0584480561123487,0.00323140593984135,0.0521145004702597,0.0647816117544378,2.10799156369196e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39860,-0.058496725472207,0.00323436863475706,-0.0648360879963308,-0.0521573629480831,2.16043572853488e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39680,0.0563929262115792,0.00312594651195736,0.0502660710481428,0.0625197813750156,4.95469254648254e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39394,0.248294532692839,0.0137770227120127,0.221291568177294,0.275297497208384,7.01283254453601e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39758,0.0531817961598382,0.00296133068440323,0.0473775880184079,0.0589860043012685,2.07961342461047e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,39594,0.0946083102772136,0.00534895542811112,0.0841243576381158,0.105092262916311,2.46384726561927e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39288,0.138637259073763,0.00787374795659314,0.12320471307884,0.154069805068685,1.01284362367154e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,39689,-0.0325928203190736,0.00185984161774702,-0.0362381098898577,-0.0289475307482894,4.09216541146987e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,39809,0.0320786868881812,0.0018418448005588,0.028468671079086,0.0356887026972765,2.58909613698398e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39288,0.103699930318886,0.0059551925733488,0.0920277528751219,0.115372107762649,2.87107074234315e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,39790,0.0809491523057457,0.00469082362703343,0.0717551379967602,0.0901431666147313,3.96155086289682e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,39860,0.0818369685934063,0.00475505239541798,0.0725170658983871,0.0911568712884255,8.65499824385349e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,39836,0.0540387173189379,0.00315778667114175,0.0478494554435,0.0602279791943757,4.52305940199721e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,39675,0.085923980918289,0.00502157348008013,0.0760816968973319,0.0957662649392461,4.7316855106346e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,37215,0.180717651372542,0.0105632514109345,0.160013678607111,0.201421624137974,6.33680260198723e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37116,0.0518386996143902,0.00303371683644532,0.0458926146149574,0.057784784613823,9.06393382009414e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,39658,-0.293425020154009,0.017189750038607,-0.327116930229679,-0.25973311007834,9.48226512487357e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,39741,0.104365113863528,0.0061373371060456,0.0923359331356787,0.116394294591377,2.79580450488961e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,36922,0.0612160151862392,0.00362460935801364,0.0541117808445325,0.068320249527946,2.54342174150887e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,36880,0.0839751830226596,0.00498769310966219,0.0741993045277217,0.0937510615175975,6.0990841043074e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,36880,0.104347710823749,0.0062111555428293,0.0921738459598036,0.116521575687695,1.11328374293202e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39632,0.0853828671390003,0.00509909935424235,0.0753886324046853,0.0953771018733153,2.13998302920372e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37268,0.103386230982507,0.00619191380344518,0.0912500799277549,0.11552238203726,5.8176667912379e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39860,-0.0388546771482424,0.00233114873316896,-0.0434237286652536,-0.0342856256312313,7.48994416428565e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39594,0.169527109440378,0.0101765873264354,0.149580998280565,0.189473220600191,8.86958730362353e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,39721,0.0640617967898399,0.00384794978998495,0.0565198152014693,0.0716037783782103,1.03950801760964e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39721,0.0551205749547419,0.0033205488091089,0.0486122992888884,0.0616288506205953,2.30091770064238e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39594,0.136467136394085,0.00828113413491245,0.120236113489657,0.152698159298514,1.66070281324181e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39636,0.0779837068506596,0.00474789312047126,0.0686778363345359,0.0872895773667833,4.00225416340452e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39680,0.0471966124214879,0.00287919441741385,0.0415533913633567,0.052839833479619,6.76503842707953e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,39275,0.0914136029390987,0.00562806255627115,0.0803826003288073,0.10244460554939,7.77604510679455e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39557,0.0490416105382309,0.00302494272073353,0.0431127228055932,0.0549704982708686,1.2336139954756e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,39817,0.0575233802074435,0.0035490933691355,0.0505671572039379,0.064479603210949,1.30255887433357e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,37277,0.0411072079135091,0.00254238322771628,0.0361241367871852,0.046090279039833,2.97287625517024e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,39668,0.0865826504551897,0.00539694043838893,0.0760046471959474,0.0971606537144321,1.82089563615475e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39673,0.0423455651224272,0.00265213600151999,0.037147378559448,0.0475437516854064,6.08452097724788e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39715,-0.0437762912546067,0.00274905076340604,-0.0491644307508825,-0.0383881517583308,1.18427459006555e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,39672,0.0471903124276907,0.00296579200720831,0.0413773600935624,0.053003264761819,1.44799838631624e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,39668,0.0495048835642423,0.00311524692023378,0.0433989996005841,0.0556107675279005,1.99499695474577e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,39668,-0.0431623079116815,0.00272276398552786,-0.0484989253233161,-0.0378256905000469,3.66473349325664e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37132,0.0420015321913918,0.00265019414047314,0.0368071516760645,0.0471959127067192,4.70132985324199e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,39865,0.0419121884607405,0.00264675502142235,0.0367245486187527,0.0470998283027283,4.73056789937273e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,39653,-0.0679669410428374,0.00431462466675681,-0.0764236053896808,-0.0595102766959941,1.74058387945859e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,37257,0.042331881731424,0.00269623601813127,0.0370472591358867,0.0476165043269613,4.65188665637177e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39646,0.042736696911238,0.00272854700656381,0.0373887447783729,0.0480846490441031,7.03150616378609e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39836,0.041969505977382,0.00268311582908307,0.0367105989523792,0.0472284130023849,9.58324771848908e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39401,0.136045692919478,0.00870393490334626,0.11898598050892,0.153105405330037,1.17861709382846e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39668,-0.0542467617521257,0.00348323508240731,-0.061073902513644,-0.0474196209906073,2.78154114027031e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,39821,-0.0781222434740503,0.00503172119232164,-0.0879844170110007,-0.0682600699370999,5.74434344996037e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39594,0.120748639658578,0.0077920883193777,0.105476146552598,0.136021132764559,9.16885868546507e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,39668,0.034955164071837,0.00226385733111043,0.0305180037028606,0.0393923244408135,2.14357267232988e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37268,0.0839675884351162,0.00545036032278713,0.0732848822024534,0.094650294667779,4.25714195943418e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39836,0.189615041544564,0.0123186477775942,0.16547049190048,0.213759591188649,4.41719986730456e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39491,0.068320607699103,0.00444445594383965,0.0596094740491773,0.0770317413490287,6.14384903893891e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39817,0.0767648847399304,0.00499873625445146,0.0669673616812055,0.0865624077986552,7.60724354881186e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39810,0.0308708906351301,0.0020220624465854,0.0269076482398227,0.0348341330304375,2.96871363368748e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,39784,-0.0521769185251836,0.00343286799731233,-0.0589053397999158,-0.0454484972504514,8.26462195642709e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39245,0.125468258267109,0.00829989699683016,0.109200460153322,0.141736056380896,2.92712283480338e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36880,0.0831854936040847,0.00550291731483057,0.0723997756670168,0.0939712115411527,3.4199175373423e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,39743,-0.0625687090150145,0.00414526646730356,-0.0706934312909295,-0.0544439867390996,4.01150732619305e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37203,0.0756387399093023,0.00502408989486478,0.0657915237153673,0.0854859561032373,8.33501621088955e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,37076,0.0334614994882488,0.00224032331251443,0.0290704657957205,0.0378525331807771,4.91505443854769e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39738,-0.0463739131335078,0.00312311148628974,-0.0524952116466357,-0.0402526146203799,1.52640235161287e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,39769,0.0972771948347595,0.00655220452537591,0.0844348739650227,0.110119515704496,1.57294637778066e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39810,0.0700193915103701,0.00474074608356966,0.0607275291865736,0.0793112538341666,4.8437393141722e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39668,-0.0373827739541247,0.00255548164064572,-0.0423915179697903,-0.0323740299384591,3.81578315182583e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,39473,0.0525265909336756,0.00359314045924113,0.045484035633563,0.0595691462337883,4.44356272097171e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,36958,0.05792619563451,0.00395998220577915,0.0501646305111829,0.0656877607578371,4.46245663955651e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36948,0.0667393980422321,0.00456594496378614,0.0577901459132113,0.075688650171253,5.24372429617111e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,39743,0.0572112823313796,0.00392031973609313,0.0495274556486371,0.0648951090141222,6.30812399022348e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,36880,0.0846227148971138,0.00580333121699019,0.0732481857118131,0.0959972440824146,8.73223759626876e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39200,0.0268206443307155,0.00184506858202768,0.0232043099099413,0.0304369787514898,1.47533943214662e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37267,0.0443110270035856,0.00304704552397818,0.0383388177765884,0.0502832362305828,1.5036996585639e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39836,0.045242352002503,0.00311539884196861,0.0391361702722445,0.0513485337327615,1.75960845649299e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37244,0.0809692773335912,0.00557219075402763,0.070047783455697,0.0918907712114853,1.77232004737711e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39594,0.0542361876393875,0.00374711736747367,0.0468918375991391,0.0615805376796358,3.54859225452287e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36958,0.0677727204979173,0.00471232499617045,0.0585365635054232,0.0770088774904113,1.51761813409956e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39179,0.137467332297571,0.00958953054361079,0.118671852432093,0.156262812163048,2.63025075477436e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,39865,0.0622228218171206,0.00434848025145111,0.0536998005242764,0.0707458431099648,3.69851741964368e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,37267,-0.0509622558601431,0.00356572140401347,-0.0579510698120095,-0.0439734419082767,5.32202662185378e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39233,0.074645338203587,0.00523039460052198,0.0643937647865639,0.0848969116206101,6.47586726664289e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,39673,0.0622855851986285,0.00437189573570303,0.0537166695566506,0.0708545008406065,9.00727909385615e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,39680,0.0860426268160345,0.0060540290156286,0.0741767299454025,0.0979085236866666,1.46262359644345e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39673,0.0686204916026811,0.00483325711906334,0.0591473076493169,0.0780936755560452,1.8046878746914e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39302,0.0686546726034643,0.00488186853529751,0.0590862102742812,0.0782231349326475,1.20550576003483e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39564,0.0349363122817574,0.00249011707963833,0.0300556828056663,0.0398169417578485,1.89531801753538e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39721,0.0288736862023328,0.00206480815538782,0.0248266622177727,0.032920710186893,3.58509508303951e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,39594,0.0973649493022008,0.00698682286809368,0.0836707764807371,0.111059122123664,7.02623402024015e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39401,0.0727320688329039,0.00522177616407038,0.062497387551326,0.0829667501144818,7.78760957586196e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39557,0.0718097827032491,0.00517140761965439,0.0616738237687265,0.0819457416377717,1.39560077035202e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36880,-0.0807163477710058,0.00581422738116137,-0.0921122334380821,-0.0693204621039295,1.64949010993652e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,39865,0.0396533934432847,0.00286061312660395,0.034046591715141,0.0452601951714284,1.92270440810877e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,39860,0.0760177110768358,0.00549436183760268,0.0652487618751346,0.0867866602785371,2.75994046808127e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,39557,0.0558064586725609,0.0040338736145899,0.0479000663879647,0.0637128509571571,2.83395430475881e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37240,-0.064202948076787,0.00464401778338784,-0.0733052229322272,-0.0551006732213469,3.57291984643193e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,39836,0.0605411902832573,0.00438350600334349,0.0519495185167041,0.0691328620498106,3.86434404881412e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,37220,0.153998395143004,0.0111707754381061,0.132103675284316,0.175893115001692,6.10173401982081e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36958,0.100369009808361,0.00729449893063786,0.0860717919043104,0.114666227712411,8.85181765052445e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,39673,0.052204231780198,0.00381326578999414,0.0447302308318095,0.0596782327285866,2.02875052924581e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,39715,0.0438946773579704,0.00320974601635573,0.0376035751659131,0.0501857795500276,2.47481252968012e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,39594,0.0901218635209827,0.00659097020985494,0.0772035619096671,0.103040165132298,2.55030157676873e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,39594,0.0468559411984901,0.00342822061301379,0.0401366287969831,0.0535752535999972,2.76009417180176e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37215,0.12721188060038,0.00931314753041796,0.10895811144076,0.145465649759999,3.40832150119381e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,37267,0.145927152644691,0.0106928116080661,0.124969241892881,0.1668850633965,4.00849057521792e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39817,-0.0277778517524533,0.0020374927119163,-0.0317713374678093,-0.0237843660370974,4.36533421149725e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,37285,0.0268697721955399,0.00197030902972888,0.0230079664972713,0.0307315778938085,4.57779414470236e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,39865,0.0440389284632407,0.00324905709383348,0.0376707765593271,0.0504070803671544,1.26685968194101e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,39836,-0.0581276050973091,0.00431997222743736,-0.0665947506630864,-0.0496604595315319,4.77868397933667e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,36958,0.0348215118684788,0.00260897333250834,0.0297079241367625,0.0399350996001952,2.26801739105189e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39594,-0.0518100816541476,0.00389166290282291,-0.0594377409436805,-0.0441824223646147,3.20605153028591e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37203,0.0888382896314603,0.00667105559234453,0.0757630206704651,0.101913558592456,3.32928780456655e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39398,0.0503548846773165,0.00378827679786624,0.0429298621534986,0.0577799072011343,4.24805933744121e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36958,0.0495373260347957,0.00373923132567896,0.042208432636465,0.0568662194331265,8.35461260632848e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,39680,0.0323072683849106,0.00244254172246801,0.0275198866088733,0.0370946501609479,9.97264456186267e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,39836,0.0331571569744388,0.00251950476852899,0.028218927628122,0.0380953863207556,2.38273239859739e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36958,0.0274086796351904,0.00208161778029958,0.0233287087858033,0.0314886504845776,2.4152612455162e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39557,0.0930737896108358,0.00708603122229161,0.0791851684151442,0.106962410806527,3.34767215473594e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,39738,0.0644583338436976,0.00490986974701111,0.0548349891395558,0.0740816785478394,3.62517360820126e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37220,-0.0459534074948472,0.0035043704735728,-0.0528219736230499,-0.0390848413666446,4.82126155517572e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39865,0.0959827172746898,0.00734323730606422,0.0815899721548039,0.110375462394576,7.63448204116841e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39521,0.0896097436390408,0.00687417377904226,0.076136363032118,0.103083124245964,1.21786079164587e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39643,0.0244444947589788,0.00187673566051797,0.0207660928643636,0.028122896653594,1.39422966592672e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,37285,0.0249706219911497,0.0019169734910087,0.0212133539487726,0.0287278900335267,1.48946787464454e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39288,0.137002295184907,0.0105425997910402,0.116338799594468,0.157665790775345,2.07451219487583e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39668,0.0650761728734667,0.00502531391985671,0.0552265575905475,0.0749257881563858,3.68897887465725e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39557,0.0641339999008931,0.00498062866014689,0.0543719677270052,0.073896032074781,9.45536057688755e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,39557,-0.0410207975450719,0.00318714934213206,-0.0472676102556507,-0.0347739848344931,1.02113333466881e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELN,Elastin,37268,0.0414894213336273,0.00322852678176378,0.0351615088413703,0.0478173338258843,1.41674406873369e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,37268,0.0364359976313608,0.00283651378637343,0.0308764306100689,0.0419955646526527,1.52055830436359e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39680,0.0513769470454397,0.00400596544833737,0.0435252547666985,0.059228639324181,1.82302606350415e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36896,0.148296886639456,0.0115948992570414,0.125570884095655,0.171022889183257,3.12779815677233e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39594,0.0434594961058774,0.00340094643725607,0.0367936410888555,0.0501253511228993,3.30372945792618e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39288,0.0826466792808469,0.00646910709074358,0.0699672293829895,0.0953261291787043,3.46355356905587e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39594,0.0539936701658503,0.0042296395419802,0.0457035766635691,0.0622837636681315,3.90257655703969e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36855,0.0840210796017891,0.00657940020250345,0.0711254552048824,0.0969167039986959,4.01370832576621e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39721,0.111249528478543,0.00873892153230926,0.0941212422752173,0.12837781468187,6.08074760700835e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39848,0.0468965097599469,0.0036900511348877,0.039664009535567,0.0541290099843268,7.95283644241268e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39743,0.0339348692901795,0.00267785870836928,0.0286862662217757,0.0391834723585833,1.26516526230369e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37220,0.0574698068515397,0.00453471317607388,0.0485817690264349,0.0663578446766445,1.35005136899081e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,39860,0.0523750573679359,0.00415285968443911,0.0442354523864352,0.0605146623494365,2.70544131910165e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEP,Leptin,39680,0.0816108446543296,0.00647424352978581,0.0689213273359494,0.0943003619727098,2.94293611630342e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39668,0.0282627404053374,0.00224315035474054,0.023866165710046,0.0326593151006289,3.16974504703619e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37221,0.132863124516227,0.0105438971831966,0.112197086037162,0.153529162995293,3.35100693849971e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,36624,-0.0522761192193817,0.00414861405578266,-0.0604074027687157,-0.0441448356700477,3.42922536950377e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,39646,0.110484286020087,0.00877906369668692,0.0932773211745807,0.127691250865593,3.8090148914098e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,39860,-0.0319986469702643,0.00255222273206438,-0.0370010035251105,-0.0269962904154182,6.85861948426909e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37268,0.0959795194395766,0.00766258794722289,0.0809608470630197,0.110998191816133,8.56308577438966e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39594,0.0716214701472719,0.00572895288055978,0.0603927225013747,0.082850217793169,1.0802247372752e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39594,-0.0237001513034812,0.00189797883908321,-0.0274201898280843,-0.0199801127788781,1.29589743397714e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39738,-0.05150729767771,0.00412597545863575,-0.059594209576636,-0.0434203857787839,1.34686054214407e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39673,0.0756229041962375,0.00606146980352174,0.0637424233813349,0.0875033850111401,1.483888235665e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39707,-0.0372570989522355,0.00298978262132533,-0.0431170728900331,-0.0313971250144378,1.77598743181885e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39288,0.0845500008503259,0.0067886360559051,0.0712442741807519,0.0978557275198998,1.95334831672937e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,39680,0.0418250546862812,0.00336058994430486,0.0352382983954437,0.0484118109771188,2.16017696662125e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,37268,0.109241541224931,0.00879024371878658,0.0920126635361092,0.126470418913753,2.89499635721833e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39594,0.135251057893161,0.010929839842252,0.113828571802347,0.156673543983975,5.22666962605632e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39594,0.115838612519202,0.00936157857180152,0.0974899185184715,0.134187306519933,5.26836870557362e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39860,0.0799540165658797,0.00647726389657901,0.0672585793285849,0.0926494538031746,7.58090841301564e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39673,0.0477480864004298,0.00387057865583381,0.0401617522349956,0.0553344205658641,8.36299143062675e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,39673,0.0383506927399659,0.00310929992585836,0.0322564648852835,0.0444449205946483,8.56840953253269e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39817,0.0789070630369379,0.00640197377370418,0.0663591944404777,0.0914549316333981,9.51131576593016e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39801,0.0671890521439966,0.00545649042360453,0.0564943309137318,0.0778837733742615,1.10021596549875e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39594,0.0512255125073098,0.00416656848601623,0.043059038274718,0.0593919867399016,1.39882626710434e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39302,0.0609356525200071,0.00495777914440422,0.0512184053969748,0.0706528996430394,1.47010166070951e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39743,-0.0236800969441895,0.00192861631805743,-0.0274601849275821,-0.0199000089607969,1.6986255634715e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,39658,0.034044042680281,0.00277274362130807,0.0286094651825171,0.0394786201780448,1.7055720307281e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39865,0.0381773340813998,0.00311412355805474,0.0320736519076125,0.0442810162551871,2.13383832233119e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39675,-0.0398671048085874,0.00325222360029459,-0.0462414630651648,-0.03349274655201,2.16928581559061e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,39656,-0.060134096505971,0.00491213805643291,-0.0697618870965795,-0.0505063059153625,2.65399303971584e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,36958,0.0623259538828641,0.00509113544832402,0.052347328404149,0.0723045793615792,2.85150411831395e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39594,0.145841933901098,0.0119444946862506,0.122430724316047,0.169253143486149,3.92430557357625e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37277,0.0256246298642654,0.00209920390800115,0.0215101902045832,0.0297390695239477,4.33319440876183e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,39836,0.0759568435651677,0.00622673843681382,0.0637524362290126,0.0881612509013228,4.48844229647445e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,39658,0.032942655302479,0.00270264499953518,0.0276454711033901,0.038239839501568,5.05494587157239e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,39557,0.103897539535327,0.00853679191041034,0.0871654273909232,0.120629651679732,6.341442107838e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37215,0.124452323273412,0.0102419176437112,0.104378164691738,0.144526481855086,8.51574927911142e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37198,0.0955254207381769,0.00788934201377784,0.0800623103911723,0.110988531085181,1.43410159154812e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39288,0.0960423458272111,0.00794701590926964,0.0804661946450426,0.11161849700938,1.78842895956769e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,37268,0.0302774988969,0.00251087553655836,0.0253561828452457,0.0351988149485544,2.60008110613899e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39701,0.026024436407132,0.00216161243420133,0.0217876760360974,0.0302611967781666,3.08181911603125e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37220,0.100890353180409,0.00838124847119911,0.0844631061768592,0.11731760018396,3.34651155066569e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,39785,0.0683554557440823,0.00568103497825414,0.0572206271867042,0.0794902843014605,3.35200252307435e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,39860,0.0681343580817677,0.00566510318158066,0.0570307558458696,0.0792379603176658,3.56195966520346e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39680,-0.0307912657054605,0.00257055240318772,-0.0358295484157085,-0.0257529829952126,6.39590389482777e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,39673,0.0613012552689351,0.0051202568202571,0.0512655519012312,0.071336958636639,6.88558541762261e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39817,0.110295386418219,0.00922481507202501,0.0922147488770501,0.128376023959388,8.30281028814057e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37203,0.0433918664781229,0.00362872830965508,0.0362795589911989,0.0505041739650468,8.68498337620431e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,36880,0.069663493539717,0.00583784993383136,0.0582213076694076,0.0811056794100265,1.17767665835554e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39594,0.062085512641502,0.00523148342760199,0.0518318051234021,0.0723392201596019,2.39434415596883e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,39817,-0.0416921776240565,0.00351895246932409,-0.0485893244639317,-0.0347950307841812,3.01245647909302e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,39865,0.0291905676233275,0.00246580748987319,0.024357584943176,0.0340235503034789,3.37766267632306e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39860,-0.0348507255965665,0.00295513822086901,-0.0406427965094697,-0.0290586546836632,5.73514997662438e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,36896,0.0959161101097983,0.00813765942780579,0.0799662976312989,0.111865922588298,6.63665927200795e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,39721,0.0608114699406172,0.00516305046183837,0.050691891035414,0.0709310488458204,6.86512020789294e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39673,0.110648618125919,0.00939697804434921,0.0922305411589942,0.129066695092843,7.14251246119136e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37203,0.0646782298842783,0.0054920491338247,0.0539138135819819,0.0754426461865747,7.39964540941683e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39621,0.0216808617632409,0.00184576741926035,0.0180631576214906,0.0252985659049912,1.00094939426669e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39546,0.0414528549698291,0.00353297423320511,0.0345282254727471,0.0483774844669111,1.16911289782739e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37268,0.0665203719596638,0.00567013058123952,0.0554069160204343,0.0776338278988932,1.25132411064454e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39288,0.0728010584465878,0.00621213565965276,0.0606252725536684,0.0849768443395072,1.38373041487295e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39673,0.0832102280800525,0.00710232032411176,0.0692896802447934,0.0971307759153115,1.42660628749174e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39785,0.064385102633083,0.00551553545682764,0.0535746531377008,0.0751955521284652,2.33890869892398e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,39649,0.0539316178002629,0.00462185431365327,0.0448727833455025,0.0629904522550233,2.47344296768183e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,39860,0.0474611370933256,0.00406756366863834,0.0394887123027944,0.0554335618838567,2.48198709867306e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36896,0.0503316903584286,0.0043192641318094,0.0418659326600821,0.058797448056775,3.16948045040082e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,39693,-0.0432484680150934,0.00372244225757077,-0.0505444548399321,-0.0359524811902547,4.44730463348549e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36896,0.0961903611566435,0.0082810979326021,0.0799594092087434,0.112421313104544,4.87866357117938e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),37021,-0.196281872831385,0.0169022267090549,-0.229410237181133,-0.163153508481637,5.02689120777784e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39288,0.0547679540332202,0.00472598622220593,0.0455050210376966,0.0640308870287438,6.31618270241584e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36855,0.0682482309784726,0.00589831929350667,0.0566875251631996,0.0798089367937457,8.20299289206607e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39557,0.0396582636661355,0.00343019449889611,0.0329350824482991,0.0463814448839719,8.60313448364572e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39594,0.0758096072845358,0.0065616570479813,0.0629487594704924,0.0886704550985791,9.43969354990543e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,39680,-0.0566562235628069,0.00491530230698741,-0.0662902160845023,-0.0470222310411116,1.28557244593177e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,37203,0.110480885749016,0.00959831291320433,0.0916681924391353,0.129293579058896,1.62830508988196e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39721,0.0914356629096229,0.00796055999987257,0.0758329653098726,0.107038360509373,2.04434694858057e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39865,-0.0285217815943834,0.00248564431258299,-0.0333936444470461,-0.0236499187417208,2.32637214720136e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39401,0.0595817760888859,0.00520971714662634,0.0493707304814983,0.0697928216962735,3.62066129009142e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,36958,0.0698678706691112,0.00612716676876077,0.05785862380234,0.0818771175358823,5.59591321138468e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,39817,0.0261615704876125,0.00230144931466188,0.0216507298308752,0.0306724111443498,7.9118718380029e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39529,0.0972599001686551,0.00858212467636419,0.0804389358029813,0.114080864534329,1.17697354211232e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39673,0.0999921091681094,0.00882345488561457,0.0826981375923048,0.117286080743914,1.17829451883937e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39697,-0.0360879438012785,0.00318513346108347,-0.0423308053850021,-0.0298450822175549,1.21048787996749e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37220,0.0449737151410736,0.00397576729514557,0.0371812112425883,0.0527662190395589,1.55994003158011e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36880,0.0924480723501309,0.00818501932006073,0.0764054344828118,0.10849071021745,1.90852574222109e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39288,0.068862903596662,0.0061231157304375,0.0568615967650045,0.0808642104283195,3.13521444124231e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39817,-0.0478756767166236,0.00426684314931765,-0.0562386892892862,-0.039512664143961,4.16173676920213e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36855,0.0606799824207813,0.00540608962962673,0.0500840467467129,0.0712759180948497,4.21311394199493e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39401,0.0762148150534493,0.00679423900749371,0.0628981065987616,0.089531523508137,4.3248978607013e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36855,0.0808764551686544,0.00721589818153074,0.0667332947328541,0.0950196156044547,5.05563837237688e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37285,0.018399406270432,0.00164407341441919,0.0151770223781704,0.0216217901626936,6.0372503579459e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,39713,-0.041379384626291,0.00370417099507757,-0.048639559776643,-0.0341192094759389,7.24498618567643e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,39612,0.0325468990005574,0.00291475500419991,0.0268339791923255,0.0382598188087892,7.65343138627343e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,39125,0.0431877267390855,0.00387674350604798,0.0355893094672315,0.0507861440109396,1.03141737992756e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39628,0.0212547578404558,0.0019095992374318,0.0175119433350895,0.0249975723458222,1.14015070446273e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,39302,0.0552653283486073,0.00496718052881057,0.0455296545121386,0.065001002185076,1.20335886369874e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,37277,0.0238867694788439,0.00214879440798909,0.0196751324391852,0.0280984065185025,1.39220492553317e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,37244,0.0459707188834911,0.00413605377238656,0.0378640534896134,0.0540773842773687,1.4201374033115e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39673,0.0918913149731212,0.00827440784591029,0.0756734755951371,0.108109154351105,1.50441585673222e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,39314,0.0524205884659715,0.00472107030942041,0.0431672906595075,0.0616738862724355,1.54594457516974e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36877,0.129731665971694,0.0116879258108695,0.10682333138239,0.152640000560998,1.69079175781665e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39594,-0.0255982671534237,0.00230821706431698,-0.0301223725994849,-0.0210741617073624,1.78751590192045e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37268,0.0809862292923881,0.00730531156790187,0.0666678186193004,0.0953046399654758,1.95108426703247e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,39673,0.0861689970405084,0.00777558461566589,0.0709288511938032,0.101409142887214,1.95237296357904e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39817,0.0623768226342938,0.00563031479209398,0.0513414056417896,0.073412239626798,2.01962633222151e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,39557,0.0555953428173805,0.00502166526068032,0.0457528789064471,0.0654378067283139,2.20684931295528e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,37262,0.0599142198306641,0.00541765078400393,0.0492956242940164,0.0705328153673118,2.62634218117406e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,39668,0.0476229341762432,0.00431030165522187,0.0391747429320084,0.0560711254204781,2.82474351735521e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37268,0.0311086254696968,0.00282104047771794,0.0255793861333696,0.0366378648060239,3.72619349792316e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37203,0.0847295707814102,0.0077044936800969,0.0696287631684203,0.0998303783944001,5.18665748255488e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37244,0.0665095469213705,0.00604820214821717,0.0546550707108648,0.0783640231318762,5.23039188450386e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,39302,-0.0775709781727186,0.00706202009674756,-0.0914125375623439,-0.0637294187830934,5.77472159549419e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,37277,0.0764881875848959,0.00697844215489689,0.062810440961298,0.0901659342084938,7.75303220880517e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39673,0.111108194871303,0.0101831063424525,0.0911493064400958,0.131067083302509,1.28067368860272e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,37285,0.0228675424397011,0.00209852409254497,0.0187544352183129,0.0269806496610892,1.55390758546538e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39680,0.0907762860594686,0.00833445683138891,0.0744407506699463,0.107111821448991,1.58144783133266e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37215,0.0627000145391327,0.00575773387696353,0.0514148561402842,0.0739851729379812,1.68405653413054e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,39673,0.0995589653365274,0.00914959969851467,0.0816257499274386,0.117492180745616,1.77230229959255e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,37268,0.0717885735178483,0.00661417531114882,0.0588247899079966,0.0847523571277,2.48655190931693e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,39673,0.092416127381662,0.00853811137019622,0.0756814290960774,0.109150825667247,3.30192432580808e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,39684,0.0487046380161928,0.00453181189502975,0.0398222867019344,0.0575869893304511,7.55545284304466e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,39401,0.0542314522421214,0.00505014302706249,0.0443331719090789,0.0641297325751638,8.32683484361088e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,37285,0.0365253286676417,0.0034012164443936,0.0298589444366303,0.0431917128986532,8.58618309957681e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,39658,0.0384282412176053,0.00358128577968002,0.0314089210894324,0.0454475613457781,9.07245379919208e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,37267,0.0778030224374989,0.00725585939161376,0.0635815380299359,0.0920245068450619,1.0210548773606e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,37215,-0.0192254578076397,0.00179478918104656,-0.022743244602491,-0.0157076710127884,1.14949234267322e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39680,0.0356984792159326,0.00333721589428822,0.0291575360631277,0.0422394223687375,1.29511856874451e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39595,-0.0648960033850233,0.00607363204131148,-0.0768003221859938,-0.0529916845840528,1.47760441078233e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39721,0.0257043560917016,0.00240658152378951,0.0209874563050742,0.0304212558783291,1.53993885281006e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39401,0.0873105811758057,0.00817692853838248,0.071283801240576,0.103337361111035,1.60006234167938e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39288,0.0626904387738561,0.00588104722208584,0.0511635862185679,0.0742172913291443,1.9409054025252e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,37267,0.0286606291118562,0.00269454601162489,0.0233793189290714,0.033941939294641,2.56530538917723e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39673,0.0569671343891689,0.00536081302561861,0.0464599408589564,0.0674743279193814,2.74954443515349e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36958,0.084820684675359,0.00798337042139871,0.0691732786494175,0.1004680907013,2.92664684747076e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39651,-0.0320071873831261,0.00301368990601807,-0.0379140195989215,-0.0261003551673306,2.93123646499736e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,39865,0.0419057017438932,0.00394941994107263,0.0341648386593908,0.0496465648283955,3.25128929559272e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37220,0.0645294147536799,0.00608012568612277,0.0526123684088793,0.0764464610984806,3.29105310885208e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,39673,0.0828906569072774,0.00782639893571006,0.0675509149932857,0.0982303988212691,4.00617591754957e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,37244,0.0520694410697477,0.00491913933512315,0.0424279279729064,0.0617109541665891,4.43140633100383e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37215,0.14373010331329,0.0135798277232015,0.117113640975815,0.170346565650765,4.48004556210341e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,39817,0.0424712266299101,0.00402045253910351,0.0345911396532672,0.050351313606553,5.34431472789757e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36896,-0.0323969482433552,0.00307399186770738,-0.0384219723040617,-0.0263719241826488,7.25171922360422e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36880,0.0710462122882325,0.00674976060693395,0.057816681498642,0.0842757430778231,8.34585285572463e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39569,0.105612940579245,0.0100377406364581,0.0859389689317867,0.125286912226702,8.37207154869614e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,39594,0.0470645992090258,0.004479282075569,0.0382852063409106,0.0558439920771411,9.74138859110789e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39302,0.0274949823568561,0.0026191304002424,0.022361486772381,0.0326284779413312,1.07963475670814e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,39452,-0.02742359595134,0.0026313847035989,-0.0325811099703939,-0.0222660819322862,2.39020517675177e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39594,0.0845834502999853,0.00811629481308837,0.0686755124663321,0.100491388133638,2.39356191205136e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,39814,0.058126335217276,0.00557939756112859,0.047190715997464,0.0690619544370881,2.47376164279893e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39594,-0.042768232976861,0.0041097021501504,-0.0508232491911558,-0.0347132167625662,2.79294640211642e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39653,0.0613640277057104,0.00589826016387464,0.0498034377845161,0.0729246176269047,2.87666768826377e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39720,0.0866800749711536,0.00833359113861656,0.0703462363394652,0.103013913602842,2.9491725521157e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37005,0.114071603330667,0.0109632048579711,0.0925837218090437,0.13555948485229,2.95000491108334e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37244,0.0982049108689849,0.00943977789304492,0.0797029461986169,0.116706875539353,2.9889080482814e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,39302,0.0648817793026533,0.00624015656142449,0.0526510724422614,0.0771124861630453,3.08467216513117e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,39266,0.0391299235107682,0.00376578473150863,0.0317489854370113,0.0465108615845252,3.3040013095933e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39680,0.077591652584467,0.00746867271829535,0.0629530540566081,0.0922302511123259,3.35533186867607e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37192,0.109303992873758,0.0105208018392637,0.088683221268801,0.129924764478715,3.46014537980908e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39673,0.0365508042863834,0.00352189784460369,0.0296478845109602,0.0434537240618067,3.75448136091295e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37241,-0.0716541503795201,0.00692731367837603,-0.0852316851891371,-0.058076615569903,5.55010336719378e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,37250,-0.0338495112434685,0.00327442437208578,-0.0402673830127566,-0.0274316394741804,5.91523371269822e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37220,0.0878368132989929,0.00850214729993911,0.0711726045911123,0.104501022006874,6.32407617141476e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39738,0.0451462060289533,0.00437172254760521,0.0365776298356471,0.0537147822222595,6.38793767404411e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36896,0.079214357576168,0.00766887593652735,0.0641833607405744,0.0942453544117616,6.47751131855296e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39302,0.0790000778080135,0.00765156151529083,0.0640030172380434,0.0939971383779835,6.56637935303555e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37215,0.02577455506024,0.00249606842264794,0.02088226095185,0.03066684916863,6.66514462787025e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39738,0.0420779552260505,0.00408344464304357,0.0340744037256851,0.0500815067264159,8.0485269248503e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39673,0.0429529532126749,0.00417033898853254,0.0347790887951511,0.0511268176301986,8.4719842711866e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39594,0.0297181135069116,0.00288710035055834,0.0240593968198173,0.035376830194006,9.0418346501635e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,36958,0.0456087755652042,0.00443889922333934,0.0369085330874591,0.0543090180429493,1.13563480945141e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39721,-0.0388350654516761,0.00379191286000845,-0.0462672146572927,-0.0314029162460596,1.53992964716615e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39564,0.0733875672445617,0.00718734138386255,0.0593003781321911,0.0874747563569323,2.1172795218851e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37203,0.0431965001748228,0.00423017154718352,0.0349053639423431,0.0514876364073025,2.16472791890013e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,39817,0.0567233901867938,0.00555825746870122,0.0458292055481394,0.0676175748254482,2.23194161487308e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,39817,0.0583390058971406,0.00572005467019943,0.0471276987435498,0.0695503130507315,2.3785411958628e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39302,0.0833962817362333,0.00820117735246471,0.0673219741254024,0.0994705893470641,3.25667588595187e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39721,0.0257225929152118,0.002538791350568,0.0207465618680985,0.030698623962325,4.72419326322003e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36896,0.0688298223602225,0.00680133470054427,0.0554992063471557,0.0821604383732892,5.52082524795052e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,37267,-0.0386103715806245,0.00381612660680335,-0.0460899797299591,-0.0311307634312899,5.62284944144364e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39673,0.0549481404326436,0.00543424617677888,0.044297017926157,0.0655992629391302,5.81257213894606e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36896,0.043236541204478,0.00428142198010774,0.0348449541234668,0.0516281282854891,6.85723942646926e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36832,0.0496496429556981,0.00491796780371284,0.0400104260604209,0.0592888598509753,7.08123196876526e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37220,0.0372990002451205,0.00370256846163396,0.0300419660603179,0.044556034429923,8.76962704065632e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,39721,0.0548436754130215,0.00544855245042544,0.0441645126101877,0.0655228382158554,9.22827425738416e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39738,-0.0290020436880808,0.00288220816902025,-0.0346511716993605,-0.0233529156768011,9.53872541889578e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39288,0.0648475984013697,0.00644584064209441,0.0522137507428647,0.0774814460598748,9.78560347269881e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,39817,0.0590775740538366,0.00587401329072646,0.0475645080040127,0.0705906401036604,1.0023609740062e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,39738,0.055412163719095,0.00550988430066402,0.0446127904897935,0.0662115369483965,1.00907041724019e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,39668,0.0347290699239297,0.00345864919798711,0.0279501174958749,0.0415080223519844,1.18229026173414e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39721,0.0332437727651353,0.00331100069595836,0.0267542114010569,0.0397333341292136,1.1914884074284e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36855,0.0651864757863397,0.00649338832044319,0.052459434678271,0.0779135168944083,1.25355979734376e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39557,0.0513910744875353,0.00512219057506853,0.041351580960401,0.0614305680146696,1.28550056460291e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39490,0.0349144411836495,0.0034862064576282,0.0280814765266982,0.0417474058406007,1.54172931247966e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,37268,-0.0260604323337365,0.00260488376267628,-0.031166004508582,-0.020954860158891,1.76107827078002e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,37005,0.124396992670134,0.0124338546620187,0.100026637532577,0.14876734780769,1.76332153769183e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,37215,0.100461091192062,0.0100420839249668,0.0807786066991275,0.120143575684997,1.77023981952157e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39738,0.0265038236949237,0.00265112035756257,0.0213076277941011,0.0317000195957463,1.83889800567821e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,39543,-0.0269806538425803,0.00270304428209631,-0.032278620635489,-0.0216826870496715,2.15518284797516e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNST,Consortin,39680,0.103431001745529,0.0103631675865904,0.0831191932758119,0.123742810215246,2.17265657657259e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39865,0.0725342510893944,0.00727054451508327,0.0582839838398312,0.0867845183389576,2.26143310301219e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37268,0.0682818727376029,0.00685040690323972,0.0548550752072531,0.0817086702679528,2.54760337711212e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,39616,0.0285731260918479,0.00286915236578485,0.0229495874549096,0.0341966647287862,2.70666797730679e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,37268,0.0422429938067503,0.00424321918143711,0.0339262842111336,0.0505597034023671,2.87631956808892e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,39288,0.0705285788156146,0.00708666736456215,0.0566387107810728,0.0844184468501564,2.89631126245592e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39721,-0.0286951070926641,0.00288498000418937,-0.0343496679008752,-0.0230405462844529,3.05896866485134e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,39594,0.0488995637195671,0.00491737128654027,0.0392615159979482,0.0585376114411861,3.12866978077095e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,37220,0.0362549156268001,0.00365074067260543,0.0290994639084935,0.0434103673451068,3.67709238060904e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39673,0.0988681224583042,0.00996348906541149,0.0793396838900976,0.118396561026511,3.86227271380418e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37268,0.0730843241021779,0.00737625039300594,0.0586268733318863,0.0875417748724695,4.60900572543325e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,39802,0.0356563745359925,0.00359996885810214,0.0286004355741123,0.0427123134978727,4.63291485299924e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36855,0.0408315058358382,0.0041216124140969,0.0327531455042083,0.0489098661674682,4.69947906297825e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,39651,0.0320275430044129,0.00324078728744294,0.0256755999210247,0.038379486087801,5.77216477019799e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39282,0.0558314151659003,0.00567113987770258,0.0447159810056032,0.0669468493261973,8.42381253089589e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37203,0.108609758258588,0.0110294858451403,0.0869919660021131,0.130227550515063,8.42739775983561e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,39865,0.0894217905378739,0.00909135954778395,0.0716027258242174,0.10724085525153,9.14855352696351e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37220,0.0658427953586982,0.00669914006577092,0.0527124808297872,0.0789731098876092,1.01300101138676e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39401,0.0664286885133231,0.00676268055942471,0.0531738346168507,0.0796835424097955,1.04545901031212e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39671,0.0474696621061694,0.0048335993244035,0.0379958074303385,0.0569435167820002,1.06420856574882e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,37042,0.0259540157589743,0.00264560903519262,0.0207686220499967,0.0311394094679518,1.21617418317186e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,39673,0.0863755768207489,0.00881695982799761,0.0690943355578736,0.103656818083624,1.35117155002429e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39401,0.0562661632267431,0.00574618431033163,0.0450036419784931,0.0675286844749931,1.41746548814833e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36880,0.0705113578341107,0.00720103021588892,0.0563973386109684,0.084625377057253,1.46019638870364e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36880,0.0687326649265551,0.00702109176368569,0.0549713250697311,0.082494004783379,1.49483204906303e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39790,0.0676897922248295,0.00694436731932198,0.0540788322789584,0.0813007521707006,2.18498398419714e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39783,0.0964637315917028,0.00989849800959296,0.0770626754929006,0.115864787690505,2.2315638798773e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,39706,-0.0335895645395896,0.0034547056715457,-0.0403607876558191,-0.02681834142336,2.78106799831611e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39594,0.0573578265208286,0.0059002514019305,0.0457933337730448,0.0689223192686124,2.82753098783476e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39816,0.0766793040577376,0.00790193381996112,0.0611915137706138,0.0921670943448614,3.34348582214569e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39668,0.0433322099800509,0.00446899550102777,0.0345729787980365,0.0520914411620653,3.60801673299037e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,39594,0.0956988814380375,0.00987091752874794,0.0763518830816915,0.115045879794383,3.65113875987792e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,39293,0.0650084581828052,0.00670856074036802,0.0518596791316839,0.0781572372339266,3.83121632703128e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39668,0.0223567033137576,0.00230732509433839,0.0178343461288544,0.0268790604986608,3.85268201976107e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,39692,0.0541702700235688,0.00559899973672023,0.0431962305395971,0.0651443095075404,4.43333185711956e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37215,0.0471193010841243,0.00487461418431613,0.0375650572828647,0.0566735448853839,4.95219963160822e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36877,0.0677482893766765,0.00702998539319854,0.0539695180060073,0.0815270607473456,6.59993095476974e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,39841,-0.0375543553582657,0.00390526551568453,-0.0452086757690074,-0.029900034947524,7.81643977558678e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37203,0.0448983207373851,0.00466781645795043,0.0357494004798022,0.0540472409949679,7.84783642166236e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39720,-0.0415310795645929,0.00432276780945132,-0.0500037044711174,-0.0330584546580683,8.52008582489867e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,39673,0.0790746552831262,0.00825064757807384,0.0629033860301014,0.0952459245361509,1.06875788709228e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39860,0.0359747109569679,0.00375572522333561,0.0286134895192301,0.0433359323947057,1.12425666968512e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,37285,-0.0208688310751473,0.00217902901838333,-0.0251397279511786,-0.016597934199116,1.1702136911897e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37215,0.0793215976393451,0.00829648552073802,0.0630604860186986,0.0955827092599916,1.36912261858552e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,37083,0.101586033184963,0.0106282801335613,0.0807546041231832,0.122417462246744,1.40835729241914e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39594,0.0256740500337353,0.0026876827818535,0.0204061917813025,0.0309419082861682,1.44875285638878e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,39401,-0.0213813609571297,0.00224618302980244,-0.0257838796955425,-0.0169788422187169,2.00064849430602e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,36601,0.021573698127863,0.00227011974571938,0.017124263426253,0.026023132829473,2.39224508874195e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,39673,0.0766928468251536,0.00807873866553663,0.0608585190407018,0.0925271746096054,2.55413816895484e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39865,0.0907422171921025,0.00955959516244994,0.0720054106737006,0.109479023710504,2.57227280768959e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39302,0.0561716075924144,0.00592603769084857,0.0445565737183512,0.0677866414664776,2.93891656786658e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,39784,0.0231906882549291,0.00244688130542091,0.0183948008963041,0.0279865756135541,2.95878958427152e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39860,-0.0259785324899992,0.00274632514706328,-0.0313613297782432,-0.0205957352017552,3.51869503873336e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39667,0.0710193101225146,0.00751148412223316,0.0562968012429376,0.0857418190020916,3.68223676850571e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39743,0.114320149642499,0.0121078344591923,0.0905887941024817,0.138051505182515,4.16090818115915e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39557,0.0401718610859778,0.00425906960293585,0.0318240846642235,0.0485196375077321,4.57138038288979e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,37268,0.0683789901848725,0.00724948273269039,0.0541700040287994,0.0825879763409457,4.66412236599953e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39302,0.045673371636477,0.00484396103404974,0.0361792080097395,0.0551675352632144,4.71962994539253e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39865,0.0328469304591168,0.00348384545470823,0.0260185933678887,0.0396752675503449,4.72383553288071e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,39288,0.0565019029745047,0.00599581054963381,0.0447501142972225,0.068253691651787,4.96642441518374e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39521,0.101162463073642,0.0107471360633695,0.0800980763894379,0.122226849757846,5.47988336217019e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39594,0.124363269753917,0.0132291957535026,0.0984340460770515,0.150292493430782,6.15239518552352e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,39680,-0.03340594001914,0.00355446604173018,-0.0403726934609311,-0.0264391865773488,6.28726490382924e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39675,0.0251917745406988,0.00268176547528731,0.0199355142091357,0.0304480348722619,6.56509666646144e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,39529,0.0465384915963594,0.00495542533225029,0.0368258579451488,0.0562511252475699,6.7174120118844e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39721,0.0853621887965714,0.00908961067465846,0.0675465518742408,0.103177825718902,6.72240334796223e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39673,-0.0348435663222143,0.00372163656926831,-0.0421379739979802,-0.0275491586464484,8.81898945184599e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39804,0.0270956337296541,0.00289858414290352,0.0214144088095632,0.032776858649745,1.01020434656041e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39557,0.0848318258964419,0.00907914156668668,0.067036708425736,0.102626943367148,1.05378368746492e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,37244,0.0948163888112109,0.0101788723866564,0.0748657989333643,0.114766978689058,1.40709355041093e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39865,0.032229170069261,0.00346406822220389,0.0254395963537414,0.0390187437847806,1.52613562501912e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39817,0.0302236052813773,0.00324849709460978,0.0238565509759421,0.0365906595868125,1.52634467743691e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39557,0.0516891535117884,0.00556368783795704,0.0407843253493926,0.0625939816741842,1.73392354168647e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39594,0.06815139636445,0.00737894988727532,0.0536886545853903,0.0826141381435096,2.88114004420203e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36855,0.0326747843090377,0.00353816679158076,0.0257399773975394,0.039609591220536,2.98010733659378e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,37285,0.0367955735176948,0.00399237213302616,0.0289705241369635,0.044620622898426,3.52105769768035e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37203,0.0646968952999312,0.00702223472851803,0.0509333152320358,0.0784604753678265,3.63404897913985e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,39521,0.0537229787390605,0.00584078479440189,0.0422750405420328,0.0651709169360882,4.1010758460031e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37205,0.0526407602994384,0.00573626205206981,0.0413976866773815,0.0638838339214952,5.08309466278807e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37267,-0.0192178660470359,0.00209533796268598,-0.0233247284539004,-0.0151110036401714,5.32526738790507e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37220,0.0959698914124784,0.0104697439128369,0.0754491933433182,0.116490589481639,5.59571946585497e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37215,-0.0258672765877848,0.00282206604312491,-0.0313985260323097,-0.02033602714326,5.61279794439481e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39401,0.085147477911475,0.00930320785154187,0.066913190522453,0.103381765300497,6.24283924394738e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37244,0.0567249929127397,0.006197292080085,0.0445783004357731,0.0688716853897064,6.31820291668413e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39860,0.0426233562802215,0.00465987686153851,0.0334899976316061,0.051756714928837,6.5516714123154e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,37215,0.08631077878211,0.00943690945128041,0.0678144362576004,0.10480712130662,6.74687906340123e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39668,0.0351120694024954,0.00384141494899163,0.0275828961024718,0.042641242702519,6.96391200492117e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,39529,0.0450854504936902,0.00493311591548217,0.0354165432993452,0.0547543576880353,7.03879458709683e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,39127,0.0804628658849041,0.00881213880530758,0.0631910738265012,0.0977346579433069,7.62882296061907e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,37183,0.0386820631685198,0.00423562876993272,0.0303802307794517,0.0469838955575879,7.64331857251721e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,36958,0.0608241238526367,0.00666229693273689,0.0477660218644724,0.073882225840801,7.87035020596799e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39720,0.0454714200612868,0.00499176288963785,0.0356875647975966,0.055255275324977,9.26340455116843e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39401,0.0365570015104453,0.00401472766186877,0.0286881352931825,0.044425867727708,9.59297976635558e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,39401,0.0416508240959904,0.00457675305113001,0.0326803881157756,0.0506212600762052,1.00615834702508e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,39781,0.0468889294273283,0.00515717400115996,0.0367808683850548,0.0569969904696018,1.08504938832238e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,39673,-0.0296237343549041,0.0032631982043357,-0.0360196028354021,-0.0232278658744062,1.23250371326346e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39743,0.0904130988264276,0.00997698018200084,0.0708582176697059,0.109967979983149,1.42514514847305e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39668,-0.0248390694629159,0.00274257202830915,-0.0302145106384019,-0.01946362828743,1.49674392173716e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,39594,0.0824133154201378,0.00912106303616147,0.0645360318692613,0.100290598971014,1.81902476021434e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,39604,0.0376595839145911,0.00417280153093921,0.0294808929139503,0.045838274915232,2.00077056990113e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37268,0.0557213121013954,0.00617936010826482,0.0436097662891963,0.0678328579135945,2.18568549074947e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39594,0.0473969917103169,0.00526402051627833,0.0370795114984114,0.0577144719222225,2.42233949157406e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39721,-0.0205766043086897,0.00228657920189819,-0.0250582995444101,-0.0160949090729692,2.53463133971622e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39680,0.0548452170341084,0.00609523312582081,0.0428985601074996,0.0667918739607172,2.55396201806952e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,37203,0.0185824523334153,0.0020654539839562,0.0145341625248611,0.0226307421419694,2.63433330519031e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39302,0.0488330561871272,0.0054308589634806,0.0381885726187052,0.0594775397555492,2.71032657677853e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39817,0.0559593337462155,0.0062280694167857,0.0437523176893155,0.0681663498031154,2.87116184514501e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,39680,0.105659833756173,0.0117802382289511,0.0825705668274292,0.128749100684918,3.31426339527867e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,37203,0.0718056794316282,0.00800688968857232,0.0561121756420265,0.08749918322123,3.41745409699179e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37215,0.0725237692375381,0.00808952228163392,0.0566683055655356,0.0883792329095406,3.50568984451977e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39668,0.0443251493810039,0.00495284611826932,0.034617570989196,0.0540327277728118,3.96334682380327e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39288,0.0436149531147752,0.00488076941944695,0.0340486450526591,0.0531812611768912,4.48096647127561e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,39592,0.0612814204257668,0.00685841059230408,0.0478389356648508,0.0747239051866828,4.50659406685553e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,39673,0.0659016489923299,0.00737649688097246,0.0514437151056239,0.080359582879036,4.55386798643351e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39557,0.0604693258878238,0.00677819916276678,0.0471840555288009,0.0737545962468467,5.11568601467682e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39510,0.0236448970305225,0.00265280443455549,0.0184454003387937,0.0288443937222512,5.49742899138585e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37220,0.0662757043063064,0.00743938759301667,0.0516945046239937,0.0808569039886191,5.82075023981743e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37268,0.0704900717021123,0.00792066701966864,0.0549655643435617,0.0860145790606628,6.32083548779126e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,39743,0.0413892539091061,0.00465601880448886,0.0322634570523079,0.0505150507659043,6.79253565851553e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37215,0.0254175218843625,0.00285998061512327,0.0198119598787209,0.0310230838900041,7.05384429547731e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36972,0.05583132911616,0.006295307264284,0.0434925268781633,0.0681701313541566,8.34619844569369e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39817,0.0491490602516362,0.00554445626325185,0.0382819259756626,0.0600161945276099,8.48029287661787e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,39679,-0.0231823621458926,0.00261753741568176,-0.0283127354806288,-0.0180519888111563,9.11478660619117e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,37215,0.0608104363781832,0.00687590797245893,0.0473336567521637,0.0742872160042027,1.03824785641702e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37244,0.0473419775132424,0.00535824318974967,0.036839820861333,0.0578441341651518,1.12085329145647e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36958,0.0664509382244179,0.00753231611638297,0.0516875986363073,0.0812142778125285,1.264015895452e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,39738,0.0853921273523654,0.00969828557257151,0.0663834876301253,0.104400767074606,1.44313943139907e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39581,0.039265958461851,0.00446155940517228,0.0305213020277133,0.0480106148959886,1.49562618382805e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39743,0.089683022364539,0.0101903871744401,0.0697098635026364,0.109656181226442,1.49682391425065e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,39607,0.0711705756191835,0.0080917053968566,0.0553108330413446,0.0870303181970225,1.56943716875788e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,39705,0.0223994667282114,0.00255105861442098,0.0173993918439463,0.0273995416124765,1.79193059230982e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39817,0.0226402372400792,0.0025814256159557,0.017580643032806,0.0276998314473524,1.9566586252604e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,39836,0.0337295951704396,0.00384721435680248,0.0261890550311067,0.0412701353097724,2.01188481673366e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,39594,-0.0370987460704785,0.00423585131615172,-0.0454010146501359,-0.0287964774908211,2.18153876111458e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39721,0.0214073801900931,0.00244829132821115,0.0166087291867993,0.026206031193387,2.47660385092499e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37267,-0.0217905127497071,0.00249280718423958,-0.0266764148308167,-0.0169046106685976,2.57444288008423e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,39715,0.0216203197202211,0.00247668284160781,0.0167660213506698,0.0264746180897725,2.80799428016748e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39697,0.0244887426990665,0.002811412816874,0.0189783735779935,0.0299991118201395,3.32081100331855e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,36888,0.0218355083972992,0.00250647597662116,0.0169228154831217,0.0267482013114767,3.35344781476441e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37268,0.0608637412580329,0.00698879632057093,0.0471657004697139,0.0745617820463519,3.42823826989759e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36877,0.0578946577693626,0.00665353446580368,0.0448537302163874,0.0709355853223378,3.67065819233008e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,37220,0.0636081821597375,0.00731819843790368,0.0492645132214463,0.0779518510980287,3.9796948885807e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,39715,-0.0221990792272271,0.00255573408126308,-0.0272083180265027,-0.0171898404279514,4.11570566926703e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,39594,0.0452168508961033,0.00520648387137092,0.0350121425082163,0.0554215592839903,4.16466238090201e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39673,-0.0437135282457384,0.00503750663772663,-0.0535870412556826,-0.0338400152357942,4.42989373559013e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39669,0.035559148045258,0.00410053758607828,0.0275220943765445,0.0435962017139714,4.65993392445186e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,39288,0.0819449367462628,0.00945253915026238,0.0634179600117485,0.100471913480777,4.78336394173746e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,39673,0.0550264931996521,0.00634925905367406,0.042581945454451,0.0674710409448533,4.87756823718411e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,39721,-0.0223949463874922,0.00258429996030234,-0.0274601743096848,-0.0173297184652996,4.91179238320264e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,39832,0.0571177010027127,0.00660100060194413,0.0441797398229022,0.0700556621825232,5.49311248313524e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,39557,0.0514887678730915,0.00595287869064124,0.0398211256394347,0.0631564101067484,5.67205917394696e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,39557,-0.0210515744616961,0.00243559421369139,-0.0258253391205312,-0.016277809802861,5.98124777600201e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37244,0.0780215415716294,0.00904451555781125,0.0602942910783194,0.0957487920649395,7.03842957488827e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36931,0.0235903215768067,0.00273459957023337,0.0182305064191493,0.0289501367344641,7.04295123781752e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37244,0.0668856631639063,0.00776616164643973,0.0516639863368845,0.0821073399909282,7.94453001364608e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37220,0.0254735076671515,0.0029577967331542,0.0196762260701693,0.0312707892641337,7.95448761820876e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39860,0.0332270504715497,0.00385917948636206,0.02566305867828,0.0407910422648193,7.98604733986378e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39430,0.0241901731929477,0.00281033059736316,0.0186819252221159,0.0296984211637795,8.16573238271736e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39680,0.0231980471258594,0.00269671634323128,0.0179124830931261,0.0284836111585927,8.53484991667562e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36896,0.0428158099560779,0.00497898445266295,0.0330570004288585,0.0525746194832973,8.92825065646683e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37220,0.0519952244743376,0.00604911487806654,0.0401389593133272,0.063851489635348,9.20286496927424e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39697,0.0386348789460507,0.00450193635926271,0.0298110836818958,0.0474586742102056,1.01925504739442e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,39860,-0.0250890922196867,0.00292853545757658,-0.0308290217165368,-0.0193491627228366,1.15663661381908e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39738,0.0341423509378581,0.00398556453095595,0.0263306444571844,0.0419540574185317,1.16350914645955e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39650,0.0682966739826657,0.00797753473696128,0.0526607058982216,0.0839326420671098,1.21941851229574e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,39521,0.065534365285905,0.00765600903616746,0.0505285875750167,0.0805401429967932,1.23369467763275e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37244,0.0640062560872251,0.00748528829561064,0.0493350910278283,0.078677421146622,1.35228048547183e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36880,0.0512410203494646,0.0059952602638662,0.0394903102322868,0.0629917304666423,1.40390884211697e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39673,0.0579857085513313,0.00681616041237949,0.0446260341430675,0.0713453829595951,1.94136745686644e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39716,0.0582166512555422,0.00685487456732801,0.0447810971035793,0.0716522054075051,2.19518004773167e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39809,0.0267621974319649,0.00315221843068157,0.0205838493078291,0.0329405455561008,2.24701398572994e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,37166,0.0283885989073068,0.00334652160183467,0.0218294165677109,0.0349477812469028,2.42415931189717e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39302,0.0548972646309601,0.00647399413962321,0.0422082361172986,0.0675862931446216,2.46076934560773e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36863,0.0654601794969013,0.00771802723018553,0.0503328461257377,0.080587512868065,2.46221982939878e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,36896,0.0373901392648759,0.00440975513723038,0.0287470191959043,0.0460332593338474,2.51485996962431e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37244,0.0625666435993148,0.00740156998454483,0.0480595664296069,0.0770737207690227,3.1261966488467e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,39865,0.030908645987961,0.00365959917600108,0.0237358316029989,0.0380814603729232,3.2728835932851e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36880,0.0628156263327198,0.00744027696370317,0.0482326834838616,0.077398569181578,3.4283008666764e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37244,0.0591959378040781,0.00701195201305861,0.0454525118584832,0.0729393637496729,3.43355741947623e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39743,0.0692350813488318,0.00820755470730561,0.0531482741225128,0.0853218885751508,3.57764445653529e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,37021,0.0202959074376316,0.00240658836403867,0.0155789942441158,0.0250128206311473,3.70248916687056e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37215,0.0880958219739672,0.0104469232973157,0.0676198523112285,0.108571791636706,3.72156692424936e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37285,0.0199215511606592,0.00236305508778175,0.015289963188607,0.0245531391327114,3.7926020822103e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36880,0.0839810053432332,0.00996350884249675,0.0644525280119396,0.103509482674527,3.8548255922032e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39637,0.0522940093451128,0.00621262452398185,0.0401172652781084,0.0644707534121172,4.17710478205274e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36958,0.01826570759039,0.00217216501942914,0.0140082641523088,0.0225231510284711,4.56042934899047e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39680,0.0585484455108882,0.00698183891565981,0.044864041236195,0.0722328497855814,5.45753048773018e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37215,0.062082752191954,0.00740792054790995,0.0475632279180505,0.0766022764658575,5.788914899913e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39673,0.0441170096475607,0.00526852882950218,0.0337906931417364,0.054443326153385,6.04759592805918e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,39594,0.0262468262136909,0.00314292654846261,0.0200866901787042,0.0324069622486776,7.32212846426185e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37005,0.0433742268140614,0.0051966673346512,0.033188758838145,0.0535596947899777,7.72618843245749e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37220,-0.052871270184061,0.00633649578410349,-0.0652908019209039,-0.0404517384472182,7.88636640416394e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,39302,0.0277377159244587,0.00333004033928265,0.0212108368594647,0.0342645949894527,8.79074033678259e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36896,0.0257427954353322,0.0030899924339279,0.0196864102648335,0.0317991806058309,8.81077122117367e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39673,-0.0205549188179691,0.00247102689600112,-0.0253981315341313,-0.0157117061018069,9.63808030063878e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,37220,0.0491611030730414,0.00591108458223009,0.0375753772918705,0.0607468288542124,9.90861409276739e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,37208,0.0605568409105707,0.00729605373465167,0.0462565755906535,0.074857106230488,1.14098876499452e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,39865,0.0397629879031863,0.0047942088398774,0.0303663385770266,0.049159637229346,1.18166830104176e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39557,0.0457631784079796,0.00551833939317916,0.0349472331973484,0.0565791236186108,1.19374168098547e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39401,0.0474540928136961,0.00572265843460952,0.0362376822818615,0.0586705033455308,1.20077808872838e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39288,0.0436267132275186,0.00526192012472899,0.0333133497830498,0.0539400766719874,1.21451571907303e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,36995,0.018036622118382,0.00218211779021512,0.0137596712495604,0.0223135729872037,1.52188807215897e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39673,0.0491754694157552,0.00595649125004647,0.0375007465656641,0.0608501922658462,1.62730105951439e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,39521,0.0508875719141442,0.00618164202785452,0.0387715535395493,0.0630035902887391,1.98421761577742e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,39865,0.0390921078168551,0.00476153420924471,0.0297595007667354,0.0484247148669747,2.37941396436908e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36958,0.0463477352282179,0.00564475997157281,0.0352840056839352,0.0574114647725006,2.4026408280699e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,39302,0.0564433984291165,0.00688414115081763,0.0429504817735139,0.069936315084719,2.61199395189997e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,39557,0.0511006796513108,0.006232976986382,0.0388840447580021,0.0633173145446195,2.62199914790325e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37215,0.0810045979853026,0.00988721430565508,0.0616256579462186,0.100383538024387,2.78144137426203e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,39594,0.0434892062679721,0.00531263769883768,0.0330764363782502,0.053901976157694,2.90598580262256e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37244,0.0614318536280114,0.00750401182612044,0.0467239904488153,0.0761397168072075,2.93029325388488e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,36880,0.0372560987026181,0.00455234283735192,0.0283335067414084,0.0461786906638279,3.00098774998931e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,36958,-0.0397492752624324,0.00485756970096699,-0.0492701118763278,-0.0302284386485371,3.02390120191397e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,37244,0.0526801654201645,0.00644898002790611,0.0400401645654685,0.0653201662748605,3.39343833745334e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37285,-0.0200143653921339,0.00245180859991508,-0.0248199102479675,-0.0152088205363004,3.55450801403901e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39668,0.0235213098100775,0.00288616291742966,0.0178644304919153,0.0291781891282396,3.91986105687288e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39743,0.032045269438699,0.00393309384193188,0.0243364055085125,0.0397541333688854,3.98633748311063e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,37203,0.0311075016587471,0.00382674662780692,0.0236070782682455,0.0386079250492486,4.70898887053069e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,39693,0.0834031232801654,0.0102740735696826,0.0632659390835875,0.103540307476743,5.09254697193974e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39288,0.0456704973024958,0.00564122738312326,0.0346136916315742,0.0567273029734174,6.10848381199686e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,39220,0.0660961345578801,0.00818046963994937,0.0500624140635793,0.0821298550521809,6.96953015098608e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,39860,-0.0223094644425246,0.00276158064434964,-0.0277221625054499,-0.0168967663795993,7.02020867106285e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,39668,0.0695194146033553,0.00860581320423088,0.0526520207230628,0.0863868084836478,7.044429456486e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,36880,0.0582120619167933,0.00720939943501336,0.0440816390241671,0.0723424848094195,7.36976964485548e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,39523,0.0563079751325806,0.00698079908448264,0.0426256089269946,0.0699903413381666,7.77843417435736e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39288,0.0427311090202376,0.00529817510149686,0.0323466858213037,0.0531155322191714,7.84214440006081e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,39743,0.0251811489692186,0.00312255328206982,0.0190609445363618,0.0313013534020755,7.88842897960075e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39401,0.0728446193092415,0.00904120171290534,0.055123863951947,0.090565374666536,8.38572599308216e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,37268,0.0355215205041222,0.00440980101606784,0.0268783105126293,0.0441647304956152,8.60623269591266e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,39836,0.028941417125198,0.00359658812741686,0.021892104395461,0.0359907298549351,9.08356592112093e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37215,0.0368715515891578,0.0045813951870526,0.0278920170225347,0.0458510861557809,9.11512108868125e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37215,0.0312046425197302,0.00387798494036616,0.0236037920366125,0.0388054930028479,9.22640474000775e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39288,0.0713252946435912,0.00888351237018761,0.0539136103980235,0.088736978889159,1.05355013320866e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39860,0.0165248611366111,0.00206341466313912,0.0124805683968585,0.0205691538763638,1.24046692968258e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36880,0.041432930600753,0.00517279341344188,0.0312942555104069,0.0515716056910991,1.24637354557035e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,39597,0.0674688731970216,0.00843669949101684,0.0509329421946286,0.0840048041994146,1.36218955764859e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39721,0.0473062562917637,0.00591552783933126,0.0357118217266745,0.058900690856853,1.3626561690529e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,39668,0.0409483517428129,0.00512203320192249,0.0309091666670448,0.050987536818581,1.38980316118112e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39865,0.0521120925110218,0.00651926959626187,0.0393343241023486,0.0648898609196951,1.3999692725934e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39720,0.0587712364920003,0.00735309340210774,0.0443591734238691,0.0731832995601315,1.41017816600981e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39865,0.0430377719558234,0.00538492589754433,0.0324833171966365,0.0535922267150102,1.4145216963154e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,39585,0.0298304450747424,0.00374292785863211,0.0224943064718235,0.0371665836776614,1.69748335404289e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39288,0.0488142717154258,0.00612510463773501,0.0368090666254652,0.0608194768053864,1.70340250168995e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36999,0.0336056780851013,0.00422306337139473,0.0253284738771676,0.041882882293035,1.89638608817792e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,36984,-0.0235958656142668,0.00296984824544533,-0.0294167681753397,-0.017774963053194,2.09713685469033e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",37285,0.0124697480904718,0.00157108992049859,0.00939041184629452,0.015549084334649,2.23476019955291e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37244,0.0504715114966695,0.00636022353035234,0.0380054733771789,0.0629375496161601,2.26254047215228e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39782,0.0518510730384481,0.00654693321310266,0.0390190839407669,0.0646830621361293,2.53296920658126e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37267,0.0177342905493181,0.00224187336772705,0.0133402187485731,0.0221283623500631,2.76399655316407e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39809,0.0455535307368236,0.00576172364978271,0.0342605523832495,0.0568465090903977,2.82553555566146e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,39817,-0.0218553814534502,0.00276764050473712,-0.027279956842735,-0.0164308060641655,3.04779529229819e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,37204,0.0646771567141885,0.00818910697201007,0.0486265070490488,0.0807278063793283,3.0560613874456e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39401,0.0283260602985358,0.00358767053941966,0.0212942260412732,0.0353578945557983,3.08637334553022e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39673,0.0767484185798337,0.00974626366577312,0.0576457417949184,0.095851095364749,3.63762679878114e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36880,0.0585606368223766,0.00745039088820836,0.0439578706814882,0.073163402963265,4.13969645665364e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36880,0.0223208119654397,0.00284334342634406,0.0167478588498054,0.0278937650810741,4.47744598621513e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,36958,0.0383999156430567,0.00489790128106266,0.0288000291321739,0.0479998021539396,4.84963105548493e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39860,0.0540380639117363,0.00689843224798832,0.0405171367056792,0.0675589911177934,5.04574593877512e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,37245,0.0338059127748266,0.00431677059520276,0.0253450424082292,0.042266783141424,5.19069937897795e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37220,0.0684785920753182,0.00875292063882599,0.0513228676232192,0.0856343165274171,5.52128448630481e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,37220,0.0284793810769058,0.00364934204894489,0.0213266706609738,0.0356320914928378,6.44292364529282e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39557,0.0588739292165012,0.00754717853804173,0.0440814592819395,0.073666399151063,6.53754815141224e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,39302,0.0456834329791115,0.00586484481541323,0.0341883371409016,0.0571785288173214,7.16092547197657e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37244,0.0802736004294799,0.0103069599593815,0.0600719589090922,0.100475241949868,7.29023077558548e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39721,0.0414953744885115,0.00533236041419883,0.0310439480766818,0.0519468009003412,7.5885236499563e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36877,0.0601728649894067,0.00774595745942685,0.0449907883689301,0.0753549416098833,8.54917721830203e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,39860,-0.0119470704430446,0.00154216856412799,-0.0149697208287355,-0.00892442005735375,9.97627667272722e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39848,0.0389949667284818,0.00503879812157446,0.0291189224101959,0.0488710110467678,1.06212938933698e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,39557,0.0721368957716459,0.00933430278326254,0.0538416623164513,0.0904321292268405,1.15700258791325e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,37215,0.0502958587049257,0.00653609700465503,0.0374851085758019,0.0631066088340496,1.51288619445403e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39743,0.0280063331436301,0.00364305906197684,0.0208659373821555,0.0351467289051047,1.58680218345147e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39401,0.054115232511883,0.00704281129496126,0.0403113223737589,0.067919142650007,1.63687637750523e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36855,0.0498797203816187,0.00649422262890869,0.0371510440289577,0.0626083967342797,1.696164915633e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37244,0.046268379927559,0.00602614233502143,0.034457140950917,0.058079618904201,1.7284881961932e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39662,0.0417935290705424,0.00544451423882672,0.031122281162442,0.0524647769786428,1.73340975529158e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,39401,0.0381037055927654,0.00496468945684096,0.0283729142573572,0.0478344969281737,1.75297064910608e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39557,0.0286751635083784,0.00373693748946641,0.0213507660290243,0.0359995609877326,1.77255346305072e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,36896,0.0683786744667542,0.00893481674886676,0.0508664336389753,0.085890915294533,2.1002527424765e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36896,0.0719793769984842,0.00942338075993903,0.0535095507090037,0.0904492032879647,2.35283947905902e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,39836,0.0818290708620326,0.0107180482483701,0.0608216962952272,0.102836445428838,2.39109660658457e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36682,0.0241941709150925,0.00316837935738386,0.0179841473746201,0.0304041944555649,2.39673983446029e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39594,0.0619313691945046,0.00814225776408641,0.0459725439768953,0.077890194412114,2.98271371307538e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,37267,0.0294100478259243,0.00386657616665659,0.0218315585392773,0.0369885371125712,3.00982502455552e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36896,0.0668259484699265,0.00879466919716477,0.0495883968434836,0.0840635000963695,3.20098306677561e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REN,Renin,39680,0.0480518826898894,0.00633472421205086,0.0356358232342697,0.0604679421455091,3.4965373465706e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,37217,0.0705464906463126,0.00930175278857472,0.0523150551807061,0.0887779261119191,3.5657265963716e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39288,0.0715705008429898,0.00944468125198063,0.0530589255891078,0.0900820760968719,3.71209168451574e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,39288,0.02964457329429,0.00391245612331524,0.0219761592925921,0.0373129872959878,3.73754895562243e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39653,0.0709118058144071,0.00936471061083604,0.0525569730171685,0.0892666386116458,3.87097068028724e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,37220,0.0789358385732856,0.0104306873858886,0.0584916912969439,0.0993799858496274,4.04864522566413e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39673,0.0360005858167902,0.00476040763506703,0.0266701868520588,0.0453309847815215,4.1707206573124e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39557,0.0362321080712832,0.00479717924609142,0.026829636748944,0.0456345793936224,4.49430802133555e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37268,0.0786367566680434,0.0104134022938815,0.0582264881720356,0.0990470251640512,4.5807169960704e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39288,0.0429171236564986,0.00568540976193336,0.0317737205231092,0.054060526789888,4.64368769412238e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36877,0.035934203643324,0.00476353381519715,0.0265976773655376,0.0452707299211104,4.87465997920111e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,39557,-0.0239941324275782,0.00318695170163744,-0.0302405577627876,-0.0177477070923689,5.39600150228522e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,39609,0.0328254810951023,0.00436481787909903,0.0242704380520682,0.0413805241381365,5.75179600206239e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36827,0.0476169181361757,0.00633307290191602,0.0352040952484203,0.0600297410239311,5.8924622212394e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37268,0.0736328006187024,0.00979558745910654,0.0544334491988536,0.0928321520385512,5.96288877952018e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37240,-0.0104636239365906,0.00139299759273283,-0.013193899218347,-0.00773334865483427,6.21138505920965e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,39259,-0.085812119462706,0.0114399562464142,-0.108234433705678,-0.0633898052197342,6.67406024460453e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36711,0.0388581510191873,0.00518718897183843,0.0286912606343839,0.0490250414039906,7.27153049185345e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37267,-0.023680042852206,0.00316229293885407,-0.02987813701236,-0.017481948692052,7.41535105093343e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,39621,0.074434159033912,0.00994190900803765,0.0549480173781582,0.0939203006896658,7.4240369661235e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37203,0.0385644933623391,0.00515209708794437,0.0284663830699682,0.0486626036547101,7.59094341958301e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,39673,0.0330033531051577,0.00441241732048658,0.024355015157004,0.0416516910533114,7.84270687118277e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,37277,-0.0343370370865102,0.00459013481424,-0.0433337013224206,-0.0253403728505998,7.85690560257306e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36958,0.0200108012922737,0.00267524560813507,0.014767319900329,0.0252542826842184,7.90604104916424e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,39640,0.0477668401539285,0.00639039835504532,0.0352416593780397,0.0602920209298174,8.13852775273428e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36855,0.0451745599142496,0.00604288180434061,0.033330511577742,0.0570186082507572,8.17310583792677e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,39266,0.0323554588665132,0.00433265861657033,0.0238634479780353,0.040847469754991,8.59066316665333e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39673,0.0434145570322382,0.00581668914674438,0.0320138463046192,0.0548152677598572,8.84389300038733e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,39720,0.0625692070508451,0.00838473303010033,0.0461351303118484,0.0790032837898417,8.94444508112874e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39617,0.0815939931412711,0.0109360151236669,0.060159403498884,0.103028582783658,9.03189358057758e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,36880,0.0499924445102336,0.00670848781317416,0.0368438083964123,0.063141080624055,9.7646498545865e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,36877,0.0584472963537341,0.00784893379400273,0.0430633861174888,0.0738312065899795,1.01856569888708e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37244,0.048790649377657,0.0065611444489674,0.0359308062576809,0.0616504924976331,1.09836940367902e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,39594,0.0938473043170721,0.012627173206742,0.0690980448318579,0.118596563802286,1.12319083375783e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39673,0.0535670044792012,0.00721503053332454,0.0394255446338851,0.0677084643245173,1.19092713335979e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37098,0.0213200247930613,0.00287252353301174,0.0156898786683583,0.0269501709177643,1.22351827942495e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39288,0.0401086286689647,0.00540612785943819,0.0295126180644659,0.0507046392734636,1.24052663125852e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39673,0.0746205400622378,0.0100661048193503,0.0548909746163112,0.0943501055081644,1.29671600467781e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39303,0.0268246559113505,0.00362122406762407,0.0197270567388074,0.0339222550838937,1.35230239073857e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37220,0.0223470528483126,0.0030165280790881,0.0164346578132999,0.0282594478833253,1.35699671045079e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37277,-0.0182380081405704,0.00246951015478995,-0.0230782480439587,-0.0133977682371821,1.6111135741196e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39401,0.0538638660540856,0.00729760805300204,0.0395605542702016,0.0681671778379696,1.65018308913457e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39288,0.0554897032911401,0.00751790721626696,0.0407546051472569,0.0702248014350234,1.6511032645406e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39288,0.0317006010038835,0.00430021813867869,0.0232721734520733,0.0401290285556937,1.76801784647749e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39721,-0.0289071603283869,0.00392325017219038,-0.0365967306658801,-0.0212175899908937,1.81505051624967e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39649,0.0462886352072776,0.00628675939374586,0.0339665867955357,0.0586106836190195,1.88862790895884e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39594,0.0318436659768573,0.00432588914781204,0.0233649232471457,0.0403224087065689,1.91297543873926e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39817,0.0333809967662085,0.00453622886910008,0.0244899881827724,0.0422720053496447,1.94667307230475e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,36958,0.0206658616714806,0.00280899345976419,0.0151602344903428,0.0261714888526184,1.99231632913805e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,37137,0.0667305517530436,0.0090789035483547,0.0489359007982684,0.0845252027078188,2.09689545039521e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39474,0.0254845503324418,0.00346809279218405,0.018687088459761,0.0322820122051225,2.10691478677019e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36896,0.0388486203179235,0.00529281504595596,0.0284747028278498,0.0492225378079972,2.26452751255886e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39288,0.0601047363186926,0.00819133189561286,0.0440497258032914,0.0761597468340938,2.28281443344383e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39817,0.0449817041210056,0.00613393080684652,0.0329591997395864,0.0570042085024248,2.35401903020518e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,39721,0.0496638553456869,0.00677569597462915,0.0363834912354138,0.0629442194559601,2.41775611750787e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39668,-0.0198426737400314,0.00270872343322088,-0.0251517716691444,-0.0145335758109185,2.49547655951957e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,39619,0.0284474345899343,0.00389010397631613,0.0208228307963547,0.0360720383835139,2.74269167836196e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,37220,0.0969343431862093,0.0132540179605754,0.0709564679834814,0.122912218388937,2.7492441537462e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,36880,0.0360944211312119,0.00493705688346131,0.0264177896396278,0.0457710526227961,2.80811036601335e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,36958,-0.0157241466512358,0.00215082144314219,-0.0199397566797945,-0.0115085366226771,2.81039653086343e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36880,0.042271131482942,0.00578813680265164,0.0309263833497448,0.0536158796161392,2.97637851145772e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,39820,-0.0315367644375732,0.00432061253696503,-0.0400051650100246,-0.0230683638651217,3.03246717879407e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,37215,0.0478613385815118,0.00656531431228181,0.0349933225294395,0.0607293546335842,3.27308888632748e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,37220,0.0389248172319732,0.00534115888881746,0.028456145809891,0.0493934886540554,3.32963618267018e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,39860,-0.0163858556472894,0.00225014610395846,-0.0207961420110479,-0.0119755692835308,3.43881585460075e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,39673,0.043743708253227,0.00600709232052318,0.0319698073050016,0.0555176092014524,3.44369725555892e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,39860,0.039041101847214,0.00536489466535883,0.0285259083031107,0.0495562953913173,3.56788364666635e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39865,0.0299413822356948,0.00412255819574037,0.0218611681720437,0.038021596299346,3.96561982639058e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,36958,0.040470189968378,0.00557211560871417,0.0295488433752983,0.0513915365614578,4.00034903269166e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39675,0.0651931015507527,0.00898134622131727,0.0475896629569708,0.0827965401445345,4.08927149536387e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37244,0.0840145588713504,0.0115756789377665,0.061326228153328,0.106702889589373,4.14960072822244e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39673,0.0789081910865971,0.0108775414697373,0.0575882098059119,0.100228172367282,4.22685674114336e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,37253,0.0325680679819969,0.00448931071872828,0.0237690189732895,0.0413671169907043,4.25055033210608e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39668,-0.0298447445357315,0.00411548481742592,-0.0379110947778863,-0.0217783942935767,4.30266922534641e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,39557,-0.0291690344994758,0.00402555607661605,-0.0370591244096433,-0.0212789445893084,4.4934506014811e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39401,0.0334951919368037,0.00462389627936462,0.0244323552292491,0.0425580286443584,4.56316108279494e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36896,0.0550515739031899,0.00760542418621767,0.0401449424982033,0.0699582053081766,4.79218064397697e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37244,0.0590752682944899,0.00817183837346823,0.0430584650824921,0.0750920715064876,5.12467541212791e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36880,0.0219253244643691,0.00303701952115803,0.0159727662028993,0.0278778827258388,5.51326519872789e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39680,-0.0537746457721681,0.00747384854973212,-0.0684233889296431,-0.0391259026146932,6.52429507926524e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39673,0.0506348324638525,0.00703922192086812,0.036837957498951,0.064431707428754,6.61067577083948e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36958,0.0473851723132364,0.00658929494200702,0.0344701542269027,0.0603001903995702,6.76931855549474e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39557,0.0561305151108034,0.00781057275891535,0.0408217925033293,0.0714392377182775,6.94753353035463e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36958,0.0481005416206135,0.00671205111751526,0.0349449214302836,0.0612561618109434,8.11792953446332e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37244,-0.0177727677620079,0.00248118503722089,-0.0226358904349608,-0.0129096450890549,8.30461122057884e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39680,0.0556005978419428,0.00776366915032254,0.0403838063073106,0.0708173893765749,8.32277188427402e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39673,-0.0239020495367739,0.00333808282840423,-0.0304446918804462,-0.0173594071931016,8.39752134332183e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,39594,0.0618092795612412,0.00863342750914316,0.0448877616433207,0.0787307974791618,8.46766960977206e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,36896,0.0289524905862114,0.00404528079971186,0.0210237402187762,0.0368812409536467,8.68096295887388e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37244,0.0417152164552709,0.00583458855998025,0.0302794228777096,0.0531510100328322,9.15181732476729e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,39743,0.0637692459645086,0.00893038495756728,0.0462656914476767,0.0812728004813405,9.68773906268741e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,39050,-0.0210921693623153,0.00295941803733836,-0.0268926287154985,-0.0152917100091321,1.07092856689058e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39790,0.0406013156795114,0.00569820602797355,0.0294328318646833,0.0517697994943396,1.08318248249535e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39817,0.0469723396196177,0.00659345447244367,0.0340491688536281,0.0598955103856073,1.09250495022856e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37005,0.0464367748590587,0.00651798857288166,0.0336615172562107,0.0592120324619068,1.09978579678883e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,37244,-0.0308582833349851,0.00433265100134248,-0.0393502792976163,-0.0223662873723538,1.11591783982082e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39594,0.0617070817685377,0.0086660945197291,0.0447215365098687,0.0786926270272067,1.12173928793511e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,37215,0.0409595966898132,0.00575296010600099,0.0296837948820513,0.0522353984975751,1.13656282538411e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,36877,0.0909572728431395,0.0127814947932404,0.0659055430483883,0.116009002637891,1.1664839170592e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,39836,-0.0113017459833761,0.00159037891836006,-0.0144188886633618,-0.00818460330339035,1.24211398478015e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39288,0.0308810331501765,0.00434859090971827,0.0223577949671287,0.0394042713332243,1.28902710571789e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,37203,0.0439454212723748,0.006194671883666,0.0318038643803894,0.0560869781643601,1.36793899694894e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36924,0.026483637558087,0.00373511089060465,0.0191628202125019,0.0338044549036722,1.40545636765391e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,39594,-0.0192923468976702,0.00272547746907758,-0.0246342827370623,-0.0139504110582782,1.51858015062634e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,36958,0.0793258520280613,0.0112195507484988,0.0573355325610036,0.101316171495119,1.62411157104662e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,39401,0.0545201480609043,0.00771734944843518,0.0393941431419713,0.0696461529798372,1.6789183473812e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37244,0.0325834047670458,0.00461777782281215,0.023532560234334,0.0416342492997576,1.79693041952028e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39675,0.0349394413955462,0.00495888199995325,0.0252200326756378,0.0446588501154545,1.91965159712569e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36922,0.0589112937022804,0.00836222720526002,0.0425213283799708,0.0753012590245901,1.94856973333763e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,39288,0.0660801355795688,0.00938194691220746,0.0476915196316422,0.0844687515274954,1.95631704270859e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39401,-0.014506292380977,0.0020602114286219,-0.0185443067810759,-0.010468277980878,1.98622087934787e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36880,0.0662229862612243,0.00941130137878972,0.0477768355587965,0.0846691369636522,2.06936839917695e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37203,0.0569799077840796,0.00810054757119599,0.0411028345445355,0.0728569810236238,2.10354921650557e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39476,-0.0257170795135415,0.00365990553073445,-0.0328904943537811,-0.018543664673302,2.20209086366474e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37215,0.0441882006492586,0.00629068727630439,0.031858453587702,0.0565179477108152,2.25425799066701e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39673,0.0650971029920795,0.00927149142517291,0.0469249797987406,0.0832692261854184,2.28902470726212e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,39865,0.0228220871403367,0.00325115901581038,0.0164498154693483,0.029194358811325,2.31311805495405e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36880,-0.0141768728274826,0.00202241096823772,-0.0181407983252286,-0.0102129473297367,2.50266475449267e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37244,0.0513012554581867,0.00732674523998115,0.0369408347878237,0.0656616761285498,2.64529609579334e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39401,0.038098211249115,0.00544229764571978,0.0274313078635042,0.0487651146347257,2.65695788765413e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,39680,0.0359319727133334,0.00513362706165117,0.025870063672497,0.0459938817541697,2.67511764361156e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,36855,0.0264677861279784,0.00379445083916552,0.019030662483214,0.0339049097727428,3.19785444202343e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36896,0.0336453061526969,0.00482695207643457,0.0241844800828851,0.0431061322225087,3.31484325515032e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39401,0.0324705154092531,0.00466257730442564,0.0233318638925788,0.0416091669259274,3.43831118915775e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39594,-0.0435096451274982,0.00625318007369981,-0.0557658780719499,-0.0312534121830466,3.58744443375686e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37220,0.0272086573204491,0.00392027566946492,0.0195249170082979,0.0348923976326003,4.08750986306449e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39836,-0.0222830528144995,0.00321805051529381,-0.0285904318244754,-0.0159756738045237,4.54522669326814e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39401,0.0371786650435688,0.00537880377824056,0.0266362096382174,0.0477211204489203,4.96215329654962e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37277,0.0317078812791753,0.00459138450266102,0.0227087676539597,0.0407069949043909,5.21130828146324e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39302,0.0428252502914599,0.00620670981465645,0.0306600990547333,0.0549904015281866,5.40886368335853e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37285,0.0200736918269405,0.00291268486876227,0.0143648294841664,0.0257825541697145,5.75424644786323e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,37220,0.047731054210765,0.00693100539670856,0.0341462836332163,0.0613158247883138,5.96971266849218e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39721,-0.0178251610692043,0.00259374610429165,-0.0229089034336159,-0.0127414187047926,6.54991951300135e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39288,0.0225487257573751,0.00328439516041215,0.0161113112429673,0.0289861402717829,6.88288088848136e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,36958,0.0445338095573086,0.00648622540378925,0.0318208077658817,0.0572468113487355,6.90494076568745e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39637,0.0449170052205354,0.00654813070745911,0.0320826690339155,0.0577513414071552,7.16620920208455e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39836,-0.0385932596021957,0.00563437904856935,-0.0496366425373916,-0.0275498766669997,7.67568110419326e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37005,0.0286811102346598,0.00418883577174222,0.0204709921220451,0.0368912283472746,7.8745051371438e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37098,0.0365889685113807,0.00534753349817247,0.0261078028549627,0.0470701341677988,8.14081575957369e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39860,0.020556476053035,0.00300561454453399,0.0146654715457484,0.0264474805603216,8.24287993224913e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,36855,0.0443805594224029,0.00649752291444056,0.0316454145100994,0.0571157043347064,8.84588433025181e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36880,-0.0229536807754447,0.00336332608145411,-0.0295457998950947,-0.0163615616557946,9.20124834716564e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39743,0.0721241750223342,0.0105730012110188,0.0514010926487374,0.0928472573959309,9.33199095502302e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,39529,0.0181162535319556,0.00265695619833428,0.0129086193832204,0.0233238876806908,9.54077461557242e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,36716,0.0459845775941485,0.00674449728682223,0.0327653629119769,0.0592037922763201,9.63820789008015e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36896,0.0385216734870088,0.00565771851141094,0.0274325452046433,0.0496108017693742,1.02803397050299e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37244,0.0316892030260699,0.00465455256669473,0.0225662799953482,0.0408121260567916,1.03028969980745e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,36896,-0.0195182854774373,0.0028692232593684,-0.0251419630657993,-0.0138946078890752,1.07204993383587e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39721,0.0194041996676362,0.00286126700546438,0.013796116336926,0.0250122829983463,1.22981030896781e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37244,0.0343402574199641,0.00506356710953367,0.0244156658852781,0.0442648489546501,1.23643444913507e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,39594,-0.0497581970598065,0.00734673542887916,-0.0641577985004097,-0.0353585956192034,1.30760026992968e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39646,0.0552448456210831,0.0081582388047445,0.0392546975637839,0.0712349936783823,1.3180185574116e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37268,0.0593496444101112,0.00877101608828206,0.0421584528770784,0.0765408359431441,1.37352936432056e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,37277,0.0450219605120804,0.00665458112667812,0.0319789815037913,0.0580649395203695,1.38303196568594e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,37203,0.0235385464676105,0.00348639657622847,0.0167052091782027,0.0303718837570183,1.52334881118163e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,37220,0.0430582552893738,0.00637891571047528,0.0305555804968422,0.0555609300819053,1.53852080205706e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37215,0.0500678754970045,0.00741749249049499,0.0355295902156343,0.0646061607783746,1.53977915657447e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,39792,0.0152848343073735,0.00226902911557948,0.0108375372408377,0.0197321313739093,1.6804579718507e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39594,0.021152883327399,0.00314110854100858,0.0149963105870222,0.0273094560677758,1.70530650236965e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39594,-0.0171755618611085,0.00255111951536825,-0.0221757561112303,-0.0121753676109868,1.72471860407255e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,39673,-0.0276562030271916,0.00410984511950902,-0.0357114994614293,-0.019600906592954,1.76389677005918e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37005,0.0691992877073039,0.0102978178421458,0.0490155647366981,0.0893830106779097,1.8947305138229e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,37268,0.0418901229371474,0.00623724020443522,0.0296651321364544,0.0541151137378405,1.94134480219284e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39658,0.0442281738052347,0.00659483286501719,0.031302301389801,0.0571540462206684,2.06125819864524e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,39673,0.0430120027335413,0.00641350903425225,0.0304415250264069,0.0555824804406757,2.06146706517813e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39622,0.0574849031315198,0.00860358744351832,0.0406218717422238,0.0743479345208157,2.44425332894401e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36880,0.0592090021470854,0.008872253028026,0.0418193862121545,0.0765986180820164,2.59881796405806e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39679,0.0608842830533589,0.00912649969506947,0.0429963436510228,0.0787722224556951,2.62219272908215e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39743,0.017153304622494,0.00257958151326982,0.0120973248564851,0.0222092843885028,3.03380621658065e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39594,0.0219538486160182,0.00330202224052012,0.0154818850245987,0.0284258122074376,3.05616524738787e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39673,0.0538457597944924,0.00810354678682153,0.0379628080923222,0.0697287114966626,3.13728052643846e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37203,0.0230322491345533,0.00346592873516368,0.0162390288136325,0.0298254694554741,3.14280367519615e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,39680,-0.0196406539303766,0.00295721034327818,-0.0254367862032018,-0.0138445216575513,3.20375190962609e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39302,0.039808948249127,0.00599388800425196,0.0280609277607932,0.0515569687374609,3.20680979085705e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37215,0.0945756121654356,0.0142544957329927,0.06663680052877,0.122514423802101,3.37487788274487e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,37213,0.0163110077608658,0.00245893102463353,0.0114915029525841,0.0211305125691475,3.40739497602576e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36877,0.0280300262655396,0.00422722902440771,0.0197446573777005,0.0363153951533787,3.46986896864217e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,39673,-0.0269253481288449,0.00406287954666135,-0.0348885920403011,-0.0189621042173886,3.53270892928938e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,39302,0.0432194084637872,0.00652407914556264,0.0304322133384845,0.05600660358909,3.59703568406185e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,39651,0.0247738905397027,0.00374172295885164,0.0174401135403535,0.0321076675390519,3.68321097298758e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,37090,-0.0686547696090825,0.0103685254756222,-0.088977079541302,-0.0483324596768629,3.69401983943276e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,39668,-0.0151583845418246,0.00229101582751471,-0.0196487755637534,-0.0106679935198958,3.79755697295501e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39860,-0.0160859551434397,0.00243451184057605,-0.0208575983509687,-0.0113143119359106,4.03293578664937e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36958,0.0269384183355664,0.00407715281627626,0.0189471988156649,0.0349296378554678,4.06900459477511e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,37174,0.0614701375624894,0.00930597777384871,0.0432304211257459,0.0797098539992329,4.11378722103797e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,39478,0.0293285150916761,0.00444634935575026,0.0206136703544056,0.0380433598289466,4.35708844208816e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37220,0.0524896204698663,0.00795911054334003,0.0368897638049199,0.0680894771348128,4.41520823835351e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36896,0.0573452852231134,0.00870096177393829,0.0402914001461943,0.0743991703000325,4.54649853063247e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37244,0.0432002152119824,0.00655821756816466,0.0303461087783797,0.0560543216455852,4.64986712440144e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39557,0.0503758323422357,0.00765053418662284,0.035380785336455,0.0653708793480165,4.70538599200553e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37267,0.0314978574209327,0.00478604507598025,0.0221172090720114,0.040878505769854,4.84057888048159e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39668,0.0167774302973608,0.00255036523909938,0.011778714428726,0.0217761461659956,4.90330523892208e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39594,0.0740175433135605,0.0112616963643224,0.0519446184394885,0.0960904681876325,5.10314861035179e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,39817,0.0139549018318126,0.00212633142722887,0.00978729223444403,0.0181225114291812,5.43970394705432e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,39865,-0.00567478310569791,0.000865890374120975,-0.00737192823897503,-0.0039776379724208,5.78444977092487e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39401,0.0270933158983494,0.00414117373715204,0.0189766153735314,0.0352100164231674,6.24215287919699e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39668,-0.0245815009628455,0.0037584029610229,-0.0319479707664504,-0.0172150311592407,6.32324938561646e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,39401,0.0363086867732971,0.00555171669300496,0.0254273220550073,0.0471900514915868,6.34039953928851e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,39697,-0.02037492855472,0.00311614600557944,-0.0264825747256557,-0.0142672823837843,6.40388636741112e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,36855,0.0504817732547765,0.00772755855980031,0.0353357584775679,0.0656277880319851,6.70041516974576e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39633,-0.0158914214904624,0.00243619877252822,-0.0206663710846177,-0.0111164718963071,7.09932680848695e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,39658,0.0239287633552565,0.00367533354419022,0.0167251096086437,0.0311324171018693,7.70892579397563e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37203,0.0679062301061345,0.0104410651601671,0.047441742392207,0.088370717820062,8.11262600167889e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39697,-0.0148369354128901,0.00228457470444241,-0.0193147018335972,-0.010359168992183,8.5849505753958e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39265,-0.0272206515499827,0.00419374945563379,-0.0354404004830249,-0.0190009026169405,8.80103311858566e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36958,0.0260063513600782,0.00400809562273367,0.0181504839395202,0.0338622187806362,8.98406276856191e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39401,0.0214084620540345,0.00330312147825413,0.0149343439566564,0.0278825801514126,9.36853729286067e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,37215,0.0647881409953005,0.0100085559554297,0.0451713713226583,0.0844049106679428,9.92523776053311e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37220,0.0386489418334686,0.00597847484237063,0.0269311311424222,0.050366752524515,1.0503935266832e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39668,0.0482453201291994,0.00746705508292158,0.0336098921666731,0.0628807480917257,1.06990170408657e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39324,0.0489625548205024,0.00757884866836249,0.034108011430512,0.0638170982104929,1.07532098510744e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36880,0.0232475671684401,0.00359820241943157,0.0161950904263542,0.030300043910526,1.07797959702381e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,39793,0.0433762983774989,0.00671680472428201,0.0302113611179062,0.0565412356370916,1.09255704264557e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39860,-0.0153566995190529,0.00237988344759656,-0.0200212710763421,-0.0106921279617636,1.13023770580862e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39721,0.0450861656855306,0.00699103875767224,0.031383729720493,0.0587886016505682,1.15742663347169e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39288,0.0406293870714621,0.00630472213793986,0.0282721316811,0.0529866424618242,1.19596266955758e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,39673,0.0302060772518693,0.00468774808816997,0.0210180909990562,0.0393940635046825,1.20028464245817e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,37220,0.0171947131443615,0.00267043087225249,0.0119606686347466,0.0224287576539764,1.24435429886802e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37268,0.0290432722133391,0.00452453419034503,0.0201751852002628,0.0379113592264153,1.41731156656393e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,36896,0.0277868956776324,0.00432978781578006,0.0193005115587035,0.0362732797965613,1.43219889905601e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36848,0.0531772431175032,0.00829080279153493,0.0369272696460947,0.0694272165889117,1.46659455084112e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,39836,0.0337659994075835,0.00527485133784601,0.0234272907854053,0.0441047080297617,1.5833628853246e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36880,0.0269372058657792,0.0042094927546866,0.0186866000665934,0.0351878116649649,1.61589255148879e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,39669,-0.0360697553014106,0.00563786092599714,-0.047119962716365,-0.0250195478864562,1.62092058838547e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39673,0.0373938769924238,0.0058455842615554,0.0259365318397752,0.0488512221450724,1.6297058566251e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,37267,0.0522799691080769,0.00817184457941457,0.0362631537324243,0.0682967844837295,1.63111046191108e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,37244,0.0339206625678454,0.00530272869291682,0.0235273143297284,0.0443140108059624,1.63910993038225e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,37203,0.0200810715171879,0.0031397926780319,0.0139270778682454,0.0262350651661305,1.65176967847927e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36958,0.0446605908721496,0.00698582112072028,0.0309683814755378,0.0583528002687613,1.68142784555333e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37215,0.040156262483801,0.00628531100095088,0.0278370529219373,0.0524754720456648,1.72619129268731e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,36880,0.0726102183582612,0.0113788249169026,0.050307721521132,0.0949127151953903,1.81693419864776e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36958,0.0645579034516012,0.0101249720415006,0.04471295825026,0.0844028486529425,1.87743460992789e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39557,0.0581236713414867,0.00911788683231425,0.0402526131501507,0.0759947295328226,1.88455638059611e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,39594,-0.0178116773970333,0.00279831388689413,-0.0232963726153458,-0.0123269821787208,2.00505234716715e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,39521,-0.0289161612389355,0.00454756809516633,-0.0378293947054615,-0.0200029277724095,2.09242823519244e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39644,0.0217687808269404,0.00343309059898658,0.0150399232529267,0.0284976384009541,2.34681952056338e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36896,0.0542002854917928,0.00854677630306957,0.0374486039377764,0.0709519670458091,2.34888566657456e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39680,0.0414678329678988,0.0065456105659218,0.0286384362586921,0.0542972296771055,2.4341985993564e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36896,0.0292260866627416,0.00461354016978392,0.0201835479299651,0.0382686253955181,2.45380901127017e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,39738,-0.0286814857627508,0.00452938654987017,-0.0375590834004963,-0.0198038881250053,2.48006541798614e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37267,0.0218439583540674,0.00345203810569399,0.0150779636669072,0.0286099530412276,2.56518420602736e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,37220,0.0568138759893424,0.00898075512801618,0.0392115959384307,0.0744161560402541,2.59318047297437e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,36877,0.0257794950404421,0.00407532620782932,0.0177918556730966,0.0337671344077875,2.60254161815844e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39865,0.020244606283143,0.00320734955159117,0.0139582011620243,0.0265310114042617,2.82807829363854e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39721,-0.0166846717055774,0.00264442116655403,-0.0218677371920233,-0.0115016062191315,2.8757619071136e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,39743,0.0463029156574864,0.00734498792918443,0.031906739316285,0.0606990919986879,2.97687676581638e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,39694,0.0376296833866732,0.00597308541778859,0.0259224359678076,0.0493369308055389,3.05755576330349e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39721,0.041027853946807,0.00651616908512079,0.0282561625399703,0.0537995453536438,3.12822478256224e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39817,0.039644596692871,0.00629744262749685,0.0273016091429772,0.0519875842427649,3.14723994171887e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39720,-0.04655815884462,0.00740908402962151,-0.0610799635426781,-0.0320363541465618,3.38738521506229e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37220,0.0217435517628613,0.00346018361769396,0.0149615918721812,0.0285255116535415,3.40370639161879e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39302,0.0350972154157303,0.00559037339019833,0.0241400835709416,0.046054347260519,3.51775332549122e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,39668,-0.0371851614849888,0.00592340719111507,-0.0487950395795743,-0.0255752833904033,3.52663179219325e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSG,Basigin,39848,0.0117417215340974,0.00187112577593111,0.00807431501327239,0.0154091280549224,3.58136120212979e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,39680,0.0399918472022896,0.0063737774048216,0.0274992434888392,0.0524844509157399,3.60036440077585e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,37267,-0.0307005485439603,0.00489449099960263,-0.0402937509031815,-0.0211073461847391,3.66281525865591e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39673,0.0469021389205107,0.00749100296987655,0.0322197730995527,0.0615845047414687,3.92063127025225e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39680,0.0772889161611992,0.0123540684812313,0.0530749419379858,0.101502890384413,4.04742397104408e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37277,0.0369173394833852,0.00590559959266709,0.0253423642817577,0.0484923146850127,4.19531206766741e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37220,0.0604842203458385,0.00967997086413729,0.0415114774521294,0.0794569632395476,4.27300692941183e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39817,0.0336535841024173,0.00538736851082934,0.0230943418211918,0.0442128263836428,4.29680912209469e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39810,0.0191400078322577,0.00306477061158962,0.0131330574335421,0.0251469582309734,4.3406667444762e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39408,0.0135825243052698,0.00217639688062201,0.00931678641925067,0.0178482621912889,4.46534446803803e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,39865,0.0385820307592732,0.00618380549298829,0.0264617719930162,0.0507022895255303,4.50858580002979e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,36896,0.0271595950732828,0.00435687286427085,0.0186201242593119,0.0356990658872536,4.69486406827662e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39860,-0.0180464175526271,0.00289821510841251,-0.0237269191651156,-0.0123659159401386,4.88140257597188e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,36958,0.0324660661920646,0.00521348162408742,0.0222476422088532,0.0426844901752759,4.88956581657308e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37244,0.0689378779661501,0.011079659464439,0.0472217454158497,0.0906540105164504,5.054183468922e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39743,0.039331122611427,0.0063260949222712,0.0269319765637754,0.0517302686590785,5.18477708751505e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37244,0.0222073032734002,0.00357499900146219,0.0152003052305343,0.0292143013162661,5.39202661977104e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39680,-0.0233298676536009,0.00375641988152913,-0.030692450621398,-0.0159672846858039,5.40788874500446e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39594,0.0530473860863599,0.0085424489549894,0.0363041861345807,0.0697905860381391,5.43645269574876e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39680,0.0498293586977574,0.00802490692880379,0.034100541117302,0.0655581762782128,5.45366049216162e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39302,0.0301214471764327,0.00485774025386992,0.0206002762788477,0.0396426180740178,5.76384193353653e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,39220,0.0704474411791547,0.0113625586049431,0.0481768263134662,0.0927180560448432,5.79204285524999e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39401,0.0220080073296015,0.0035512575159602,0.0150475425983195,0.0289684720608835,5.89098832617357e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,36958,0.0196223817483332,0.0031660712919784,0.0134168820160555,0.0258278814806108,5.90102549011161e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37220,0.0586384066144881,0.00947361199630273,0.0400701271017347,0.0772066861272415,6.20589883604633e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39521,0.0139799968862035,0.0022616262672758,0.00954720940234295,0.0184127843700641,6.51133062451009e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,37220,0.0274778990609386,0.00445072255275335,0.018754482857542,0.0362013152643351,6.85954674339673e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37215,0.0531732774762156,0.00861365715563098,0.0362905094511789,0.0700560455012523,6.88869336090894e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39288,0.0172639289234159,0.00280076467273392,0.0117744301648574,0.0227534276819744,7.26918083793582e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39832,-0.0207964812712481,0.00337504992883331,-0.0274115791317614,-0.0141813834107348,7.36341914972558e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39741,0.0666131955425638,0.0108143733210378,0.0454170238333298,0.0878093672517978,7.46431056673148e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39658,0.0287611078340198,0.0046695004136099,0.0196088870233444,0.0379133286446952,7.48107803383604e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36958,0.0316979493675759,0.00515202525681207,0.0215999798642242,0.0417959188709276,7.8482595905411e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,36827,0.0235195422995775,0.00382563691606669,0.0160212939440868,0.0310177906550682,8.08321056744441e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39668,-0.0307509878136983,0.00500642345594212,-0.0405635777873448,-0.0209383978400517,8.32784148574085e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36896,0.0216550116302375,0.00352522080340429,0.0147455788555651,0.0285644444049099,8.33962295279974e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39721,0.0429018349222437,0.00698927041349007,0.0292028649118031,0.0566008049326842,8.54248182864534e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39302,0.0400006166827963,0.0065193890103193,0.0272226142225704,0.0527786191430221,8.68875438926812e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,39557,0.0196651480297538,0.00320559934881793,0.0133821733060706,0.0259481227534369,8.74082569211121e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36896,0.0268300695179425,0.00437558685080896,0.018253919290357,0.0354062197455281,8.94205272598407e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36896,0.0339604590701462,0.00554806039661222,0.0230862606927863,0.0448346574475062,9.55737141463457e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39668,0.0338680295583106,0.00553469161421865,0.0230200339944421,0.0447160251221792,9.62484208146914e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,39720,0.0334515509512088,0.00546670479053302,0.022736809561764,0.0441662923406535,9.62908882251447e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36863,0.0341245430005853,0.00557672936312112,0.0231941534488679,0.0450549325523027,9.6811402242862e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36780,-0.0366559796543817,0.00600088650789482,-0.0484177172098555,-0.0248942420989078,1.03507212951326e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPART,Spartin,36958,0.0460936354190304,0.00755587345725421,0.0312841234428122,0.0609031473952487,1.08803890337729e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39860,0.0250492331489543,0.00411734501380706,0.0169792369218925,0.0331192293760161,1.20015942586524e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37203,0.0502221770885139,0.0082564064645868,0.0340396204179238,0.0664047337591041,1.2132063908861e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36880,0.0432612454629179,0.00711224114798925,0.0293212528128589,0.0572012381129768,1.2152791303386e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39688,-0.0287559845970922,0.00472940571520957,-0.0380256197989029,-0.0194863493952814,1.22748750384248e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,39860,0.0519642425270861,0.00856429792662657,0.035178218590898,0.0687502664632741,1.3280858943696e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,39624,0.0277358239992565,0.00458248311292488,0.0187541570979238,0.0367174909005893,1.4577713491815e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37268,-0.0189388622338059,0.00312928000876975,-0.0250722510509946,-0.0128054734166172,1.46739733508722e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,39817,-0.0171664323995832,0.00283850123214476,-0.022729894814587,-0.0116029699845795,1.50195820678237e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39288,0.0348964541560255,0.00578403633408616,0.0235597429412167,0.0462331653708344,1.64382384134677e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37158,-0.0156586032913314,0.00259566050930373,-0.0207460978895667,-0.0105711086930961,1.65617613281128e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39860,-0.00908014183125687,0.0015065707489704,-0.0120330204992389,-0.00612726316327488,1.70668451964868e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36958,0.0502313253318951,0.00833758630686395,0.0338896561704418,0.0665729944933485,1.73984624959601e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,39669,-0.0125712190133027,0.0020926224811126,-0.0166727590762834,-0.00846967895032198,1.92656797839007e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,36877,0.0396333301326714,0.00660244327248619,0.0266925413185985,0.0525741189467444,1.99069370264092e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37203,0.0253574098040599,0.00422432065968726,0.0170777413110728,0.0336370782970469,1.99075012651959e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,39604,0.0460749414235827,0.00768345358921776,0.0310153723887159,0.0611345104584495,2.0584057829221e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39480,0.0680328197233672,0.011345264494592,0.0457961013139669,0.0902695381327674,2.05953976566558e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCN,Decorin,39401,-0.0124680113172935,0.00208742250799791,-0.0165593594329694,-0.00837666320161758,2.38124508741288e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,39668,0.0300752336129328,0.00503999495469654,0.0201968435017276,0.039953623724138,2.46342467741259e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,37215,0.0455678449540784,0.00763766828219991,0.0305980151209665,0.0605376747871902,2.48990517401165e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39632,-0.0270973531413197,0.00454395192232946,-0.0360034989090854,-0.0181912073735539,2.52334886404979e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37005,0.028776291854212,0.0048354246274873,0.0192988595843369,0.0382537241240871,2.73059914257267e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37223,0.0114059642054101,0.00191683046912337,0.0076489764859283,0.0151629519248919,2.74133890969441e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,37189,0.0182531988642847,0.00307315692337815,0.0122298112944635,0.0242765864341059,2.92908724952628e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39557,0.0577752186201869,0.00974033886017744,0.0386841544542392,0.0768662827861347,3.06409805154828e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,39721,0.0315476662459232,0.00532148768563441,0.0211175503820798,0.0419777821097667,3.12333228936346e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,37268,0.0307157580922986,0.00518596171640462,0.0205512731281455,0.0408802430564516,3.24126818198773e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,39631,0.0385121440656013,0.0065072725474085,0.0257578898726806,0.0512663982585219,3.31981185088161e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,39594,0.0337252688671245,0.00570329968278409,0.0225468014888677,0.0449037362453813,3.42283596457542e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,36877,0.0282308237891461,0.00477598603963004,0.0188698911514713,0.037591756426821,3.48563778208972e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39860,0.0181984063846326,0.00307926899505918,0.0121630391543166,0.0242337736149486,3.49108242454533e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39557,0.0190425224714148,0.00322569417771694,0.0127201618830896,0.02536488305974,3.63455775613031e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,36958,0.0314679616721453,0.00534521467883568,0.0209913409016274,0.0419445824426633,4.02587708386727e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36880,0.0526920005853076,0.00895402231212563,0.0351421168535414,0.0702418843170739,4.08511843927688e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39668,0.0155190483410046,0.00263822752520629,0.0103481223916003,0.020689974290409,4.12581300591742e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36855,0.0430558879054765,0.0073207441285399,0.0287072294135383,0.0574045463974147,4.16929393687859e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37139,0.0172260990136683,0.00293017974091069,0.0114829467214834,0.0229692513058533,4.23038261870041e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,39288,0.0249603104035893,0.00424868097705836,0.0166328956885549,0.0332877251186237,4.31971894704805e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37230,0.0228509780117086,0.00389223160175196,0.0152222040722747,0.0304797519511424,4.43667214245972e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36896,-0.0150214124286793,0.0025645232427041,-0.0200478779843793,-0.00999494687297924,4.81539466800416e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39192,0.0690860692708452,0.011822798027165,0.0459133851376018,0.0922587534040885,5.21641581814704e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39567,0.0337245143980248,0.00577894290158552,0.0223977863109172,0.0450512424851324,5.46010494923225e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,39162,0.0428697182011393,0.00735761096181829,0.0284488007159755,0.0572906356863032,5.77112522998067e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,37220,0.0474693599912912,0.00815715071537503,0.0314813445891562,0.0634573753934263,6.04297709897051e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39653,0.0338899389636556,0.00582472428998581,0.0224734793552834,0.0453063985720278,6.06033197116002e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36959,0.029605748787912,0.00509133424401372,0.0196267336696451,0.0395847639061789,6.20744089765667e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37175,0.0270949282983552,0.00466128607636717,0.0179588075886756,0.0362310490080349,6.28596726808751e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,39836,0.0239280657562064,0.00411695867614825,0.0158588267509558,0.031997304761457,6.28795056939939e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37005,0.0189050881103838,0.00325298440477619,0.0125292386770225,0.0252809375437452,6.33084532213538e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37244,0.0233686362431068,0.00402437596444718,0.0154808593527903,0.0312564131334233,6.51341409801613e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,37172,0.0264744735279801,0.00456182569213919,0.0175332951713873,0.0354156518845729,6.64307460198681e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37220,0.0301999266550978,0.00520621576381186,0.0199957437580266,0.0404041095521691,6.75163546383745e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,39673,0.0324837787926576,0.00560620989067234,0.0214956074069398,0.0434719501783754,6.99327679715332e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,39539,-0.0159873021895852,0.00276002730560892,-0.0213969557085787,-0.0105776486705917,7.06989248986414e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,39648,0.0500467573308821,0.00864853031328219,0.033095637916849,0.0669978767449151,7.31278062205992e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37215,0.0267651174665118,0.00463437777927324,0.0176817370191362,0.0358484979138873,7.85069575211053e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,39778,0.0333879169384863,0.0057880032833158,0.0220434305031873,0.0447324033737852,8.14802629945224e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39689,0.0217649695892347,0.00377389971378023,0.0143681261502255,0.029161813028244,8.20856768097968e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,39600,0.0416167541621878,0.00721918214062787,0.0274671571665572,0.0557663511578184,8.33125972389321e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39594,0.0302219479912715,0.00524755844533162,0.0199367334384215,0.0405071625441215,8.60709176313283e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,39585,0.0310197167993829,0.00538614351506942,0.0204628755098468,0.0415765580889189,8.61073389668624e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,36958,0.0414289981356839,0.00719309481742552,0.0273305322935298,0.0555274639778379,8.62325937120782e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39401,0.0513207607764867,0.0089151413005569,0.0338470838273952,0.0687944377255782,8.74525283046483e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37215,0.0505288696268489,0.00878710052669538,0.0333061525945259,0.0677515866591718,9.10106152936064e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39288,0.0469999230406477,0.00817880153869869,0.0309694720247983,0.0630303740564971,9.28000666156026e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37244,0.0274532036273987,0.00477898694639531,0.0180863892124639,0.0368200180423335,9.41624419714331e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,37215,0.0462559916896419,0.00805474793123464,0.030468685744422,0.0620432976348618,9.52085789719938e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,39680,0.0237045253693223,0.00413272010561167,0.0156043939623234,0.0318046567763212,9.88166951707742e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37268,0.016616895941699,0.00290046345511322,0.0109319875696771,0.0223018043137209,1.03165784096033e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39296,0.0157853104375834,0.00275594451150601,0.0103836591950316,0.0211869616801352,1.03678317229934e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39865,-0.0158317503077908,0.00276752580329711,-0.0212561008822532,-0.0104073997333285,1.08081820938008e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37215,0.048711323196739,0.00853536809785908,0.0319820017249352,0.0654406446685427,1.17430137110848e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39401,-0.0218380622877596,0.00383270437091568,-0.0293501628547544,-0.0143259617207649,1.23547917135977e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39668,0.0205987403357643,0.00361652427978149,0.0135103527473925,0.027687127924136,1.25031701883612e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39727,0.0181592138703627,0.00319042651245657,0.0119059779059478,0.0244124498347775,1.27942073860274e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,36827,0.0354260203547207,0.00622522148028041,0.0232245862533711,0.0476274544560703,1.29240061947595e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36958,-0.0213660934983843,0.00376412853896683,-0.0287437854347593,-0.0139884015620093,1.40609637625207e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37203,0.027994155017475,0.00493366335615669,0.0183241748394079,0.0376641351955421,1.42309283527536e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39680,0.0363722106888189,0.00641127550870344,0.0238061106917602,0.0489383106858776,1.42638315423395e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,39743,0.0213159540588974,0.00376133972803403,0.0139437281919507,0.0286881799258441,1.47740763417212e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,39721,0.0343739834795743,0.00606584534025461,0.0224849266126752,0.0462630403464733,1.4801035110193e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37244,0.0325467325948852,0.00574556508954815,0.0212854250193708,0.0438080401703996,1.50341069198465e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39302,0.0405473721996968,0.00716729630829141,0.0264994714354456,0.0545952729639479,1.56522496279739e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39614,0.0145771317148878,0.00257695884850765,0.00952629237181278,0.0196279710579628,1.56975432864416e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,37180,0.0483137951954933,0.00854038144309641,0.0315746475670244,0.0650529428239623,1.57120932074792e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,39668,0.0142704756019401,0.00252400497850174,0.00932342584407669,0.0192175253598035,1.59557006250058e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37268,0.0218781631001837,0.00387081440505734,0.0142913668662713,0.029464959334096,1.61745588450493e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39401,0.0359367274867186,0.00636155003543708,0.023468089417262,0.0484053655561753,1.64162217329091e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39738,-0.014817809254936,0.00262417996025696,-0.0199612019770397,-0.0096744165328324,1.66411559553634e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36600,0.0270932359685332,0.00479831150165218,0.017688545425295,0.0364979265117715,1.673339500074e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39658,0.0614181843992799,0.0109000867812276,0.0400540143080739,0.082782354490486,1.78406771674146e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,36922,0.0565946018977036,0.0100494914501578,0.0368975986553944,0.0762916051400128,1.82240274930258e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,39636,0.0361062720010495,0.00641508593739714,0.0235327035637511,0.0486798404383479,1.85050164683948e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39288,0.0235110218732996,0.00418362531783687,0.0153111162503394,0.0317109274962599,1.9451674746384e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39288,0.0368498271992613,0.00655895524109516,0.0239942749267148,0.0497053794718078,1.96238477761561e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,39673,0.0368863117588195,0.00657497295026357,0.0239993647763029,0.0497732587413361,2.0558874112516e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37197,0.02257374355994,0.00402813675208735,0.0146785955258488,0.0304688915940312,2.13590873899591e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36855,0.0367628569251516,0.00656348594616498,0.0238984244706682,0.0496272893796349,2.17297093520074e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39716,0.0272380575925369,0.00486419831422652,0.0177042288966529,0.0367718862884209,2.18284494095791e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,39860,0.0292654933201901,0.00523310501987823,0.0190086074812288,0.0395223791591514,2.27646726579209e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39817,0.0286505196765194,0.00512548481174196,0.0186045694455052,0.0386964699075336,2.31031723324431e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,39554,0.0122659971056298,0.00219710386022606,0.00795967353958668,0.0165723206716729,2.40594816095664e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,36880,0.0218868003534177,0.00392117063502502,0.0142013059087687,0.0295722947980667,2.42938168360662e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39302,0.0605675748527264,0.0108586649934307,0.0392845914656021,0.0818505582398506,2.47652521216023e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,39668,0.0389310616052762,0.00698435150829751,0.025241732649013,0.0526203905615393,2.5296611935072e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37244,0.0253487391878284,0.00455040530333401,0.0164299447932937,0.0342675335823631,2.5867774181361e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37244,0.0253415529057724,0.00455053336409587,0.0164225075121445,0.0342605982994003,2.61261878482973e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37203,0.0509340790249571,0.00915843615223663,0.0329835441665733,0.0688846138833409,2.7270296200171e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37244,0.046013137652819,0.00827564102500481,0.0297928812438096,0.0622333940618284,2.74829993937301e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,39423,0.039966529362277,0.0071897248324502,0.0258746686906746,0.0540583900338793,2.760358176427e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37215,0.0313064367757075,0.00564231414640236,0.0202475010487589,0.0423653725026562,2.93597132790408e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,39680,-0.0371980787944882,0.00670808017225397,-0.0503459159321059,-0.0240502416568704,2.98208759808732e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36896,0.019424388550942,0.00350269162251376,0.012559112970815,0.026289664131069,2.98715607705703e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39673,0.0536829017879397,0.00968150670830001,0.0347071486396717,0.0726586549362077,2.98846436717247e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,37268,0.0300239182340295,0.00542279698516144,0.0193952361431131,0.0406526003249459,3.14176357064677e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37215,-0.037613873801834,0.00680598220562968,-0.0509535989248682,-0.0242741486787998,3.32632687522237e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,39288,0.0247428266513596,0.00448394677322232,0.0159542909758439,0.0335313623268754,3.48221264938473e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36827,0.0410611699664393,0.00744640584204196,0.026466214516037,0.0556561254168415,3.57019826143355e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,37267,-0.0160852571064455,0.00292103499876596,-0.0218104857040268,-0.0103600285088642,3.72355587885276e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37268,0.0525446890782659,0.00955945875407414,0.0338081499202806,0.0712812282362512,3.94218129410534e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,39668,-0.0166115351972527,0.00302635843101279,-0.0225431977220378,-0.0106798726724677,4.10550492812336e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39673,-0.0230627318149401,0.00420484161236281,-0.0313042213751712,-0.014821242254709,4.20279552853036e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37285,0.0174228808703716,0.00317719625443642,0.0111955762116762,0.023650185529067,4.23983808335782e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37268,0.0472913442196027,0.00863034794150443,0.030375862254254,0.0642068261849514,4.33844073343567e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36880,0.0290326302838595,0.0052986844040138,0.0186472088519924,0.0394180517157265,4.35157923580879e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36958,-0.0149228053926356,0.00272491788111595,-0.0202636444396228,-0.0095819663456483,4.42009729115287e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39288,0.0277348822806802,0.00507328649213101,0.0177912407561034,0.0376785238052569,4.65224612364556e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39743,0.0679990458294129,0.0124415666869252,0.0436135751230396,0.0923845165357862,4.68630210549048e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39594,0.0297836034368619,0.00545044463049731,0.0191007319610872,0.0404664749126366,4.71440227234762e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36896,0.0177566775227309,0.00324947655752611,0.0113877034699797,0.024125651575482,4.72812080220536e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36896,0.029816991128971,0.00546836774072614,0.0190989903571477,0.0405349919007942,5.05339687020375e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C3,Complement C3,36653,0.0242371740270304,0.00444967130590454,0.0155158182674575,0.0329585297866033,5.2185734937516e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36827,0.0524831884523834,0.00965551394542163,0.0335583811193571,0.0714079957854098,5.56106551567942e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39385,-0.015694710770492,0.0028884559256309,-0.0213560843847286,-0.0100333371562555,5.60608781689637e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,36880,-0.0223230189048595,0.00411714153976858,-0.0303926163228059,-0.0142534214869131,5.99972402250486e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,37277,0.0480326694588651,0.00886995213376193,0.0306475632766917,0.0654177756410385,6.22705534538501e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39721,0.0435839475068687,0.00805151890061867,0.0278029704616561,0.0593649245520813,6.28312163687824e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37268,0.0459883480513944,0.00850563557971993,0.0293173023151434,0.0626593937876455,6.52565262574016e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,39865,0.0403783498508441,0.00747596317572477,0.0257254620264236,0.0550312376752647,6.71827677420211e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39842,0.0120628899311555,0.0022357069710446,0.00768090426790811,0.0164448755944029,6.92830550602126e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39738,-0.0299869139616852,0.00556163821637262,-0.0408877248657756,-0.0190861030575949,7.07755985701112e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37215,0.0277304062558397,0.00514420686730195,0.0176477607959279,0.0378130517157515,7.14130892139713e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39288,0.0397905623529838,0.00738921871961477,0.0253076936625388,0.0542734310434287,7.35263510687852e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,37244,0.0398660846801208,0.00741087998400037,0.02534075991148,0.0543914094487615,7.5992051835192e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37244,0.0406103760347955,0.00755210046097627,0.025808259131282,0.055412492938309,7.68550330767302e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37005,0.0381673049327022,0.00710713569176246,0.0242373189768478,0.0520972908885566,7.99527061665701e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36896,0.0416766647779701,0.0077654631416345,0.0264563570203665,0.0568969725355738,8.14611995002503e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37220,-0.0156310491303335,0.00292110699739571,-0.0213564188452291,-0.00990567941543787,8.88791835517875e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39836,0.0277768868373499,0.00519588023592747,0.017592961574932,0.0379608120997677,9.11827715509484e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,39302,0.0316152990615046,0.00593941645162583,0.019974042816318,0.0432565553066912,1.03517482324344e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,39668,-0.0120396324727154,0.00226268400416154,-0.016474493120872,-0.00760477182455879,1.04633408872077e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39715,-0.0136513615510973,0.00256671940253029,-0.0186821315800567,-0.00862059152213795,1.05986250682104e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36855,0.0334037649422671,0.00628174829177764,0.0210915382903829,0.0457159915941513,1.06892496822345e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37277,0.0136625032040756,0.00257445856647891,0.00861656441377699,0.0187084419943743,1.13253974631899e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37268,0.0251452306076774,0.00474381636373845,0.01584735053475,0.0344431106806047,1.1723145527524e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,37220,0.0109123470919854,0.0020606971743639,0.00687338063023213,0.0149513135537386,1.20596672002521e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39521,0.0372773174124097,0.00705076536883723,0.0234578172894888,0.0510968175353307,1.26015769040084e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,36880,0.0265278843293427,0.00502093035327784,0.0166868608369181,0.0363689078217673,1.28810803120471e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39288,0.0266563982088546,0.00504582454287563,0.0167665821048184,0.0365462143128909,1.28908951111198e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,37203,0.0248499186366907,0.00470551607908713,0.01562710712168,0.0340727301517015,1.30485063850845e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,36958,0.0558024280971553,0.0105670185882335,0.0350910716642177,0.0765137845300929,1.30670827607659e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,36795,0.0288721667772477,0.0054680447423667,0.0181547990822089,0.0395895344722864,1.31159117291379e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,37005,0.0276316149117234,0.00523405196420482,0.017372873061882,0.0378903567615649,1.31813822025635e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39296,0.0244471327876615,0.00464945731571342,0.0153341964488632,0.0335600691264598,1.475231561791e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,39430,0.021446905452888,0.00407962408616609,0.0134508422440025,0.0294429686617736,1.4829504914104e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,39673,0.0329349050739088,0.00626600033617039,0.0206535444150149,0.0452162657328028,1.49031352041203e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39594,0.0302208345735651,0.00575624351564577,0.0189385972828994,0.0415030718642308,1.53996377538085e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37268,0.0346789688881612,0.00660699875056319,0.0217292513370574,0.0476286864392651,1.55409733720152e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,36880,0.0154471970941978,0.00294413898473287,0.00967668468412142,0.0212177095042743,1.57224810897329e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,36896,0.0292815790519003,0.00558714928741208,0.0183307664485726,0.040232391655228,1.62306634205709e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,36880,0.0456793657648145,0.00873301397260989,0.0285626583784991,0.0627960731511299,1.71531602926848e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,39836,0.0191144920102245,0.00365643713946596,0.0119478752168712,0.0262811088035777,1.73861282205128e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36958,0.0419086304823042,0.00801763558649151,0.0261940647327808,0.0576231962318275,1.74877957730672e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36958,-0.0143433686673329,0.0027444214144715,-0.019722434639697,-0.00896430269496871,1.7552399682188e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,39559,0.0332056748906757,0.00635462535853992,0.0207506091879375,0.0456607405934139,1.75970602909948e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36855,0.0337521015044264,0.0064624362581948,0.0210857264383646,0.0464184765704882,1.78946568261915e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,39809,0.0303168916282823,0.00580643552754414,0.0189362779942957,0.0416975052622688,1.79944200305486e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37267,0.0135343571850737,0.00259481222057017,0.00844852523275619,0.0186201891373913,1.85621641191039e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36896,0.0433452393197714,0.00834092136919915,0.0269970334361411,0.0596934452034018,2.05924024307407e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,39269,0.0458534571230142,0.00883415498440209,0.0285385133535861,0.0631684008924423,2.12423326724445e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36896,0.0457377042764571,0.00881269548790119,0.0284648211201707,0.0630105874327434,2.13477672579689e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39401,0.0441901462599824,0.00851891058080412,0.0274930815216063,0.0608872109983584,2.16045564246751e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,39817,-0.0113469382835374,0.00218784747483677,-0.0156351193342174,-0.0070587572328573,2.17080102923775e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36958,0.0347970750929254,0.00672426235442111,0.0216175208782601,0.0479766293075908,2.31461440555568e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39521,0.0379604019978222,0.00734037572957031,0.0235732655678644,0.05234753842778,2.35143593795785e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,37220,0.0353023239944552,0.00682953940927234,0.0219164267522814,0.048688221236629,2.38664496020888e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAX,Protein max,39302,0.0525046733213957,0.010162478922884,0.0325862146325431,0.0724231320102483,2.41459052192313e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39673,0.0407115838721137,0.0078889680235604,0.0252492065459353,0.056173961198292,2.49176581771036e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36900,-0.0168846801892812,0.00327345963261512,-0.0233006610692068,-0.0104686993093556,2.53189145263032e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37268,0.0119805279813431,0.00232341904525157,0.00742662665265005,0.0165344293100362,2.55298546689779e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39288,0.0194946043115332,0.0037828075648157,0.0120803014844944,0.026908907138572,2.58858412111025e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37267,0.0410095149458396,0.00796785985484244,0.0253925096303484,0.0566265202613308,2.68618205886037e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39401,0.0181222378207953,0.00352181116936831,0.0112194879288334,0.0250249877127572,2.6974872111441e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,39668,-0.012692685750541,0.00247176218944442,-0.0175373396418521,-0.00784803185922999,2.85379830020072e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36958,0.0196552049048544,0.00382740527529242,0.0121534905652813,0.0271569192444275,2.85605439324809e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37244,0.0333756880058776,0.00650660073621072,0.0206227505629046,0.0461286254488506,2.94554838079443e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37244,0.0289119723966413,0.00563865722835168,0.017860204229072,0.0399637405642106,2.97781157125795e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37244,0.0494097332628109,0.0096400221778341,0.030515289794256,0.0683041767313657,3.00918082263602e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,37285,0.0357492092641187,0.00698188957365284,0.0220647056997591,0.0494337128284782,3.09309201402056e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,39434,0.0342442709748126,0.00669196131493504,0.02112802679754,0.0473605151520853,3.13751376426736e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,39720,-0.0150181735637098,0.00293949183803277,-0.0207795775662541,-0.00925676956116562,3.27444373241746e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,39646,-0.03389366642267,0.00663542223360234,-0.0468990940005306,-0.0208882388448094,3.29398327277631e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39695,0.0589408280995753,0.0115394262658381,0.0363235526185326,0.0815581035806179,3.29754474599652e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36880,0.0381936411117505,0.00747769682696477,0.0235373553308996,0.0528499268926015,3.3075839586368e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,37267,-0.0112719997394037,0.00220877705967115,-0.0156012027763592,-0.00694279670244827,3.38389657013811e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,39668,-0.0225354449903548,0.00441747542522806,-0.0311936968238018,-0.0138771931569078,3.409976379729e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37215,0.014537251486607,0.00284975623897739,0.00895172925821133,0.0201227737150027,3.42087051889852e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,37260,0.0184953811400113,0.00362795552925295,0.0113845883026755,0.0256061739773471,3.47907968906541e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,36855,0.0232629178878903,0.00456674094089082,0.0143121056437443,0.0322137301320363,3.55525642326137e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36880,0.0503937460065562,0.00991176051974251,0.0309666953878609,0.0698207966252515,3.7423089455156e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39401,0.045542417607439,0.00896402965714747,0.02797291947943,0.063111915735448,3.80657139400058e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36880,0.023195159373041,0.00457190420609058,0.0142342271291034,0.0321560916169785,3.96123713495613e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,39401,0.0413122701308775,0.00814408112030916,0.0253498711350715,0.0572746691266834,3.96782866253351e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39743,0.0127504331633161,0.00251538505044233,0.00782027846444911,0.0176805878621831,4.04451361689103e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39557,-0.0537379682118343,0.0106094135732456,-0.0745324188153956,-0.0329435176082729,4.12768290023596e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,39646,0.0431548857086766,0.00852527120001258,0.0264453541566519,0.0598644172607012,4.1955743586778e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,39526,0.0220223965378135,0.00435199911490905,0.0134924782725917,0.0305523148030352,4.23348559742222e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37277,-0.0699683707704899,0.0138594787696129,-0.0971329491589311,-0.0428037923820487,4.51335123691936e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37268,0.030454106302052,0.0060327576634721,0.0186299012816467,0.0422783113224574,4.5202149649848e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,39302,0.023013688249227,0.00456578041895257,0.01406475862808,0.0319626178703741,4.69638194205229e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39645,0.046660235762311,0.00925842403244745,0.028513724658714,0.064806746865908,4.71270561640098e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,39288,0.018282093490933,0.0036284562543981,0.0111703192323127,0.0253938677495533,4.74419121409014e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37277,-0.0297031417477833,0.00589492001833346,-0.0412571849837169,-0.0181490985118497,4.7463105710322e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,39594,0.0366902709763969,0.00728519332519549,0.0224112920590138,0.0509692498937801,4.79919228474456e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,37277,0.0303147833387152,0.00602101044721688,0.0185136028621701,0.0421159638152603,4.84468962174234e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,39793,0.0346832850365151,0.0068967536754194,0.021165647832693,0.0482009222403371,4.98585577586224e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,39865,0.0168042822280808,0.00334359679406185,0.0102508325117195,0.023357731944442,5.06721020415546e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39668,-0.0173852159963626,0.00346732151135441,-0.0241811661586172,-0.0105892658341079,5.38817782195733e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,39710,0.0141930763032674,0.00283353254529122,0.00863935251449662,0.0197468000920382,5.53109554771548e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,39668,0.0587291844490869,0.0117468366007275,0.035705384711661,0.0817529841865129,5.80720765466054e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39743,-0.0135044828750696,0.0027028690534732,-0.018802106219877,-0.00820685953026208,5.90461829929608e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,36880,0.0135748506110774,0.00271733949126162,0.0082488652082046,0.0189008360139502,5.94014567526723e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39860,-0.0131574778324559,0.00263518794229021,-0.0183224461993447,-0.00799250946556708,6.0075947729061e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39652,0.0453379819650635,0.00908786415231654,0.0275257682265231,0.0631501957036039,6.13856174291058e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,39401,0.0206670840730592,0.00414318903775422,0.0125464335590609,0.0287877345870574,6.16001314188602e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDK,Midkine,39651,0.0242690431923373,0.0048659581168552,0.0147317652833011,0.0338063211013735,6.18099609140915e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39817,0.0224587823783563,0.00452786949664098,0.01358415816494,0.0313334065917726,7.11736804156944e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,39557,0.017376577971435,0.00350833554844092,0.0105002402964908,0.0242529156463792,7.38602892454632e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36877,0.0294239491638198,0.00594314063312779,0.0177753935228894,0.0410725048047503,7.47930523767475e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36867,0.0174426814785387,0.00352385194721362,0.010535931662,0.0243494312950774,7.51855168251611e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,39591,-0.0196236586752298,0.0039666202530446,-0.0273982343711972,-0.0118490829792624,7.60666982844491e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39401,0.0192632542852162,0.00389828698642863,0.0116226117918161,0.0269038967786164,7.83441844632073e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,39288,0.0276503049078714,0.00559711897243637,0.0166799517218961,0.0386206580938467,7.89019364283609e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36855,0.0286718626757606,0.00580588202613557,0.0172923339045348,0.0400513914469863,7.97383510497912e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39594,0.0501309035244333,0.0101544059032997,0.030228267953966,0.0700335390949007,8.02026696257064e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36880,0.0241431187268108,0.00489426305229656,0.0145503631443095,0.0337358743093121,8.20003554004995e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39401,0.0532433509569251,0.0108006229167615,0.0320741300400725,0.0744125718737777,8.32241791361486e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37261,0.0229899653403341,0.00466480801976721,0.0138469416215904,0.0321329890590778,8.39037317621028e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39269,0.033359595468602,0.00678650152327962,0.020058052482974,0.0466611384542301,8.94302604037485e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39817,-0.0126326448757544,0.00257593421816394,-0.0176814759433557,-0.0075838138081531,9.47793428068705e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37267,0.0254092479676683,0.00518946889399638,0.0152378889354354,0.0355806069999012,9.87907974622917e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37215,0.048495120513237,0.00990517501217151,0.0290809774893808,0.0679092635370931,9.89820786975403e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39680,-0.0160250588735506,0.00327476630096009,-0.0224436008234324,-0.00960651692366885,1.0003512032453e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39288,0.0239741371161589,0.00491231661400954,0.0143459965527002,0.0336022776796176,1.06921382125778e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,37268,0.0144137785958969,0.00295482105417119,0.00862232932972139,0.0202052278620724,1.08367517517277e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,39401,0.0228285180583114,0.00468154267131948,0.0136526944225252,0.0320043416940976,1.09173357811539e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39288,0.0159043564765987,0.00326214456595997,0.00951055312731721,0.0222981598258803,1.09652476928287e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,39302,0.0197875819741693,0.00405955715218077,0.011830849955895,0.0277443139924436,1.10268461506637e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37220,0.0216882574937973,0.00445243605209045,0.0129614828317,0.0304150321558945,1.12251076371846e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36958,0.0563264962514047,0.0115695509076962,0.0336501764723201,0.0790028160304893,1.13753667988013e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39594,0.0444073468867794,0.0091362633380967,0.0265002707441098,0.0623144230294489,1.18183649515737e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39302,0.0174221020072232,0.00358559522202166,0.0103943353720608,0.0244498686423857,1.191892546556e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39836,-0.0148535055184017,0.00305791738890514,-0.0208470236006558,-0.00885998743614764,1.20068377091508e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37203,0.0184150951270301,0.00379088150149528,0.0109849673840994,0.0258452228699609,1.20084790272101e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39680,0.0265244528320504,0.00546471226055291,0.0158136168013667,0.0372352888627341,1.22292248715695e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,37268,0.0338235772833858,0.00697520283579643,0.0201521797252248,0.0474949748415468,1.25403684152155e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,39680,0.0262220683412811,0.00541509650958639,0.0156084791824918,0.0368356575000704,1.29492332323753e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,39680,0.0180084509650311,0.00372010870676305,0.0107170378997756,0.0252998640302867,1.30512228031774e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36855,0.032940082240828,0.00680949589152641,0.0195934702934362,0.0462866941882197,1.33074698358238e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37220,0.0180100818213779,0.00372330994037907,0.010712394338235,0.0253077693045209,1.33206132408084e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,39694,0.0428756717866485,0.008882024243057,0.0254669042702567,0.0602844393030402,1.39729397526112e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,36390,0.0113640441772881,0.00236102072397194,0.00673644355830305,0.0159916447962731,1.50272732255934e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,37285,0.0123280957084599,0.00256583448402603,0.00729906011976889,0.0173571312971509,1.56650657800209e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37005,0.0354099208682948,0.00737304028151982,0.020958761916516,0.0498610798200737,1.58328998604832e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39649,0.0292144116215131,0.00610164813868804,0.0172551812696845,0.0411736419733416,1.70017945016829e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39668,0.0191153483335592,0.00399676923702662,0.011281680628987,0.0269490160381314,1.74515947988267e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,39288,0.0372693130690189,0.00779245958571828,0.0219960922810111,0.0525425338570267,1.74519290198372e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,36855,0.0275428667507611,0.00577141504277526,0.0162308932669216,0.0388548402346006,1.84125935579435e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39836,0.0292272877730106,0.00612525383294149,0.0172217902604452,0.0412327852855759,1.84380582805025e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,36877,0.0209118368656629,0.00439943314481729,0.012288947901821,0.0295347258295048,2.02262349308252e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39557,0.0214947262334472,0.00453594464738312,0.0126042747245763,0.0303851777423181,2.16921029579107e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39594,-0.00950428959163384,0.00200608325548225,-0.0134362127723791,-0.00557236641088862,2.18009063291948e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39401,0.0241134945956795,0.0050960246897127,0.0141252862038426,0.0341017029875164,2.24469559561935e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39288,0.0262560604341578,0.00554947175343075,0.0153790957974336,0.0371330250708821,2.25095013634924e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39266,0.0301499712398845,0.0063769832852219,0.0176510840008495,0.0426488584789194,2.2882111793861e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,37053,0.0150575582666122,0.00318873153848881,0.00880764445117412,0.0213074720820503,2.35806974247592e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37203,0.0231359003750095,0.00490238809331923,0.0135272197121038,0.0327445810379152,2.39046418990317e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36880,0.0367154057729673,0.00778526224126459,0.0214562917800887,0.0519745197658459,2.43006369863877e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,39594,0.0376678603409458,0.00799688676002853,0.0219939622912899,0.0533417583906017,2.49446627286174e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,39865,0.0249817678134303,0.00530812843219423,0.0145778360863296,0.0353856995405309,2.54335960983731e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37203,0.01313522546126,0.00279954867208784,0.00764811006396786,0.0186223408585522,2.7335615607278e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39743,0.0397648820895591,0.00847611621810921,0.023151694302065,0.0563780698770531,2.73598176529623e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39401,0.0238250448357355,0.00507977505302128,0.0138686857318138,0.0337814039396572,2.75291161859366e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36877,0.0219558258534371,0.00468520004146643,0.0127728337721629,0.0311388179347113,2.8113203619858e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36855,0.0307370321474487,0.00655961934715272,0.0178801782270294,0.0435938860678681,2.81704467788272e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,39671,0.0141645454533673,0.00302326553120491,0.00823894501220567,0.0200901458945289,2.82042543823439e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39743,0.0117102475668937,0.00250313190867913,0.00680410902588257,0.0166163861079048,2.91735360492113e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39721,0.0152847677163973,0.00326722560503107,0.00888100553053639,0.0216885299022582,2.91778788472345e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37203,0.0312272962198399,0.00667986491133275,0.0181347609936277,0.0443198314460521,2.97063993236807e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37220,0.0218377117653234,0.00467274787948074,0.0126791259215412,0.0309962976091057,2.99118893379637e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39288,0.0256925712625956,0.0054988070222199,0.0149149094990445,0.0364702330261466,3.00229513753602e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39521,0.0433027670243355,0.00928395970825441,0.0251062059961568,0.0614993280525142,3.12295113064791e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39673,0.0167725092914665,0.00360042495007702,0.00971567638931549,0.0238293421936174,3.21146982167594e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,39680,-0.0117364569751102,0.00251941386881035,-0.0166745081579785,-0.00679840579224187,3.21259181058836e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37005,0.0252409879865132,0.00542462458820289,0.0146087237936355,0.0358732521793908,3.30271725739123e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36855,0.0276991428094264,0.00596347131212662,0.0160107390376582,0.0393875465811946,3.4374150537336e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,39333,0.0399090430881382,0.0085985517315947,0.0230558816942126,0.0567622044820638,3.48951109391532e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37220,0.0128303406745211,0.00277480982127982,0.00739171342481262,0.0182689679242295,3.801894291318e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39557,0.0129442229301681,0.00280366490111752,0.0074490397239778,0.0184394061363585,3.92614808635594e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36877,0.0306841034715346,0.00664624818669935,0.0176574570256039,0.0437107499174654,3.93514312052005e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,37122,0.0445677444529355,0.00965748397404067,0.0256390758638157,0.0634964130420552,3.97085368899556e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37203,0.0317399179522923,0.00687985044688095,0.0182554110764056,0.045224424828179,3.99704680222734e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39557,-0.0219178330400948,0.0047529594450587,-0.0312336335524099,-0.0126020325277798,4.03107936957735e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,39720,0.0258571635966762,0.00561246844183631,0.014856725450677,0.0368576017426753,4.11515467745006e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37215,0.0213404499944523,0.00463932080218067,0.0122473812221782,0.0304335187667265,4.26562389303206e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37244,0.0167822100251828,0.00365841370897674,0.00961171915558837,0.0239527008947772,4.5310887642417e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39673,0.0163236418715199,0.00356301151941438,0.00934013929346769,0.023307144449572,4.65364030421276e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37215,-0.0237314917915898,0.00518187258140871,-0.0338879620511509,-0.0135750215320287,4.69821451089159e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,39594,0.018433290214429,0.00402816658058039,0.0105380837164914,0.0263284967123666,4.77346979476549e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,37220,0.0288868461924322,0.00632107632183273,0.0164975366016401,0.0412761557832244,4.92270029920186e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39288,-0.0133900504173893,0.00293218639560813,-0.0191371357527813,-0.0076429650819974,4.9959080800522e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,39668,0.0108821814070651,0.00238306536207006,0.00621137329740781,0.0155529895167224,4.99764323186455e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39594,-0.0145433498417903,0.00318563743518048,-0.0207871992147441,-0.00829950046883657,5.02589381907787e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37268,-0.01506665525248,0.00330154221265065,-0.0215376779892753,-0.00859563251568472,5.07496208703288e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37244,0.0561030723627087,0.0123051550233887,0.0319849685168668,0.0802211762085505,5.17757996442257e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,39668,0.0338484619739962,0.00743158338531801,0.0192825585387729,0.0484143654092195,5.28581697733069e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39720,0.02141206489864,0.00470584000394664,0.0121886184909046,0.0306355113063754,5.40170199358476e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39622,0.0286269487842559,0.00629675252332094,0.0162853138385469,0.040968583729965,5.50025313174181e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,36492,0.0540773969616281,0.0119064465068602,0.0307407618081821,0.077414032115074,5.62765930480589e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39680,-0.0133894601143595,0.00295313780344478,-0.0191776102091113,-0.00760131001960771,5.83079131456604e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39673,0.01917274835228,0.00422882454699571,0.0108842522401684,0.0274612444643916,5.83502970718857e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39738,-0.0143890870692925,0.0031779765539903,-0.0206179211151135,-0.00816025302347147,6.00482223535216e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39817,-0.0193962365084197,0.00428636814317495,-0.0277975180690426,-0.0109949549477968,6.0803300589116e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36880,0.0137035789601521,0.00302988507703902,0.00776500420915565,0.0196421537111486,6.15647280035565e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39865,0.0226573136841614,0.00503154143934683,0.0127954924630416,0.0325191349052812,6.74563427034348e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,37252,-0.01548600234199,0.00344001493404916,-0.0222284316127263,-0.00874357307125361,6.7972755128227e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37005,0.0153123323625191,0.00340355962630271,0.00864135549496577,0.0219833092300724,6.88862273082442e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37220,0.0197990021755692,0.00440145441600088,0.0111721515202075,0.0284258528309309,6.90810672226491e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36855,0.0119138471144461,0.00265391679155271,0.00671217020300281,0.0171155240258894,7.21209995246591e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36855,0.0301737476223263,0.00672851824178047,0.0169858518684366,0.0433616433762161,7.37263537743793e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39630,0.047398404550118,0.0105730973152318,0.0266751338122638,0.0681216752879723,7.41456121161727e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39557,-0.0154938910329411,0.00345775797363518,-0.022271096661266,-0.00871668540461611,7.48519247595688e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,36855,-0.0179843553280592,0.00401737121928739,-0.0258584029178625,-0.010110307738256,7.6469605499399e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39680,0.0268985935809693,0.00601414261498912,0.0151108740555906,0.038686313106348,7.78280765973339e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37203,0.014608183106577,0.00327178998832335,0.00819547472946327,0.0210208914836908,8.07671502874927e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,39680,0.0297064246046838,0.00667299124282222,0.0166273617687523,0.0427854874406154,8.57596761894037e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39754,-0.010290572403408,0.00231297336820498,-0.0148240002050898,-0.00575714460172623,8.68300616693441e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36855,0.0515195737374923,0.0115867103927174,0.0288096213677663,0.0742295261072184,8.80304311029163e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,39738,-0.0128521160082789,0.00289294613259785,-0.0185222904281707,-0.00718194158838711,8.9491627110786e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39671,0.0403946596129486,0.00909581003893337,0.0225668719366392,0.058222447289258,9.01412235571172e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,37005,-0.0142073111539557,0.00319978035924447,-0.0204788806580748,-0.0079357416498365,9.06546328704955e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39743,0.0514056354471059,0.0115897119840682,0.0286897999583323,0.0741214709358796,9.24955818697802e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,39668,0.0274229677136662,0.00618643136252719,0.0152975622431129,0.0395483731842195,9.36607002810479e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39546,0.0204858017254904,0.00462470137222813,0.0114213870359233,0.0295502164150575,9.50255692924819e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36877,-0.0133416216718437,0.00301774427222194,-0.0192564004453987,-0.00742684289828866,9.90144195208035e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37267,0.018000452681396,0.00407288321350888,0.0100176015829185,0.0259833037798734,9.96672974486256e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39755,-0.0108243723618985,0.00245168705155122,-0.0156296789829388,-0.00601906574085807,1.01642769932685e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,39673,0.0225017309760287,0.00510756345481839,0.0124909066045846,0.0325125553474727,1.06199478555123e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,39817,0.0280373187752629,0.00636638491094727,0.0155592043498063,0.0405154332007196,1.06982983464871e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,37215,0.0243254780211738,0.00553251121257759,0.0134817560445218,0.0351691999978259,1.10695364976378e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39680,-0.0118507806234203,0.00270092000600462,-0.0171445838351893,-0.00655697741165125,1.15305866777345e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37203,0.0253391528186375,0.00577923738756039,0.0140118475390192,0.0366664580982559,1.17134165669665e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39594,0.0228219940733632,0.00520598448344281,0.0126182644858153,0.0330257236609111,1.17383080477072e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37267,0.0260423714858477,0.00594511397792938,0.0143899480891062,0.0376947948825893,1.19324445519628e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39601,0.0189134680594965,0.00431817734274233,0.0104498404677215,0.0273770956512714,1.19464733727526e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36855,-0.015577813760754,0.00355647903328573,-0.0225485126659941,-0.00860711485551402,1.19541230538996e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39817,0.032731410275658,0.00748293615725842,0.0180648554074315,0.0473979651438845,1.2268492920752e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39288,0.0224251638168706,0.00512852187243243,0.012373260946903,0.0324770666868382,1.23558638675654e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37267,-0.0150077908797036,0.00343424215143173,-0.0217389054965097,-0.00827667626289737,1.25155515048641e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39557,0.0241923741773176,0.00554143468318442,0.0133311621982761,0.0350535861563591,1.27512908708174e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37005,0.0282929946287435,0.00648964668445872,0.0155732871272044,0.0410127021302826,1.31223410093401e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,39500,0.0210611041368244,0.00483604844181603,0.011582449190865,0.0305397590827838,1.33898955381947e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39836,-0.0234337583250328,0.00539348306883113,-0.0340049851399418,-0.0128625315101237,1.4024468130413e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,39293,0.0464315891409987,0.0106939800154314,0.0254713883107531,0.0673917899712443,1.42192315474308e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37277,0.00938617674993684,0.00216225334806571,0.00514816018772805,0.0136241933121456,1.42924391160459e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36896,0.013719428181018,0.00316209095202827,0.00752172991504261,0.0199171264469934,1.44393315722058e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,36907,0.0275416210330338,0.00635812517451618,0.015079695690982,0.0400035463750855,1.49054306106181e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37215,0.040374555418338,0.00932408241008683,0.0220993538945678,0.0586497569421082,1.50102838211163e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37195,0.0297267696146889,0.00687498688690685,0.0162517953163514,0.0432017439130263,1.54406435479303e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,36880,0.0303805613233276,0.00704430548143218,0.0165737225797205,0.0441874000669346,1.62399464389229e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37215,0.0316115431698885,0.00733271160520226,0.0172394284236921,0.045983657916085,1.63660226587579e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39697,0.0110495124541494,0.00256415165657989,0.00602377520725277,0.016075249701046,1.64814115716387e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37220,0.0271452505832561,0.00629999456431266,0.0147972612372033,0.0394932399293089,1.65336139617189e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39673,-0.0205998779199628,0.00478374370564442,-0.0299760155830259,-0.0112237402568998,1.67064547854021e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39288,0.0248536745561557,0.00577771948230682,0.0135293443708343,0.0361780047414771,1.70580709667667e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37005,0.0308723525428945,0.00718712621161807,0.0167855851681231,0.0449591199176659,1.75546280638512e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37215,0.041099166230276,0.00957272061662422,0.0223366338216925,0.0598616986388594,1.77228553693559e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36958,0.0398094354733038,0.00927691063892832,0.0216266906210043,0.0579921803256033,1.78955373515854e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,36855,0.0163470366656699,0.00380952052599143,0.00888037643472672,0.0238136968966131,1.79076310231546e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39736,0.0332925641603856,0.00776309676616362,0.0180768944987049,0.0485082338220663,1.8089159189716e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36855,0.0145673899622449,0.00340221550699196,0.00789904756854068,0.0212357323559492,1.86771542546696e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36958,0.0358505185220491,0.00837442929636324,0.0194366371011772,0.0522643999429211,1.87420839289901e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36880,0.0138682460175789,0.00323959851168114,0.00751863293468386,0.0202178591004739,1.8751068350625e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36801,0.0229969506158845,0.00537925733757331,0.0124536062342408,0.0335402949975282,1.924063169711e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,39594,0.0302823080107678,0.00708571060093324,0.0163943152329387,0.044170300788597,1.93373627774569e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37267,0.0192711247771102,0.00451165401045046,0.0104282829166273,0.0281139666375931,1.95579543838609e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,39817,0.0218509169094334,0.00512676329345067,0.0118024608542701,0.0318993729645967,2.03652612393519e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,39836,-0.0186201180322807,0.00437270032751075,-0.0271906106742018,-0.0100496253903597,2.07196566632202e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37268,0.030520706103776,0.00717707774202913,0.0164536337293989,0.0445877784781531,2.12805436336875e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37268,0.0117189164840814,0.00275895068799828,0.00631137313560473,0.017126459832558,2.17531270782878e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39401,-0.0130065515065701,0.00306235164525268,-0.0190087607312654,-0.00700434228187487,2.17676002441985e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39721,-0.00957051979787015,0.00225727083231821,-0.0139947706292139,-0.00514626896652646,2.24922086577091e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36880,0.00992927211120077,0.00234367797885233,0.0053356632726502,0.0145228809497513,2.28471081051151e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,37285,0.0223972546150198,0.0052938293100287,0.0120213491673636,0.0327731600626761,2.34383142362658e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,39836,-0.0244760532421881,0.0057895176527042,-0.0358235078414884,-0.0131285986428879,2.37457628470751e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36855,0.0495013278439723,0.0117183484413882,0.0265333648988515,0.0724692907890931,2.41363301713947e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,36896,0.0479697060101978,0.0113593695651777,0.0257053416624495,0.0702340703579461,2.42794355331281e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37268,0.0107886099977533,0.00255705038265651,0.00577679124774649,0.01580042874776,2.46824346275819e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39594,0.00830782045885351,0.00197210625407436,0.00444249220086776,0.0121731487168393,2.53782050240834e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36880,0.0187164555618016,0.00444802340614411,0.00999832968575916,0.0274345814378441,2.5958117845596e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,39865,-0.0159156911709237,0.00378845499932134,-0.0233410629695935,-0.0084903193722539,2.67056106023658e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37244,0.0279285766450776,0.00664881192633785,0.0148969052694554,0.0409602480206997,2.68008069401342e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,37267,0.00927069012765594,0.00220832739025964,0.00494236844274704,0.0135990118125648,2.70948520074463e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,39529,-0.0126325037956558,0.00301026923995077,-0.0185326315059593,-0.00673237608535229,2.7260152718868e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36958,-0.00854189323983632,0.00204308389746035,-0.0125463376788586,-0.00453744880081402,2.92268120536622e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39594,0.0281311758320802,0.00673878656576624,0.0149231541631784,0.0413391975009821,3.00225787878724e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39401,0.0270207013613796,0.00647935137671749,0.0143211726630133,0.0397202300597459,3.05877652211473e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,39680,0.0271526196598996,0.00652747104227739,0.014358776417036,0.0399464629027633,3.20283642237955e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37158,0.0246502521038879,0.00592913679469178,0.013029143986292,0.0362713602214837,3.23798065094413e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37215,0.0203173687707046,0.00490692497833147,0.0106997958131749,0.0299349417282343,3.48602990941471e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39571,0.0112871658619201,0.00272719094205613,0.00594187161549006,0.0166324601083501,3.51021220527412e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39203,0.0232243553225311,0.00561496960796293,0.0122190148909238,0.0342296957541385,3.55062632592844e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36877,0.0269957835768346,0.00653266742565781,0.0141917554225453,0.0397998117311239,3.61196144076977e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,37203,0.0152309563130025,0.00371780892449331,0.00794405082099559,0.0225178618050094,4.21454735547751e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39680,0.0343678027281639,0.00839127249129104,0.0179209086452335,0.0508146968110944,4.23060934915916e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36880,0.0164110602247422,0.00400761256583299,0.00855613959570955,0.0242659808537749,4.24771554907227e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,39401,0.0203738300683326,0.0049798489161212,0.0106133261927351,0.0301343339439302,4.31209751146512e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37846,-0.0120736271202363,0.0029511951389011,-0.0178579695924825,-0.00628928464799015,4.31742967369144e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36877,-0.0127235647073523,0.00311000882325698,-0.018819182000936,-0.00662794741376865,4.31793718686742e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37244,0.0356938448756124,0.00873177329778166,0.0185795692119603,0.0528081205392645,4.38004413474633e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36855,-0.010243249067847,0.00250872612491003,-0.0151603522726707,-0.00532614586302338,4.47150224960887e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36958,0.0446858124936096,0.0109531622981199,0.0232176143892946,0.0661540105979246,4.53574428530374e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,37257,0.0088848111636595,0.00218019867895128,0.004611621752915,0.013158000574404,4.62339438862743e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39504,-0.0103011357428544,0.00252798301893993,-0.0152559824599767,-0.00534628902573217,4.62724758087967e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36795,-0.0103155781059341,0.00253258416161147,-0.0152794430626925,-0.00535171314917557,4.66593583076208e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,37203,0.0161256318247155,0.00396090792092991,0.0083622522996929,0.0238890113497381,4.70421791174298e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39401,0.0256524894214203,0.00630314458321493,0.0132983260383191,0.0380066528045216,4.72877091699669e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39673,0.0139401513564992,0.00343481061125632,0.00720792255843682,0.0206723801545616,4.96280897069955e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39756,-0.00788160775113585,0.00194482083003717,-0.0116934565780087,-0.00406975892426299,5.088947896409e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,37208,0.0249068310919126,0.00615068125618006,0.0128514958297996,0.0369621663540255,5.16297937894718e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,39673,-0.0230364074797038,0.00568981915096346,-0.0341884530155921,-0.0118843619438154,5.17468450722055e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,37215,0.0131112231908027,0.00324251557592646,0.00675589266198684,0.0194665537196186,5.29470826967287e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36896,-0.0169184375130938,0.0041864077318389,-0.025123796667498,-0.00871307835868953,5.34658713968016e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,37213,-0.0182610738887909,0.00451996390682474,-0.0271202031461674,-0.00940194463141445,5.37291415740533e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37195,0.0158413935009107,0.00392160939783572,0.00815503908115264,0.0235277479206687,5.38623005387818e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37151,-0.0110081561684039,0.00273378707195429,-0.0163663788294343,-0.00564993350737344,5.68778777138859e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39288,0.0187166150024311,0.00465185226694246,0.00959898455922393,0.0278342454456384,5.76189354146285e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36872,0.0108705001665421,0.00270732923691121,0.00556413486219615,0.0161768654708881,5.97257439134689e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39673,-0.015773208228106,0.00394190826441528,-0.0234993484263599,-0.00804706802985204,6.32518753543171e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,39594,0.0272515132697797,0.00681198218319874,0.0139000281907102,0.0406029983488493,6.34909533504377e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39817,-0.010820029015684,0.00270698932049481,-0.0161257280838539,-0.0055143299475142,6.44193853975221e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37236,0.0237810723682396,0.00595712396930941,0.0121051093883931,0.035457035348086,6.58573664555736e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37244,0.0148835438460369,0.0037300130927891,0.00757271818417022,0.0221943695079035,6.63659081725453e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36795,-0.0115614357281996,0.00290235998373551,-0.0172500612963212,-0.00587281016007796,6.82910705652814e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36958,0.0340499268381415,0.0085482828457591,0.0172952924604537,0.0508045612158294,6.83475346715709e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37244,0.0254721500365112,0.00640552993151849,0.012917311370735,0.0380269887022875,7.02789631124764e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,39288,0.0282292040441623,0.00711247811220492,0.0142887469442407,0.042169661144084,7.25111825726964e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39302,0.024696032397094,0.00622625593862246,0.012492570757394,0.036899494036794,7.32852688837783e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,36827,0.0211185447788209,0.00532582298401816,0.0106799317301453,0.0315571578274965,7.3693949562675e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37220,0.0408931785557858,0.010317109332178,0.020671644264717,0.0611147128468546,7.42035405280194e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36855,-0.0159610592813,0.00402694982225294,-0.0238538809329158,-0.00806823762968426,7.42351731195716e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39557,0.0157556370082182,0.00399230489682694,0.00793071941043745,0.023580554605999,7.96468680279521e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,39401,0.0316346135965822,0.00801598416028328,0.015923284642427,0.0473459425507374,7.96702091304679e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36958,0.0231544554177665,0.00587520234507897,0.0116390588214118,0.0346698520141213,8.15477374896008e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,37268,0.0202926310430567,0.00516029171511396,0.0101784592814334,0.0304068028046801,8.45047616561296e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36827,-0.0342224761884946,0.00870306142553495,-0.0512804765825431,-0.0171644757944461,8.45978552106869e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,37285,-0.0115150353324715,0.00293043381052207,-0.0172586856010948,-0.00577138506384828,8.55619353251317e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36855,-0.0106108411601304,0.00270058863806376,-0.0159039948907354,-0.00531768742952547,8.57111826353199e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36827,-0.0109594326997961,0.00279246837605065,-0.0164326707168553,-0.00548619468273678,8.7308192370918e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCT,Secretin,36877,0.0168241146153595,0.00428751578119738,0.0084205836842126,0.0252276455465063,8.75467721564239e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36855,-0.00766527676550232,0.00195390613832065,-0.0114949327966108,-0.00383562073439385,8.78839250482901e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36855,0.0136313429053346,0.00347575603136675,0.00681886108385575,0.0204438247268134,8.83286919554245e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36896,-0.0112680163159125,0.00287737268054392,-0.0169076667697786,-0.00562836586204646,9.04596424804341e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39561,-0.008705144728911,0.00223104559229271,-0.0130779940898047,-0.00433229536801729,9.58692230703271e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAT,Catalase,37086,0.019848938583147,0.00509487079206851,0.00986299183069272,0.0298348853356013,9.83299500726452e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39820,0.0351621547840477,0.00902617377025988,0.0174708541943384,0.0528534553737571,9.83647894569469e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37220,0.00827861565886363,0.00212657675232556,0.00411052522430554,0.0124467060934217,9.95219421726992e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39511,-0.0235274253260131,0.00604723145868651,-0.0353799989850387,-0.0116748516669876,0.000100405995397036
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36958,0.0476862033552373,0.0122619647672229,0.0236527524114804,0.0717196542989942,0.000101174933291071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39557,-0.0105257245225363,0.00270703895983184,-0.0158315208838067,-0.00521992816126589,0.000101372967752139
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39680,-0.00954262596098596,0.00245638518296989,-0.014357140919607,-0.00472811100236497,0.000102820701456037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37267,-0.0126244458994205,0.00325693737370634,-0.019008043151885,-0.00624084864695611,0.000106618855100585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,39836,0.00927096129129796,0.00239300447323424,0.00458067252375884,0.0139612500588371,0.000107405485855341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,39401,0.0173351865248185,0.00447739768020127,0.00855948707162405,0.026110885978013,0.000108516661715615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36877,0.0227181692889351,0.00588252586034885,0.0111884186026514,0.0342479199752189,0.000113018450770762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39401,-0.0123176311347826,0.00319032929211437,-0.0185706765473268,-0.00606458572223846,0.000113414694296101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39790,-0.0125742839003587,0.00326031994368614,-0.0189645109899835,-0.00618405681073386,0.000115350155169658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,36877,0.0162764769534103,0.00422186105677191,0.00800162928213735,0.0245513246246832,0.000116150899055205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37005,0.0197623062176213,0.00512688587462631,0.00971360990335372,0.0298110025318888,0.000116451036027496
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,39817,0.0427330448842597,0.0111263167386705,0.0209254640764655,0.064540625692054,0.000123149294037805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,37215,0.0261237623835495,0.00680153957265254,0.0127927448211505,0.0394547799459484,0.000123170570534981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,39680,0.0284145552414041,0.0074006196218441,0.0139093407825897,0.0429197697002185,0.000123773786019214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,39594,-0.00555777543022954,0.00144858814220006,-0.00839700818894165,-0.00271854267151743,0.000125193677074071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,39401,0.0140171538501138,0.00365892086432565,0.00684566895603556,0.0211886387441921,0.000128149816003714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36880,0.0229440011763537,0.00599581591082406,0.0111922019911386,0.0346958003615689,0.000130496352573888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39302,0.0140906290477501,0.00369553913019689,0.00684737235256423,0.0213338857429361,0.000137893513329102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37168,0.0177755349572191,0.00467830917798286,0.00860604896837269,0.0269450209460655,0.000145596297653936
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39648,-0.00635351269816154,0.00167309435699542,-0.00963277763787257,-0.00307424775845051,0.000146732394399406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,36855,-0.0260735015698309,0.00687689429835243,-0.0395522143946016,-0.0125947887450601,0.000150438903665969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36855,0.0162109580364241,0.00427964626345038,0.00782285136006136,0.0245990647127868,0.000152598439598761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39288,0.0160505519286025,0.00424521875515185,0.00772992316850487,0.0243711806887001,0.000156880449739305
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37104,-0.0150709896292031,0.00399484572099979,-0.0229008872423627,-0.00724109201604353,0.000162253206137983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36958,0.0135261555694204,0.0035878913990901,0.00649388842720383,0.020558422711637,0.000164000325440755
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36880,0.0190748646229677,0.00506039390715212,0.00915649256494957,0.0289932366809859,0.000164335114545922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,36907,0.0159853604765576,0.00424158691996192,0.00767185011343226,0.024298870839683,0.000164808423812072
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,36896,0.0191015193518573,0.00506868730426765,0.00916689223549265,0.0290361464682219,0.000164932967179795
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37268,0.0260883857697472,0.00692278792322532,0.0125197214402256,0.0396570500992689,0.000164948549197376
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39675,0.0135905354617695,0.00361058928563839,0.00651378046191822,0.0206672904616207,0.000167769904304586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39668,-0.00882380070298157,0.00234452900292855,-0.0134190775487215,-0.00422852385724161,0.000168109932294363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36855,0.0184476070405649,0.00490222499815933,0.00883924604417262,0.0280559680369572,0.000168551922957929
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36896,0.0235073362057262,0.00625589913382792,0.0112457739034235,0.0357688985080289,0.000172280005561082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39860,-0.0148664205308564,0.00396370418115089,-0.0226352807259122,-0.00709756033580067,0.000177006952118561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,39548,0.0209311567735984,0.00559325417735557,0.00996837858598152,0.0318939349612153,0.000183056169047358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39680,0.0106036361292234,0.00283451830306505,0.00504798025521587,0.0161592920032309,0.000184013462068403
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,39630,0.0144397822275991,0.00386051313756559,0.00687317647797054,0.0220063879772277,0.000184393589964202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39401,-0.0140574588785318,0.00376288159636147,-0.0214327068074003,-0.00668221094966332,0.000187771579354516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36877,0.0217932809355721,0.00584319394410833,0.0103406208051198,0.0332459410660244,0.000192532036234538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37203,0.017545991955942,0.00470679015537494,0.00832068325140712,0.0267713006604769,0.000193953690439669
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,39557,-0.0126265549508253,0.00338729937230962,-0.0192656617205522,-0.00598744818109848,0.000193977613351794
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,37268,0.0240108372530067,0.00644871049444049,0.0113713646839033,0.03665030982211,0.000197397889838039
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37215,-0.0178333264344586,0.00480621414771333,-0.0272535061639767,-0.00841314670494045,0.000207711994325319
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37005,0.0255990250924293,0.00690701784995974,0.0120612701065082,0.0391367800783504,0.000211227367631045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,39302,0.0260371864784475,0.00705028988889195,0.0122186182962193,0.0398557546606757,0.000222330167057866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,39860,-0.00950488693789196,0.00257581973658815,-0.0145534936216047,-0.0044562802541792,0.000224959295442561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36880,0.0203900769885095,0.00553036241132599,0.00955056666231054,0.0312295873147084,0.000227895220899405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37285,-0.00925030920362493,0.00251989534947971,-0.0141893040886052,-0.00431131431864469,0.000242625397063861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_E,,39673,0.00967437515879191,0.00263600013714637,0.00450781488998504,0.0148409354275988,0.000243256050917467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37244,-0.015929687318839,0.00435052370858868,-0.0244567137876728,-0.0074026608500052,0.000251653389394253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,39817,-0.0108408257381513,0.00296257744014978,-0.0166474775208448,-0.00503417395545769,0.000253764845240476
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,37277,-0.00845269118232991,0.00231020569593987,-0.0129806943463721,-0.00392468801828776,0.000254322425854064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,36827,0.0153653087585629,0.00420591016111086,0.0071217248427856,0.0236088926743402,0.000259946429405509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,37203,0.0230931610312376,0.00632794980962715,0.0106903794043684,0.0354959426581068,0.00026386607516924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36896,0.0187772385865848,0.0051535050435699,0.00867636870118779,0.0288781084719818,0.000269909646288568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36855,0.0161100291029983,0.0044226182241956,0.00744169738357489,0.0247783608224216,0.000270900608146196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,39302,0.0180579575705611,0.00496206750667386,0.00833230525748033,0.0277836098836419,0.000274378139595389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,39269,0.0217940147612626,0.00599036293462128,0.0100529034094049,0.0335351261131203,0.000275468834424692
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,39715,-0.0190641687006969,0.00524435267653079,-0.0293430999466972,-0.00878523745469651,0.000278664918444286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37268,0.0112493165871179,0.00310579429718665,0.00516195976463212,0.0173366734096038,0.000293365912839926
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36880,0.0176543696513431,0.00487801618425646,0.00809345793020041,0.0272152813724857,0.000296669714477001
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36877,0.0215759748714884,0.00596323455876006,0.00988803513631872,0.0332639146066582,0.000297821302705247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39302,0.0141721792004368,0.00391847179710921,0.0064919744781027,0.0218523839227708,0.000299262354618634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,39302,0.0247134805870697,0.00684872181071053,0.0112899858380771,0.0381369753360623,0.000308968663775481
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39288,0.0251365170009205,0.00699621112089928,0.0114239432039579,0.0388490907978831,0.000328066354793848
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36795,0.017186372707833,0.0047981445875624,0.00778200931621074,0.0265907360994553,0.000342383929936974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,39743,0.0123311811288086,0.00344863962242471,0.00557184746885615,0.019090514788761,0.000350375445441262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36880,0.0147800924377245,0.00413510667455773,0.00667528335559133,0.0228849015198576,0.000352442661767953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39721,0.00876936616966057,0.00245544034560457,0.00395670309227561,0.0135820292470455,0.000356125435351217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,39675,-0.00761498662715553,0.00213362151408783,-0.0117968847947677,-0.00343308845954338,0.000359348700621938
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37005,0.0203069254397191,0.0056950011104857,0.00914472326316715,0.0314691276162711,0.000364111444208346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,39585,0.00973117419833886,0.00272924591040416,0.00438185221394671,0.015080496182731,0.000364216273067924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39674,-0.0137428925515672,0.00385900661789944,-0.0213065455226501,-0.00617923958048433,0.000370175575591151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39865,0.0156634337528058,0.00440032406905517,0.00703879857745762,0.0242880689281539,0.000372483121790832
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39268,0.0262369987130117,0.00737151916826094,0.0117888211432203,0.0406851762828032,0.000373049738983048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39721,-0.0155141854307194,0.00436262066137959,-0.0240649219270234,-0.00696344893441538,0.000377408302494695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39668,-0.0301999673320655,0.00849691603433741,-0.0468539227593668,-0.0135460119047642,0.000380197676417018
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,39302,0.0229215222155353,0.00644973017179083,0.0102800510788253,0.0355629933522454,0.000380735382631564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39401,0.0247468696535286,0.00696501120017611,0.0110954477011834,0.0383982916058738,0.000381954412728142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37203,0.0188879049950853,0.00531755850720028,0.00846549032097271,0.0293103196691978,0.000383650239346032
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37005,-0.00950257013461983,0.00268699035710418,-0.014769071234544,-0.00423606903469564,0.000406846098233342
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,39302,0.0266411231022259,0.00753609031999918,0.0118703860750275,0.0414118601294243,0.000408754081232405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37267,0.0202244107374601,0.00573136776271799,0.0089909299225328,0.0314578915523873,0.000418967599336155
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39594,0.00701584240499832,0.00199365930624816,0.00310827016475193,0.0109234146452447,0.000434272211295791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39865,0.0234302934398838,0.00666351572414127,0.0103698026205669,0.0364907842592007,0.000438972654693396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39673,0.0281200151670793,0.00800353654179926,0.0124330835451528,0.0438069467890059,0.000443565024518141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,39470,0.0356593388439038,0.010175134985221,0.0157160742728707,0.055602603414937,0.000458649595776963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,39820,-0.00984040479824439,0.00281449843347523,-0.0153568217278558,-0.00432398786863295,0.000472993097220617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36840,0.0135276782132818,0.00387024964889611,0.00594198890144541,0.0211133675251182,0.000475112081394779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,39680,-0.0127823718279518,0.00365812000511759,-0.0199522870379823,-0.00561245661792137,0.000476702556121247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,36855,-0.0105335846394897,0.00301687613523085,-0.0164466618645422,-0.00462050741443724,0.000481814658310305
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,36855,0.0208504613465175,0.00598861828393583,0.0091127695100033,0.0325881531830318,0.000499913079990016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39637,-0.0181798600180783,0.0052372443232559,-0.0284448588916599,-0.00791486114449675,0.000519399559340874
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,37268,0.0331966109320641,0.00956445949486774,0.0144502703221234,0.0519429515420049,0.000520485754733892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,36855,-0.0113605396745035,0.00328204670652989,-0.0177933512193021,-0.00492772812970489,0.000539062649654924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39266,0.0158690381868886,0.00458651781597735,0.00687946326757297,0.0248586131062042,0.000541775042673558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,37177,0.00934163827467414,0.0027055042565217,0.0040388499318916,0.0146444266174567,0.000556468683124429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36880,0.0199966185858815,0.00580005758091587,0.00862850572728637,0.0313647314444766,0.000567255813925003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,39790,0.0204476717356892,0.00594068408598891,0.00880393092715098,0.0320914125442275,0.000578971458478752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,37215,0.015036280617578,0.00436901828822929,0.00647300477264858,0.0235995564625074,0.000580120310668263
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39673,0.0305489956429049,0.00890160776511741,0.0131018444232747,0.047996146862535,0.000601009407083253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39594,0.0285371191990702,0.00832354409662526,0.0122229727696847,0.0448512656284557,0.000608522180430351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39693,0.0210030176849769,0.00613302973593421,0.00898227940254585,0.0330237559674079,0.000617323730573987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39538,-0.0110150375088595,0.00322564249517582,-0.0173372967994041,-0.00469277821831488,0.000639822721777808
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39621,-0.0192818504323738,0.00564749767399814,-0.0303509458734102,-0.00821275499133747,0.000641238432855447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36827,-0.0186154737538249,0.00545893044511738,-0.029314977426255,-0.00791597008139485,0.000651380438366508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39302,0.0144387462202966,0.00423571311305948,0.00613674851869998,0.0227407439218931,0.000654133221150267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37058,0.00442956531306906,0.00129971132596325,0.00188213111418109,0.00697699951195702,0.000656088035789572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,36896,-0.00887263416305163,0.00260385774923069,-0.0139761953515438,-0.00376907297455947,0.000657600984278931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39384,0.0136636399114153,0.00401229170155776,0.00579954817636207,0.0215277316464685,0.000662235050495869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,39368,0.01774874910368,0.00521202378464393,0.00753318248577789,0.0279643157215821,0.000662475255491108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,36880,0.0100474785401514,0.00295061075316738,0.0042642814639433,0.0158306756163594,0.000663103600344771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39673,0.0395242972987216,0.0116214053391914,0.0167463428339064,0.0623022517635368,0.000673080776500276
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,39726,-0.0127568188042216,0.00375228815371225,-0.0201113035854976,-0.00540233402294556,0.000676150556840592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,36855,-0.0156933096044689,0.00461801156438396,-0.0247446122706615,-0.00664200693827633,0.000680138128514703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36880,0.0208907420336108,0.00615100885005331,0.00883476468750634,0.0329467193797153,0.00068504768750616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,37005,-0.0138918829395178,0.00409031271570624,-0.0219088958623021,-0.00587487001673359,0.000685085195687378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39860,-0.0191716614827305,0.0056483895121985,-0.0302425049266396,-0.00810081803882147,0.000690009868881926
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,39653,-0.0217353023481813,0.00641017258244927,-0.0342992406097819,-0.00917136408658075,0.000698719807053566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,39401,0.0371935567716786,0.010983073818649,0.0156667320871265,0.0587203814562307,0.000709803051713518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37203,0.0205623378189666,0.00607366642953057,0.00865795161708665,0.0324667240208465,0.000712560769237434
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39836,0.0107726377505174,0.0031825889802188,0.00453476334928861,0.0170105121517463,0.000713842740918415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39721,-0.00929688860385526,0.00274745919310451,-0.0146819086223401,-0.00391186858537043,0.000716596418009184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,39836,-0.0144210876456937,0.00426262903613147,-0.0227758405565114,-0.00606633473487607,0.000718331184496494
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,39594,0.00946624047598539,0.00279834618520441,0.00398148195298475,0.014950998998986,0.00071926191505309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,36896,0.0161191735907687,0.00476524633316089,0.00677929077777333,0.025459056403764,0.00072000505094901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36855,0.0322485951678182,0.00953923482443061,0.0135516949119342,0.0509454954237022,0.000725335564247964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,39673,0.0183029184593062,0.00541516261114566,0.00768919974146072,0.0289166371771517,0.000726772152158364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,39495,0.0186900028467687,0.00553086105909438,0.00784951517094372,0.0295304905225937,0.000728690747133858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39288,0.0153070851466243,0.00453766181070592,0.00641326799764074,0.0242009022956079,0.00074444314457268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36795,-0.00991586242906233,0.00294819600123985,-0.0156943265914924,-0.00413739826663222,0.000772216389002919
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36795,-0.0182970888741149,0.00544358940548629,-0.028966524108868,-0.00762765363936173,0.000778243123964095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,39207,-0.0224786432731981,0.00669707997380794,-0.0356049200218617,-0.00935236652453456,0.000791318208882143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36880,0.0284099396678941,0.00846860679024646,0.0118114703590111,0.0450084089767772,0.000796676343979575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37267,-0.00807937892725201,0.00241583136138767,-0.0128144083955718,-0.00334434945893218,0.000827025472249064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,36855,-0.0118284386618216,0.00353913527352739,-0.0187651437979353,-0.0048917335257079,0.000833567076046235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39538,0.0304607788736129,0.00911696144247267,0.0125915344463665,0.0483300233008594,0.000836387971617505
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36896,-0.0134861242297926,0.00404165091810912,-0.0214077600292864,-0.00556448843029868,0.000849901461427677
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,39698,-0.00898115238400375,0.00269262806468042,-0.0142587033907774,-0.00370360137723014,0.00085354157982181
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,39288,0.0218602684435257,0.00655393624879581,0.00901455339588589,0.0347059834911655,0.000853650608587774
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37244,0.0193327951295218,0.00581043951225531,0.00794433368550143,0.0307212565735422,0.000879434182870864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,39850,0.0103685574129563,0.00311881165715703,0.00425568656492853,0.0164814282609841,0.000887694251837687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39288,0.0165024344341907,0.00496430442693518,0.00677239775739779,0.0262324711109837,0.00088873116976627
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39848,0.0160523136968238,0.00482942319408465,0.00658664423641792,0.0255179831572298,0.000889810774466163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37056,0.0179354178648753,0.00539927911796964,0.00735283079365484,0.0285180049360958,0.000896762225477241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,39805,-0.0130826653984264,0.00394088997036695,-0.0208068097403456,-0.0053585210565072,0.00090308681008765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,37005,-0.0108593848625027,0.00327706213654653,-0.0172824266501339,-0.00443634307487151,0.00092300511733522
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,39401,0.0153081508603887,0.0046224352073329,0.00624817785401626,0.0243681238667612,0.000929400724092652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37262,-0.0347364573956431,0.0105059251240932,-0.0553280706388657,-0.0141448441524205,0.000947622382291653
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37215,0.0134350128731373,0.00406503662710674,0.00546754108400804,0.0214024846622665,0.000952209879454218
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37244,-0.0152146127090615,0.00460422633115073,-0.024238896318117,-0.0061903291000061,0.000953998364858667
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39673,-0.0109928983408191,0.00333223137264678,-0.0175240718312068,-0.00446172485043139,0.000972581003407902
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39680,0.0209114569645699,0.00634047422601456,0.00848412748158133,0.0333387864475584,0.000975595570586181
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,36896,-0.0171042960182459,0.00519180611069789,-0.0272802359952138,-0.00692835604127804,0.000988672852955822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36827,-0.0107839043662711,0.00327817113972536,-0.0172091198001328,-0.00435868893240939,0.00100593863204287
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,37244,0.00954238028148714,0.00291019162055557,0.00383840470519823,0.0152463558577761,0.00104459090329126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,36855,-0.0111040145621347,0.00338765581375538,-0.0177438199570952,-0.00446420916717414,0.00104898951501979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,39245,-0.0285163678485952,0.00870869058193084,-0.0455854013891797,-0.0114473343080108,0.00106093285276217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37268,-0.0104495587650256,0.00319517134496923,-0.0167120946011652,-0.00418702292888589,0.00107658119580429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39668,0.0086844841365079,0.00265898442129079,0.00347287467077794,0.0138960936022378,0.00109275555244435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37215,0.037409278189378,0.0114773156997488,0.0149137394178703,0.0599048169608857,0.00111923508868651
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36958,-0.0103131856991734,0.00316548253681282,-0.0165175314713266,-0.0041088399270203,0.00112480732058635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37080,-0.00254346828575704,0.000781340391802981,-0.00407489545369088,-0.00101204111782319,0.0011357249450861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36795,0.0193138226191765,0.00595405718287148,0.00764387054074843,0.0309837746976046,0.0011824224611015
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37220,0.0749554157021829,0.0231140914108638,0.0296517965368898,0.120259034867476,0.00118633034436322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,37215,0.0104184647025941,0.0032151603729449,0.00411675037162215,0.0167201790335661,0.00119646687907364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,36880,-0.0204756985127832,0.00632389504177725,-0.0328705327946666,-0.00808086423089979,0.00120744069303631
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39716,0.0199763787857136,0.00617416737040845,0.00787501073971309,0.0320777468317142,0.00121688524295193
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39266,0.0130390542288037,0.00403528711458583,0.00512989148421544,0.0209482169733919,0.001235054423963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39302,0.0229711833161299,0.00711066464859347,0.00903428060488668,0.0369080860273731,0.00123821586050249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39570,0.00830313330784079,0.00257262324047248,0.00326079175651472,0.0133454748591669,0.00125134530401806
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,39401,0.0139654151574019,0.00432974730757134,0.00547911043456207,0.0224517198802417,0.0012603171420121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39557,0.0182327995569353,0.00565738956377506,0.00714431601193618,0.0293212831019344,0.00127190408325911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,39697,0.00919500189172065,0.00285667358040594,0.003595921674125,0.0147940821093163,0.00128996804177753
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,36795,-0.0110689199662294,0.00344744134025632,-0.0178259049931318,-0.00431193493932703,0.0013270618981592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39605,-0.00802236207040158,0.00250103593709362,-0.0129243925071051,-0.00312033163369807,0.0013410791679549
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39594,0.0165958449363954,0.00517541312399281,0.00645203521336953,0.0267396546594213,0.00134549141784813
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,37244,0.0158682361103314,0.00495406132571477,0.00615827591193045,0.0255781963087323,0.0013628626732383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,39401,0.0123668715000769,0.00386272464984057,0.00479593118638938,0.0199378118137644,0.0013694506474523
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39564,0.00742224472033711,0.00231842237047296,0.00287813687421011,0.0119663525664641,0.00137024124359131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36807,0.0303767908354825,0.00949215182340928,0.0117721732616004,0.0489814084093647,0.00137663162584416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36827,-0.0186844364449906,0.0058430651243064,-0.0301368440886312,-0.00723202880135007,0.00138855435709281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37005,0.0229602643259047,0.00718489769890992,0.00887786483604128,0.0370426638157682,0.00139856320724315
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,39156,0.0183194810147625,0.00574240429512401,0.00706436859631944,0.0295745934332056,0.00142455870243175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37203,0.0137015553233766,0.00429544186605646,0.00528248926590597,0.0221206213808473,0.00142705688534308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38834,0.0109970241163778,0.00345047368539459,0.00423409569300441,0.0177599525397512,0.00143999445498642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,39673,0.00954007137690357,0.00299590657889983,0.0036680944822599,0.0154120482715472,0.00145351325648179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39673,0.037476854795667,0.0117830154834054,0.0143821444481923,0.0605715651431416,0.0014726291251398
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,39379,0.0151337403860407,0.0047605068356657,0.0058031469881359,0.0244643337839454,0.00148064673145062
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,39302,0.0119838874618908,0.00377169397903289,0.0045913672629863,0.0193764076607952,0.00148934451353348
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39631,0.00869679379764801,0.00273754230175085,0.00333121088621635,0.0140623767090797,0.00149164823313949
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,37220,-0.0113093768566351,0.00358642843106394,-0.0183387765815204,-0.00427997713174974,0.0016174805942906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39647,0.0219680575085281,0.00699908153769375,0.00824985769464838,0.0356862573224079,0.00170008234696295
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,36855,-0.0164909335777204,0.00526506186640178,-0.0268104548358679,-0.00617141231957293,0.0017391982872564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39288,0.0231221326376717,0.00738278562034656,0.00865187282179248,0.037592392453551,0.00174004776670164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39680,0.00982785098227838,0.00314178170613355,0.00366995883825662,0.0159857431263001,0.00176251294490665
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39738,0.00889713136658405,0.00284467831956659,0.00332156186023352,0.0144727008729346,0.00176533988165744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,36855,-0.0129773808682033,0.00416231787621553,-0.0211355239055857,-0.00481923783082085,0.00182588369398699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36927,-0.0147720125941072,0.00474515061114347,-0.0240725077919484,-0.005471517396266,0.00185548304679146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39668,-0.00993913504404536,0.00319729149888931,-0.0162058263818684,-0.00367244370622231,0.00188302766809229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36795,0.0204198701584653,0.00656908800203342,0.00754445767447976,0.0332952826424508,0.00188461116483786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,39207,-0.0193543236872496,0.0062269686630816,-0.0315591822668895,-0.00714946510760963,0.00188609480527737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39557,0.00686242282028675,0.00220927400426415,0.00253224577192901,0.0111925998686445,0.00189853287150051
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,39836,0.00612043023113039,0.0019711362644779,0.0022570031527537,0.00998385730950707,0.00190594764434163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,36958,-0.0131169601121142,0.00423070540832312,-0.0214091427124276,-0.00482477751180093,0.00193656993713931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,35499,0.030262011909003,0.00976705971888439,0.0111185748599896,0.0494054489580164,0.00195048698326201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,37268,0.0110221827861213,0.00356238739692765,0.00403990348814305,0.0180044620840995,0.00197854487097907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36795,-0.0100436876148239,0.0032490712609313,-0.0164118672862493,-0.00367550794339858,0.00199740172092129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,37203,0.012631611895298,0.00409207700540342,0.0046111409647073,0.0206520828258887,0.00202706924234585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39401,0.0181865364790674,0.00589654605326714,0.00662930621466381,0.029743766743471,0.00204410684961706
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,37285,0.00916953734130641,0.00297679579381715,0.0033350175854248,0.015004057097188,0.00207183716096458
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,39288,0.0170934639362612,0.00556180657045093,0.00619232305817739,0.027994604814345,0.00212028323867931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37285,-0.00568015927064735,0.00184858478246131,-0.00930338544427152,-0.00205693309702318,0.00212551605510494
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37215,0.0148683679323443,0.00484059411664377,0.00538080346372247,0.024355932400966,0.00213343124402187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,36880,0.0154472446755399,0.00503165833450393,0.00558519433991217,0.0253092950111676,0.00214491818013469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,36795,-0.013919429352101,0.00453882945117903,-0.0228155350764119,-0.0050233236277901,0.00216850596184389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,37285,0.00765080314521317,0.00249867576335525,0.00275339864903688,0.0125482076413895,0.00220340065204689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36855,-0.0141086404174979,0.00461446976966159,-0.0231530011660346,-0.00506427966896118,0.00223661493282616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,39700,0.0110525577393716,0.00361893340994843,0.00395944825587269,0.0181456672228705,0.00226117158382781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39681,0.0168810177783594,0.00552798128387124,0.00604617446197182,0.0277158610947471,0.00226383332868518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39641,0.0111702721416398,0.00366244185922913,0.00399188609755067,0.0183486581857289,0.00229257390425275
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LXN,Latexin,39491,-0.0195694818755758,0.00642496232831103,-0.0321624080390654,-0.00697655571208616,0.0023240881410484
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39529,0.0115529180740592,0.00380028687942175,0.00410435579039259,0.0190014803577258,0.00236959017661203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,37220,-0.00885070728773294,0.00292413138111613,-0.0145820047947206,-0.00311940978074533,0.00247643231998081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_DRA,,39606,-0.0103247817051204,0.00341145724928828,-0.0170112379137255,-0.00363832549651542,0.00247800982059174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39302,0.0245600275219762,0.00811768221152737,0.00864937038738254,0.0404706846565698,0.00248632841688458
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,37220,0.0281909328287296,0.00932491241255202,0.00991410450012759,0.0464677611573315,0.00250603890794695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36880,0.00816952955805567,0.0027030041264763,0.00287164147016212,0.0134674176459492,0.00251275751209378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39743,0.0188932534486533,0.00625572530147044,0.00663203185777128,0.0311544750395354,0.00253047774238289
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,37267,0.0251613159318,0.00834430275766996,0.00880648252676688,0.0415161493368331,0.00257130636384353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37267,0.0179767886292303,0.00597387702734786,0.00626798965562847,0.0296855876028321,0.00262394751565057
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39656,-0.00643071547402278,0.00214148590721731,-0.0106280278521687,-0.00223340309587685,0.00267819310677435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39061,0.0084936012500607,0.00283070340034413,0.00294542258538619,0.0140417799147352,0.00269950124526151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,37215,0.0104175052446177,0.00347749865728804,0.00360160787633318,0.0172334026129023,0.00274327818776538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39302,0.0155793718639367,0.00520122213318066,0.00538497648290257,0.0257737672449707,0.0027458375615027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39680,0.0140630851209478,0.00470703265121784,0.00483730112456083,0.0232888691173347,0.00281539231883246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37203,0.0112798115057619,0.00377748625763401,0.00387593844079921,0.0186836845707245,0.00283107489058177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39770,0.0120298194620294,0.00403125445179813,0.00412856073650511,0.0199310781875538,0.00284810376614766
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39288,0.014941193692026,0.00500887210572917,0.00512380436479687,0.0247585830192552,0.00285935054686218
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37215,0.00779818799706604,0.00261747603464686,0.0026679349691582,0.0129284410249739,0.00289448446457953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37268,0.0155791474450743,0.00523247193012242,0.00532350246203439,0.0258347924281143,0.00291226676975702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,36708,0.0232619458502388,0.00782590367569951,0.00792317464586774,0.0386007170546098,0.00296000946522038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36855,-0.0145773074900569,0.00491751420660202,-0.0242156353349969,-0.00493897964511697,0.00303858671247094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,36958,0.00965941858256718,0.0032611659144235,0.00326753339029712,0.0160513037748372,0.00306243736872704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39401,0.0150247360848174,0.00508113991361606,0.00506570185412988,0.0249837703155048,0.00311153892570626
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,39344,0.0168468219169193,0.0056994376347171,0.00567592415287381,0.0280177196809648,0.00312253934119502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,37244,0.0198166343159628,0.0067122535511872,0.0066606173556359,0.0329726512762897,0.00315956594816758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36877,0.0167397635535027,0.00568050812050529,0.00560596763731232,0.027873559469693,0.00321569176206589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,39597,0.0205600862924143,0.0069808369184703,0.00687764593221254,0.0342425266526161,0.00323199569359125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39817,0.00826645039875227,0.00280713124580809,0.00276447315696841,0.0137684276405361,0.00323625863695011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39743,-0.012012394315611,0.00408785866842113,-0.0200245973057165,-0.00400019132550562,0.00330221235223344
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36880,0.0116815837596644,0.00397794117303419,0.00388481906051736,0.0194783484588114,0.00332422959021231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36880,0.013034697860052,0.00444748238571569,0.00431763238404926,0.0217517633360547,0.00338673881419564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39508,0.00837299390701449,0.00286069116303718,0.00276603922746162,0.0139799485865674,0.0034283733048722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39836,0.0083520707225872,0.00285930952893069,0.00274782404588305,0.0139563173992913,0.00349387149240657
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,37005,-0.00819182976804324,0.00280877040225396,-0.013697019756461,-0.00268663977962548,0.00354560716014469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,39668,0.0126711452980661,0.00435532855647471,0.00413470132737568,0.0212075892687565,0.0036269379132587
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36827,-0.00795196050048528,0.0027333637341801,-0.0133093534194783,-0.00259456758149229,0.00362945554577225
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39636,0.00628036448004082,0.00215906382085297,0.00204859939116899,0.0105121295689127,0.00363282320504149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39288,0.0111931735783794,0.00384822569588107,0.00365065121445246,0.0187356959423062,0.00363501207071379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,39721,-0.0079439727059693,0.00273237852668895,-0.0132994346182796,-0.00258851079365895,0.00365013512008255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39288,0.0131096410452726,0.0045143371369608,0.00426154025682947,0.0219577418337158,0.00368949151416815
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,37203,-0.030480298753277,0.0105002000575074,-0.0510606908659915,-0.00989990664056243,0.00370412599763526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39673,-0.0128420863713031,0.00442618760842043,-0.0215174140838071,-0.00416675865879901,0.00372026313405386
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36896,0.0113922524587525,0.00393470068358829,0.00368023911891944,0.0191042657985855,0.00379390455634942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39817,0.0181746932565456,0.0062874896836725,0.0058512134765475,0.0304981730365437,0.00385010958168094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,39266,0.0241283362837936,0.00835610736354594,0.00775036585124352,0.0405063067163436,0.00388845589903954
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,39641,0.00731229647709732,0.00253948120055255,0.00233491332401433,0.0122896796301803,0.00398911386166989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,39865,0.0168737325180599,0.00586112275216131,0.00538593192382377,0.0283615331122961,0.00399561933970204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37005,-0.0173652414764806,0.0060426032299507,-0.029208743807184,-0.00552173914577727,0.00406213971647202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,37285,-0.00616953530693284,0.00214796642328486,-0.0103795494965712,-0.0019595211172945,0.00408175478753142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,39737,-0.00750881788187616,0.00261478318532868,-0.0126337929251204,-0.00238384283863195,0.00408837840700593
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,36896,0.0175987115917396,0.00612900443832133,0.00558586289262976,0.0296115602908494,0.00409340133776934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,36795,-0.0114676200025239,0.0039988968077194,-0.0193054577456539,-0.00362978225939391,0.00414141040929604
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37244,-0.0102135765240699,0.00356329409327149,-0.0171976329468821,-0.00322952010125781,0.00415908762375923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,36855,-0.00982866107047753,0.00343070963498416,-0.0165528519550465,-0.00310447018590857,0.00417801617440224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36855,0.0101257176360796,0.00353460188464573,0.00319789794217392,0.0170535373299852,0.00418019881469667
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,39518,0.0125359742507631,0.00438002262338301,0.00395112990893242,0.0211208185925938,0.00421428879214241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39836,-0.0164804888345836,0.00576154102061504,-0.0277731092349891,-0.00518786843417812,0.00423614543697081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36896,0.0117361521530723,0.00410561317227877,0.00368915033540592,0.0197831539707387,0.00426239844899427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37203,0.0100909781567822,0.0035384737380512,0.0031555696302018,0.0170263866833625,0.00435407971087547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,36795,-0.0163290108964374,0.00573390361727345,-0.0275674619862934,-0.00509055980658146,0.00440919591420343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,36855,-0.013592202204401,0.00477492909014876,-0.0229510632210926,-0.00423334118770948,0.00442612933140504
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,39817,0.00684573953576992,0.00240998450182355,0.00212216991219577,0.0115693091593441,0.00450894129921658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,36795,-0.00852419156262939,0.00300110868830741,-0.0144063645917119,-0.00264201853354686,0.00451347681007535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37244,0.00873936869247403,0.00308116210421579,0.00270029096821109,0.014778446416737,0.00456955909922241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39673,0.0127287838963443,0.00449421403131664,0.00392012439496365,0.0215374433977249,0.0046278624286097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,39760,-0.0107484116425874,0.0037953084201171,-0.0181872161460169,-0.0033096071391579,0.0046312227215151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,36827,0.0231726770505618,0.00818273190440182,0.00713452251793424,0.0392108315831894,0.00463436321692699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,39668,-0.00520940451129303,0.00183990373199235,-0.00881561582599803,-0.00160319319658802,0.00464110475059031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,37220,0.0103756744847328,0.00367558127274597,0.00317153519015074,0.0175798137793149,0.00476667708733481
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36877,-0.0100176644464452,0.00355184425703665,-0.0169792791902371,-0.00305604970265341,0.00480345493754064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37220,0.00985198295756374,0.00349378458409423,0.00300416517273905,0.0166998007423884,0.00481153680666634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,39133,0.00940676140972511,0.0033371996553964,0.00286585008514817,0.015947672734302,0.00482717115786593
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36896,-0.00796204493327515,0.00282788233186764,-0.0135046943037357,-0.00241939556281457,0.00487668515138389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,36972,-0.0057478016813316,0.00204209557866092,-0.00975030901550701,-0.0017452943471562,0.00489018636001744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,39236,0.0185690629310734,0.00660678223811878,0.00561976974436058,0.0315183561177862,0.0049510785545752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36795,0.0201051931682647,0.00715660083217057,0.00607825553721039,0.034132130799319,0.00497205184327298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39401,-0.0163552448831951,0.00583387708060475,-0.0277896439611804,-0.00492084580520974,0.00506146803902982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,39860,-0.00523263918726949,0.00186773432566084,-0.00889339846556474,-0.00157187990897424,0.00509113927689683
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,39302,0.0137647137011292,0.00492272277467432,0.00411617706276748,0.0234132503394908,0.00517779122050606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,39302,0.013148356743611,0.0047189126606608,0.00389928792871578,0.0223974255585061,0.00533767893961876
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39680,-0.00753739776810284,0.00270820089092308,-0.0128454715143121,-0.00222932402189361,0.0053893559404004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39634,0.0073822669984548,0.00265355948478361,0.00218129040827893,0.0125832435886307,0.00540851540640724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37215,0.0135346112147123,0.00486829265374693,0.00399275761336828,0.0230764648160562,0.00544088923853319
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,36795,-0.00971151826117769,0.00349405490109688,-0.0165598658673276,-0.0028631706550278,0.00545312105070752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,37285,-0.00851611498605486,0.00306633155551947,-0.014526124834873,-0.00250610513723669,0.00548890106593539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36958,0.0172845084782678,0.00623367184575161,0.00506651166059469,0.029502505295941,0.00556607633051031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36855,-0.0145709296757904,0.00526019075342011,-0.0248809035524938,-0.00426095579908693,0.00561292707461104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,39860,-0.0194585839973709,0.00703567563933655,-0.0332485082504705,-0.00566865974427128,0.00568654827983163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,39743,-0.0170907420654808,0.0061799337788996,-0.029203412272124,-0.00497807185883753,0.00568974069114242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,39675,0.00659542715661382,0.00238611268093928,0.00191864630197284,0.0112722080112548,0.00571480787256571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39288,0.0206912976099488,0.00750062656615549,0.00599006954028407,0.0353925256796136,0.00581162797705116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36896,-0.00740449742140115,0.00268666235273263,-0.0126703556327571,-0.00213863921004521,0.00585905646409243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36896,0.00956147799055383,0.0034740544937713,0.00275233118276209,0.0163706247983456,0.00592685514759661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,37203,0.0214003339774825,0.00779888660691809,0.00611451622792304,0.0366861517270419,0.00607721567059955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37277,0.0193498276621743,0.00706867980880576,0.00549521523691503,0.0332044400874336,0.00620079018339452
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39668,0.00982631190441872,0.00359466350631757,0.00278077143203627,0.0168718523768012,0.00627189854850648
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,39680,0.00625958986659634,0.00229641443008401,0.00175861758363167,0.010760562149561,0.00642144546076707
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39401,0.0149366130701782,0.00548925397064198,0.0041776752877199,0.0256955508526365,0.00651445353893134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37215,0.0128090957868724,0.00471794017944795,0.00356193303515445,0.0220562585385904,0.00663656850975307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,36877,0.0130993276265098,0.00482785052355835,0.00363674060033546,0.0225619146526842,0.00667077011081761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,37203,0.0132533542533321,0.00488895134290075,0.00367100962124666,0.0228356988854176,0.00671910050558096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37196,0.0147424010968225,0.0054532290351148,0.00405407218799748,0.0254307300056475,0.00687157043020256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39668,0.00657565866967743,0.00243786475978909,0.00179744374049082,0.011353873598864,0.0069977869211151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37244,-0.0112920217507378,0.00419587794572312,-0.0195159425243551,-0.00306810097712053,0.00712801351578621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39288,0.0120173614179494,0.00446712639024524,0.00326179369306876,0.0207729291428301,0.00714909581544701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36896,-0.0142526329666116,0.00530350409281939,-0.0246475009885376,-0.00385776494468558,0.00721022133943837
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,37215,0.00792438315529352,0.00294875974753076,0.00214481405013323,0.0137039522604538,0.00721081963026624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39288,0.0122148940893271,0.00454786995652355,0.00330106897454099,0.0211287192041133,0.00724230936774748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39673,-0.0139977334960548,0.00521833520672957,-0.0242256705012448,-0.00376979649086489,0.00731689870480049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,36795,-0.011649571844653,0.00435548875313732,-0.0201863298008021,-0.0031128138885038,0.00748929717716718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37005,0.0184929679292903,0.00692079434698663,0.00492821100919647,0.032057724849384,0.00754739490256792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39288,0.0104264461719659,0.00390392291126548,0.00277475726588552,0.0180781350780462,0.00757588151186005
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37104,0.0162781743256659,0.00611531836425087,0.00429215033173422,0.0282641983195976,0.0077802005656139
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,39668,-0.0121569048818362,0.00458209203163451,-0.0211378052638399,-0.00317600449983261,0.00798278822853291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FST,Follistatin,39720,0.0130883187570153,0.00494331669112092,0.00339941804241833,0.0227772194716123,0.00811264522313086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36795,0.00924399152680332,0.00349221814964064,0.00239924395350768,0.016088739100099,0.00813015473335164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37285,0.00447440073513648,0.00169237137705592,0.00115735283610688,0.00779144863416609,0.00820607215228422
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36896,-0.00905170967912969,0.00342653931346437,-0.0157677267335199,-0.00233569262473952,0.00826022984675588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39721,0.0251358622005678,0.00953232346073336,0.00645250821753042,0.0438192161836052,0.00837470066474125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36827,-0.0157372753087239,0.00597693630239426,-0.0274520704614166,-0.00402248015603113,0.00847346337349374
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37220,-0.0152108067146653,0.00578366591185837,-0.0265467919019077,-0.00387482152742294,0.00854929467018838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,36827,-0.0244983222001553,0.00934729320585149,-0.0428190168836242,-0.00617762751668634,0.00878002516806107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39401,-0.00905119590515206,0.00345387749803143,-0.0158207958012937,-0.00228159600901045,0.00878632287470592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36855,-0.00828671105373332,0.00316745311986002,-0.014494919168659,-0.00207850293880768,0.00890156424472342
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39790,0.0177326899556267,0.00678372207357582,0.00443659469141814,0.0310287852198354,0.00895716554236086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,37257,-0.00940894663195618,0.00361012326816257,-0.0164847882375548,-0.00233310502635754,0.00916362823238833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37220,0.0148508547620669,0.00571576778911719,0.00364794989539718,0.0260537596287365,0.00938097475670763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36855,-0.0144220842497454,0.00558987634725181,-0.0253782418903589,-0.00346592660913181,0.00988986550955952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39836,0.00955897648011709,0.00370932005998931,0.00228870916253805,0.0168292437976961,0.00997462441279443
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36855,-0.00764448091804472,0.00298162004184923,-0.0134884562000692,-0.00180050563602022,0.0103624258627881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36896,-0.0053987221244146,0.00210743356635768,-0.00952929191447566,-0.00126815233435354,0.0104257087579166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,39401,-0.0117004608863309,0.00456876465244315,-0.0206552396051195,-0.0027456821675423,0.0104474489567929
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36958,0.0221863670237846,0.00868050077505456,0.00517258550467771,0.0392001485428916,0.0106029804464934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36855,0.013892603157838,0.00545029650622978,0.0032100220056276,0.0245751843100483,0.0108157739759296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,37215,0.0280140581211491,0.0109998161915583,0.00645441838569486,0.0495736978566033,0.0108834682269093
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,36795,-0.0120512131722998,0.00473965737874268,-0.0213409416346355,-0.00276148470996419,0.0110135982339076
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37005,-0.00907577419211608,0.00357185833314339,-0.0160766165250771,-0.00207493185915503,0.0110678017419735
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37220,-0.0102738832079787,0.00404623792034345,-0.0182045095318518,-0.0023432568841055,0.0111244154420833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,36896,-0.00845638826342299,0.003330446222809,-0.0149840628601286,-0.00192871366671736,0.0111248285605857
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,39362,0.0176089867805278,0.00695026807960929,0.00398646134449354,0.031231512216562,0.0113005042713273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39508,-0.00692384236940379,0.00273553859863128,-0.0122854980227211,-0.00156218671608647,0.011381194819214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37244,0.0191440913646135,0.00757104980547617,0.00430483374588017,0.0339833489833468,0.0114635221448592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,39557,-0.01022901763178,0.00404717478561448,-0.0181614802115844,-0.00229655505197562,0.0114992658795081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,39521,0.00783863152629649,0.00310279170305125,0.00175715978831604,0.0139201032642769,0.0115363540025792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,39673,0.0228591322628668,0.0090666186588657,0.00508855969149,0.0406297048342436,0.011703914794685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39557,0.0148878718807682,0.005906944307256,0.00331026103854641,0.0264654827229899,0.011731932368343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39517,-0.00670557647703102,0.00266097967153852,-0.0119210966332465,-0.00149005632081552,0.0117465027563105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39860,-0.00844073007913395,0.0033574546286384,-0.0150213411512652,-0.00186011900700268,0.0119458786450569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39680,-0.010586776017924,0.00421650062149263,-0.0188511172360496,-0.00232243479979849,0.012055793485019
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,39628,-0.0153076922975933,0.00610861500941557,-0.0272805777160478,-0.00333480687913881,0.0122233633042805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,39668,-0.00812737782235584,0.00324369622488577,-0.014485022423132,-0.00176973322157973,0.0122346460910524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,39614,0.0111839912811901,0.004476618754286,0.00240981852278954,0.0199581640395907,0.0124887326425945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,36855,-0.0125617943454486,0.00503466652906415,-0.0224297407424143,-0.00269384794848285,0.0126058999527747
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,39680,0.0275404310348729,0.0110801641771346,0.00582330924768909,0.0492575528220567,0.0129449662359675
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36795,-0.0154045269823163,0.00619785697782838,-0.0275523266588599,-0.00325672730577268,0.0129509401451512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37005,0.00918754633625391,0.00370061907071117,0.00193433295766001,0.0164407597148478,0.0130512758095017
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,36896,0.00938410341073069,0.00378715324935596,0.00196128304199302,0.0168069237794684,0.0132292055832309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37277,-0.00942111406640433,0.00381018659495329,-0.0168890797925128,-0.00195314834029589,0.0134252597642392
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,37277,-0.00541924839563929,0.00219171532899564,-0.00971501044047074,-0.00112348635080784,0.013425495902858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,39607,0.00765293676086878,0.00309776371107142,0.0015813198871688,0.0137245536345688,0.0135040213970164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36958,0.0179037469763797,0.00726277034684803,0.00366871709655759,0.0321387768562019,0.0137086965083231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,36827,-0.0126520434224473,0.00514426578133911,-0.0227348043538719,-0.00256928249102265,0.0139281256582841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39648,0.0104617347874579,0.0042553319087197,0.00212128424636726,0.0188021853285485,0.0139625227697068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,36827,-0.0112712802626959,0.0045845999127074,-0.0202570960916024,-0.00228546443378942,0.0139645025412112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36855,-0.00897554747174918,0.00365154600389171,-0.0161325776393769,-0.00181851730412142,0.0139837687788781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36855,-0.00890169181044742,0.00362192805765004,-0.0160006708034415,-0.00180271281745334,0.0139951025886326
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36827,-0.0133502980822645,0.00543873919868871,-0.0240102269116944,-0.00269036925283462,0.0141145258040881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36546,0.0260010888729853,0.0106041961191431,0.00521686447946483,0.0467853132665057,0.0142213362205323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39675,-0.00942864850193245,0.00384934461829291,-0.0169733639537866,-0.00188393305007835,0.0143195550159179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36855,-0.0146864413334389,0.00600739938399712,-0.0264609441260733,-0.00291193854080458,0.0145094399283597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36896,-0.0160231818189513,0.00655529764933774,-0.0288715652116533,-0.00317479842624933,0.0145260920305538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,36896,-0.00645300367712784,0.00266467343994153,-0.0116757636194132,-0.00123024373484243,0.0154622256575336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,39622,0.0138594783225171,0.00573325965761056,0.00262228939360043,0.0250966672514338,0.0156438767459717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,37277,0.0142586932931056,0.0059022756606263,0.00269023299827801,0.0258271535879331,0.0157141297607751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,37215,0.0140841980641263,0.00583551028392919,0.00264659790762511,0.0255217982206275,0.0158120572150158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,36896,-0.0100348886721901,0.00415842418075774,-0.0181854000664753,-0.00188437727790492,0.0158291459106653
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36880,0.0124343706121171,0.00515483638817322,0.00233089129129758,0.0225378499329366,0.0158713803068099
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,39668,-0.0118264021988826,0.00490375672077212,-0.0214377653715959,-0.00221503902616925,0.0158895552865579
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37268,0.00781143278415187,0.00324540767768567,0.00145043373588795,0.0141724318324158,0.0161011776082263
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39401,0.00852119889135627,0.003550681439127,0.00156186327066735,0.0154805345120452,0.0164122721846717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,39302,0.00985330807422412,0.00411465673199088,0.00178858087952199,0.0179180352689262,0.0166464802253233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36795,-0.0060108353534334,0.00251119553530793,-0.0109327786026369,-0.00108889210422986,0.0166974101961525
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,39302,0.00817695827771652,0.00341710359868486,0.00147943522429419,0.0148744813311389,0.0167253870276081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39594,-0.00894175285369794,0.00373831502129853,-0.0162688502954431,-0.00161465541195283,0.0167721322510306
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39288,0.0185894558461848,0.00778116595877845,0.00333837056697906,0.0338405411253906,0.0169047638150021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36795,-0.00962467076404509,0.00404163840763085,-0.0175462820430016,-0.00170305948508864,0.0172623600208161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36896,-0.00517508909062507,0.00217871035563743,-0.00944536138767444,-0.000904816793575707,0.0175491041416079
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,39680,-0.00908015624576379,0.00382720157876137,-0.0165814713401361,-0.0015788411513915,0.0176785444240348
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39743,0.00568376672587613,0.0023981616498219,0.000983369892225206,0.0103841635595271,0.0177974816496547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36958,0.00729269144590746,0.00308132572266409,0.00125329302948585,0.0133320898623291,0.0179600801686941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,39817,0.0078808837141655,0.00333338657597355,0.00134744602525735,0.0144143214030737,0.0180796269070257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36795,0.019844543732486,0.00839421559044052,0.00339188117522258,0.0362972062897494,0.0180899103590974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36877,0.0120745495200037,0.00511137167361229,0.00205626103972361,0.0220928380002838,0.0181769878633675
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39673,0.0338824452906846,0.0143442007880348,0.0057678117461363,0.0619970788352328,0.0181837559159005
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,37267,-0.0113872561517417,0.0048224914434154,-0.0208393393808359,-0.00193517292264754,0.018226159735576
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39288,-0.00733739551811884,0.00310815654887957,-0.0134293823539228,-0.00124540868231488,0.0182533163471031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39348,0.0114131080746562,0.0048358361001228,0.00193486931841549,0.0208913468308969,0.0182818152451175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,36896,0.00730470590458078,0.00310473229077734,0.00121943061465719,0.0133899811945044,0.0186491780308975
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,36795,-0.00680796113175344,0.0028995847781482,-0.0124911472969239,-0.00112477496658297,0.018894115498995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,36896,-0.0132196373682996,0.00564957229975425,-0.024292799075818,-0.00214647566078132,0.019302054321923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,39531,-0.0110322608925425,0.00472693399218608,-0.0202970515172273,-0.00176747026785782,0.0196127602590682
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39604,-0.00771853515602115,0.00331056827619299,-0.0142072489773594,-0.00122982133468289,0.0197404324201988
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39630,0.00910346086266218,0.00390746444943482,0.00144483054176994,0.0167620911835544,0.019831307127831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,36855,-0.0103530320299292,0.00445228430167874,-0.0190795092612196,-0.0016265547986389,0.0200696164042149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,39618,0.00612702908841123,0.00263628785486105,0.000959904892883579,0.0112941532839389,0.0201321233265884
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36827,-0.0137850431558539,0.00593469653217466,-0.0254170483589162,-0.00215303795279153,0.0202059276358901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37220,-0.00797711133309112,0.00344920849728436,-0.0147375599877685,-0.00121666267841377,0.0207522330199281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39743,-0.00448348373765976,0.0019389602666336,-0.00828384586026162,-0.000683121615057906,0.0207731425217074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37005,0.00981918371850186,0.00425913261230247,0.00147128379838901,0.0181670836386147,0.0211573183163638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,39292,0.0123816744059589,0.00537570830152151,0.00184528613497672,0.022918062676941,0.0212772342461469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,37267,-0.0104437822512363,0.00453555141681911,-0.0193334630282017,-0.00155410147427083,0.0213138473933983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,36765,-0.00900968438843803,0.00392440885712665,-0.0167015257484063,-0.0013178430284698,0.0217028877752154
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36958,0.0188697118583131,0.00822841352256047,0.00274202135409462,0.0349974023625317,0.0218500629973169
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,39485,-0.00731840750737678,0.00320137861223363,-0.0135931095873547,-0.00104370542739887,0.0222665579926703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36896,-0.0105766153898723,0.00463257556873819,-0.0196564635045991,-0.00149676727514545,0.0224407269569666
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,36855,-0.0182502042097694,0.00799394873420184,-0.033918343728805,-0.00258206469073383,0.0224462996870316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36855,-0.00959517458646907,0.00420559097762194,-0.0178381329026081,-0.00135221627033006,0.022533306980483
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36855,-0.011408491548452,0.00502366133330479,-0.0212548677617294,-0.0015621153351746,0.023166198286894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39680,-0.0201996686804021,0.00891043206984944,-0.037664115537307,-0.00273522182349719,0.023405588339936
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,36866,-0.0153111615135816,0.00675389867156374,-0.0285488029098465,-0.00207352011731663,0.0234059075596546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36896,0.00999052366193762,0.00440889871698604,0.00134908217664498,0.0186319651472303,0.0234682748843411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,36958,-0.0107982769915156,0.00478308741258572,-0.0201731283201836,-0.00142342566284759,0.0239872798731217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,39680,0.00728264750949383,0.00322982972976971,0.000952181239145205,0.0136131137798425,0.0241589665569019
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,37125,0.00940993328633262,0.00417633519515359,0.00122431630383158,0.0175955502688337,0.0242656019434963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,39524,0.0153118294469064,0.00680576645138227,0.00197252720219711,0.0286511316916156,0.0244734511468008
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,39401,-0.0073120227508965,0.00325224673792218,-0.013686426357224,-0.000937619144569017,0.0245710926090853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,39288,-0.0181234223188605,0.00806340341278484,-0.0339276930079188,-0.00231915162980226,0.0246148510140399
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,36795,-0.00911615977386547,0.00406250644975169,-0.0170786724153788,-0.00115364713235215,0.0248509038747986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39865,0.0160112198062524,0.00713996687690183,0.00201688472752485,0.03000555488498,0.0249441196080794
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,39302,0.00628994051261316,0.00280707224173387,0.000788078918814768,0.0117918021064115,0.0250565834299423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36795,0.00785432564509806,0.00350788265995134,0.000978875631593434,0.0147297756586027,0.0251695766196665
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39302,0.0104257287988582,0.0046572652913074,0.00129748882789566,0.0195539687698207,0.0251964971631333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39302,0.0101141330085202,0.0045198368453147,0.00125525279170339,0.018973013225337,0.0252534690768176
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37005,0.0155820602625418,0.0069712066236858,0.00191849528011766,0.029245625244966,0.025420768860434
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37220,0.0119828816997953,0.00536129918758927,0.00147473529212033,0.0224910281074702,0.0254291814807394
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,36896,-0.00881338119951131,0.00394710579598824,-0.0165497085596483,-0.00107705383937437,0.0255743092140182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37267,-0.00639343289279133,0.00286342637196449,-0.0120057485818417,-0.00078111720374094,0.0255791665958719
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37005,0.00998919246438322,0.00447426192503987,0.00121963909130507,0.0187587458374614,0.0255927674472882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,36877,-0.00749474393509193,0.00335755930386608,-0.0140755601706694,-0.000913927699514406,0.0256186919018226
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39700,0.00756057025625291,0.00339019343513465,0.000915791123389,0.0142053493891168,0.0257528047629757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36855,-0.00743760576194484,0.00334594309518107,-0.0139956542284997,-0.000879557295389946,0.0262415193940851
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39594,0.0155899644968184,0.00702154757597705,0.0018277312479034,0.0293521977457334,0.0264123852711918
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36958,0.0143721534685494,0.0064762458289306,0.00167871164384545,0.0270655952932534,0.0264894667407452
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39288,0.00757828443913157,0.00342044499523757,0.000874212248465937,0.0142823566297972,0.0267345239322464
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36855,-0.00790524363269194,0.00357419752709581,-0.0149106707857997,-0.000899816479584155,0.0270010397662323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39594,0.00814388290459383,0.00370166748026715,0.000888614643270215,0.0153991511659175,0.0278172689918912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RETN,Resistin,39599,0.00860143755147823,0.00391055165752452,0.000936756302730158,0.0162661188002263,0.0278536215857246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,36827,-0.0101869235909545,0.00463370931195785,-0.0192689938423918,-0.00110485333951706,0.0279354966885521
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36855,0.0185345621043384,0.00843167140679011,0.0020084861470298,0.035060638061647,0.0279519020201353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,36827,-0.00923328691833511,0.00421142153075752,-0.0174876731186198,-0.000978900718050372,0.0283654945628292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39770,-0.00726758828912047,0.00331527671243068,-0.0137655306454846,-0.000769645932756333,0.0283830165427512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,36983,-0.00676290623456125,0.00309639196279853,-0.0128318344816464,-0.000693977987476131,0.0289707239581028
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,37220,0.00577929228782514,0.00264680369325163,0.000591557049051939,0.0109670275265983,0.0290164453492164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36827,-0.0160220814609355,0.00736326038759591,-0.0304540718206235,-0.00159009110124754,0.0295770428221679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,39401,-0.00691526846617347,0.00318188634122207,-0.0131517656949687,-0.000678771237378216,0.0297710256925792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36855,0.00926337911958967,0.00427581182708641,0.000882787938500305,0.017643970300679,0.0302941015847637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,37005,0.0152622190460074,0.00705950159104335,0.00142559592756239,0.0290988421644523,0.0306407855502447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37005,-0.0071668291966714,0.00332304516385629,-0.0136799977178297,-0.000653660675513068,0.031046706186201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,36877,0.0137765616862393,0.00638959512121886,0.00125295524865031,0.0263001681238282,0.0310946618500536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39860,-0.00653945046704055,0.00303341744666888,-0.0124849486625116,-0.000593952271569547,0.0311139116462045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39668,0.00722543149596417,0.00335217207440875,0.000655174230123027,0.0137956887618053,0.0311418661312176
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,37268,0.00546500509245241,0.0025357207418957,0.000494992438336831,0.010435017746568,0.0311633220952128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36896,-0.00898938362587972,0.00417965817292624,-0.0171815136448152,-0.000797253606944286,0.0315145696097178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,37203,0.00784689001960435,0.00364865814380016,0.000695520057756045,0.0149982599814527,0.031523833887768
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36827,-0.00791351809207199,0.00368470064919453,-0.0151355313644933,-0.000691504819650706,0.0317585197475431
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36877,-0.00901628873712125,0.00420007649011482,-0.0172484386577463,-0.000784138816496206,0.0318358873841075
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,39673,-0.0133007869978465,0.00620652619964787,-0.0254655783491564,-0.00113599564653672,0.0321257081508298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,36855,-0.00839246185285471,0.00391617653383018,-0.0160681678591619,-0.000716755846547565,0.0321296538522177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39836,-0.00727804140003627,0.00341826460389933,-0.013977840023679,-0.000578242776393585,0.0332560525745835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36827,-0.0147174002709912,0.00691628701287362,-0.0282733228162235,-0.00116147772575895,0.0333613880784796
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36880,0.0199033851500047,0.00935880544437415,0.00156012647903138,0.038246643820978,0.033463648302395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36827,-0.00710510780654268,0.00334435200789089,-0.0136600377420088,-0.000550177871076537,0.0336464225473958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36855,0.0130092229291109,0.00612843959880376,0.000997481315455526,0.0250209645427663,0.0337925960145425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37005,-0.0148685939054856,0.0070058714589955,-0.0286001019651168,-0.00113708584585445,0.0338308049050824
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,39673,-0.00789309036547514,0.0037192143653857,-0.0151827505216311,-0.000603430209319168,0.0338325281772664
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36855,0.0134772588531699,0.00635255243974579,0.00102625607126814,0.0259282616350716,0.0338944021057111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39288,0.0104204278059495,0.00493163519678377,0.000754422820253337,0.0200864327916457,0.0346188210885306
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,39817,0.00606812890602127,0.00288029081101617,0.000422758916429579,0.011713498895613,0.0351525282613389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36958,0.00844889650194011,0.00401368826983803,0.00058206749305756,0.0163157255108227,0.0353085097645878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,39721,0.00770064419470572,0.00365973532311118,0.000527562961407814,0.0148737254280036,0.0353807734119095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36775,-0.00514888918735481,0.0024485034504987,-0.00994795595033227,-0.000349822424377356,0.0354962653735671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37215,0.0160565846135933,0.0076526597323918,0.00105737153810536,0.0310557976890812,0.0359088281089532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39302,0.0110597251404074,0.00527157160284465,0.000727444798831887,0.0213920054819829,0.0359218910647624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,39401,-0.0057482099888419,0.00274583342006324,-0.0111300434921658,-0.000366376485517957,0.0363269556812643
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39738,-0.00855715015102771,0.00408822318863729,-0.0165700676007568,-0.000544232701298608,0.0363540874387072
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37220,0.00660635964591953,0.00315940898972272,0.000413918026063009,0.0127988012657761,0.0365459023724168
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,36958,0.00730812542186047,0.00349804742114863,0.000451952476409158,0.0141642983673118,0.0367088513824067
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39065,-0.00945783228799988,0.00452856533827108,-0.0183338203510112,-0.000581844224988569,0.036770868434793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,39673,0.00658282955321035,0.00315626479081591,0.000396550563211165,0.0127691085432095,0.0370273102480318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36877,-0.0064096525863468,0.00307876561890894,-0.0124440331994083,-0.000375271973285283,0.0373719690938372
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39673,0.00664558024363791,0.00319610987311257,0.000381204892337268,0.0129099555949386,0.0376084768568634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,39590,0.00580705931851623,0.00279759574060696,0.00032377166692658,0.0112903469701059,0.0379349414723224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39401,0.00535118208303026,0.00258303714802379,0.000288429272903627,0.0104139348931569,0.0383133533217187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39675,-0.00488902790518466,0.00236527619395053,-0.00952496924532769,-0.000253086565041623,0.038750307782469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36827,-0.0150628444303229,0.00728857018894456,-0.0293484420006542,-0.000777246859991544,0.0387879752183954
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36958,0.0105531428003237,0.00510747778812267,0.000542486335603245,0.0205637992650441,0.0388278787493095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39860,0.00620605812456093,0.00301538042364649,0.000295912494213802,0.0121162037549081,0.0395933947913654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39401,0.0119679568474814,0.00582064526772857,0.000559492122733412,0.0233764215722294,0.0397874201950519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36855,-0.0169540297591583,0.008246126166252,-0.0331164370450122,-0.000791622473304349,0.0398025118059981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,37083,0.0120719390707723,0.00587161303838457,0.000563577515538507,0.023580300626006,0.039803700395177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,39860,-0.00335421892611095,0.00163209991365519,-0.00655313475687513,-0.000155303095346772,0.039880196037337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,36880,0.0172102242551556,0.00837687549257121,0.000791548289716053,0.0336289002205952,0.0399480051685641
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,39721,-0.0058064009483835,0.00282994644317799,-0.0113530959770124,-0.000259705919754649,0.0402083428270743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36855,0.00748571999011487,0.00364875494814388,0.000334160291752868,0.0146372796884769,0.0402303009960756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,39796,-0.00592766491428386,0.00289401050118399,-0.0115999254966045,-0.000255404331963243,0.0405515915988355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,36896,-0.00943760864870036,0.00461033155929104,-0.0184738585049108,-0.00040135879248992,0.040672554199334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39845,0.0102881349017964,0.00502877981898051,0.000431726456594577,0.0201445433469982,0.0407873488872918
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,37244,0.00499360139757283,0.00244608296905909,0.000199278778217014,0.00978792401692865,0.0412238477590457
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,39817,-0.0148611285395857,0.007290781159317,-0.029151059611847,-0.000571197467324397,0.0415318780282694
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,39401,-0.00551660169624025,0.00270677305697286,-0.0108218768879071,-0.000211326504573453,0.0415595063681744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39557,0.0118149777618609,0.00579822893403654,0.000450449051149248,0.0231795064725725,0.0415979429277714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36795,0.00584404124158799,0.00286932717983147,0.000220159969118297,0.0114679225140577,0.0416975498321727
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,39673,0.0167370154627637,0.00823755512875558,0.000591407410402707,0.0328826235151246,0.0421911942319478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,39288,-0.00777120172917025,0.00382943972407811,-0.0152769035883634,-0.000265499869977147,0.0424416934593231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37174,0.00877750249484756,0.00434367827326224,0.000263893079253572,0.0172911119104415,0.0433252803542654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36855,-0.00643866384752357,0.00318974818882,-0.0126905702976108,-0.000186757397436369,0.0435545906000558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,37005,0.00842453844515097,0.00417401686315976,0.000243465393357838,0.0166056114969441,0.0435772998574159
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36896,-0.00423522634808992,0.00209913069001223,-0.00834952250051389,-0.000120930195665957,0.0436523813047716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,39836,-0.0114438646138928,0.00567889664869166,-0.0225745020453285,-0.000313227182457142,0.043904986895488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,39288,-0.010954660385197,0.00543680027731525,-0.0216107889287349,-0.000298531841659086,0.0439314489426564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36765,0.017091503436794,0.00850630863312578,0.000419138515867449,0.0337638683577205,0.0445288830414313
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37005,-0.0085769205170231,0.00426949845117146,-0.0169451374813192,-0.00020870355272703,0.0445700103109401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,36827,-0.00683655616187574,0.00340648854482041,-0.0135132737097237,-0.000159838614027736,0.0447787070012792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39594,0.0162434663298429,0.00810271573122185,0.0003621434966481,0.0321247891630377,0.0450128622379363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,37005,-0.00772820258493683,0.00385811439755646,-0.0152901068041475,-0.000166298365726165,0.0451866694703759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,36795,-0.0104286117346301,0.00521475601956007,-0.0206495335329679,-0.000207689936292383,0.0455397831112161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,38653,-0.00926319281964075,0.00463326396800673,-0.018344390196934,-0.00018199544234755,0.0455963060254205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39668,-0.0227760642151986,0.011402501618117,-0.0451249673867079,-0.000427161043689353,0.0457921213518473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36880,-0.0113260602836029,0.0056786043402457,-0.0224561247904845,-0.000195995776721362,0.0461166403422377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36795,-0.00633423401252116,0.00317905476614527,-0.0125651813541659,-0.000103286670876435,0.046338329496233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37215,0.0219511585327904,0.0110536763043493,0.000285952976265783,0.043616364089315,0.047068229521906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERVV_1,,36855,-0.00921993951387445,0.00465371452170217,-0.0183412199764107,-9.86590513381881e-05,0.0475898860104113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39652,0.00462106179510969,0.00233824274636405,3.81060122361465e-05,0.00920401757798324,0.0481385387385033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39615,0.0354296983907055,0.0179604788846715,0.000227159776749253,0.0706322370046617,0.048553164397477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39636,0.0167658213044594,0.0085025541930536,0.000100815086074343,0.0334308275228445,0.0486433715078462
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39288,-0.00938071830695447,0.00476196520480516,-0.0187141701083726,-4.7266505536353e-05,0.0488647288516866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,39557,-0.00231742921401497,0.00118377932369689,-0.00463763668846088,2.77826043094172e-06,0.0502884288442155
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36827,-0.00928627994653929,0.00475188088287538,-0.018599966476975,2.74065838964561e-05,0.0506951935428964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36877,-0.0128663745658645,0.0065849718938652,-0.0257729194778403,4.01703461112742e-05,0.0507344662300231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37244,0.00911929392667994,0.00466915875917453,-3.22572413021301e-05,0.018270845094662,0.0508295726548574
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39860,0.00440815125198429,0.00226084041384522,-2.30959591523425e-05,0.00883939846312093,0.0512192711718973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37215,-0.00621717057450904,0.00319172482601184,-0.0124729512334923,3.86100844741643e-05,0.0514474854531858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,36855,0.0113603361850362,0.00583409347681935,-7.44870295297656e-05,0.0227951593996021,0.0515283831034257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39594,0.00591411600619964,0.00304068326234152,-4.56231879897321e-05,0.011873855200389,0.0517932814715205
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39675,0.00554096914071021,0.00285031765026349,-4.56534538062214e-05,0.0111275917352267,0.051915208551983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,39673,-0.0107874064844272,0.00555041100396789,-0.0216662120522043,9.13990833498607e-05,0.0519695203850628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,36896,-0.00489891299777403,0.00252304423870153,-0.00984407970562903,4.62537100809823e-05,0.0521988828628995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39302,0.026434546403333,0.0136400976248519,-0.000300044941376816,0.0531691377480428,0.0526410949554423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,36795,-0.00826078512916278,0.00427024757857022,-0.0166304703831604,0.000108900124834851,0.0530737153361553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39668,-0.00759686534672465,0.00393021589211347,-0.0153000884952671,0.000106357801817752,0.0532616207478777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39401,0.00670613067427478,0.00346996152384759,-9.49939124665058e-05,0.0135072552610161,0.0533006903924586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37199,0.0165124430017511,0.00854569483647515,-0.00023711887774017,0.0332620048812424,0.0533494564341575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37005,0.0156987564926136,0.00813900869308187,-0.00025370054582689,0.031651213531054,0.0537735913836699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,37220,0.0105209246127229,0.00545622801718513,-0.000173282300959971,0.0212151315264057,0.0538462758907471
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36896,-0.00776207985558624,0.00402795824126875,-0.015656878008473,0.000132718297300514,0.0539950156871033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36880,-0.00485545702650562,0.00252495130638702,-0.00980436158702418,9.3447534012951e-05,0.05450304603078
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37268,-0.0196242250943521,0.0102086727971477,-0.0396332237767615,0.000384773588057271,0.0545880334595184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36880,-0.00673445758611242,0.00350741939881443,-0.0136089996077887,0.000140084435563859,0.0548720757306798
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,36896,0.00792907989806503,0.00413242522280274,-0.000170473538628335,0.0160286333347584,0.0550381300784431
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,36922,-0.00570088808999994,0.00297809871578827,-0.0115379615729449,0.000136185392945061,0.055607359631741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,36827,0.0206679011228516,0.0108005950740105,-0.000501265222209089,0.0418370674679122,0.0556946712954713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,36896,-0.00756278130453014,0.00397200849442692,-0.0153479179536069,0.000222355344546628,0.0569296506715195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,39302,0.0102437287251069,0.00538286435392245,-0.000306685408581078,0.0207941428587949,0.0570557820434597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37005,-0.0076676592590911,0.00403258808159484,-0.015571531899017,0.00023621338083479,0.0572683591340748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37203,0.00983907904808851,0.00517698919964893,-0.000307819783223402,0.0199859778794004,0.0573837204824903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36855,0.00876996155822092,0.00462446512623901,-0.00029399008920754,0.0178339132056494,0.0579257320649255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,36795,0.0134412985126925,0.00709089244792063,-0.000456850685231899,0.027339447710617,0.0580389080383227
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37220,0.0105563924014992,0.00557211888730246,-0.000364960617613654,0.021477745420612,0.058179935240179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36827,-0.00885316569970258,0.00467502315359753,-0.0180162110807537,0.000309879681348581,0.0582849667217415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36827,-0.0059418093282749,0.0031448281792983,-0.0121056725596996,0.000222053903149767,0.0588617763098188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37220,0.0126852013089949,0.00672636047469585,-0.000498465221408978,0.0258688678393988,0.059330945075425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,36827,-0.0172594235048185,0.00915693619243783,-0.0352070184419967,0.000688171432359611,0.0594728433911659
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37244,0.00500297007250657,0.00265658167418506,-0.000203930008896147,0.0102098701539093,0.0596900663094573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,36855,-0.00773465447492174,0.00410735746992712,-0.0157850751159789,0.000315766166135425,0.0597061757958167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36983,-0.00957585869574075,0.00508783128436808,-0.0195480080131022,0.000396290621620683,0.0598431760704416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39798,-0.00727199968866453,0.00386900880173761,-0.0148552569400703,0.000311257562741196,0.0601875134594843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,39401,0.0211105116958571,0.0112577020528523,-0.000954584327733481,0.0431756077194477,0.0607831094629789
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36896,0.00747539971614285,0.00399517795193051,-0.000355149069640948,0.0153059485019266,0.0613528325414152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36827,-0.0135712605566938,0.0072676572372348,-0.027815868741674,0.000673347628286379,0.0618752559627161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39675,0.05271789969448,0.0282470432585036,-0.00264630509218714,0.108082104481147,0.0620157065389617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,39401,-0.00876306714950021,0.00470953467251404,-0.0179937551076277,0.000467620808627322,0.0628043464560317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39865,-0.00452748164657703,0.00243699890805694,-0.00930399950636862,0.000249036213214568,0.0632143103841467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36880,0.00648527048328141,0.00349510006363384,-0.000365125641440924,0.0133356666080037,0.0635428577233167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,36896,-0.0182411305875927,0.00986076292579813,-0.037568225922157,0.00108596474697165,0.0643548892913875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39060,0.0109357503190233,0.00591287304234977,-0.000653480843982238,0.0225249814820289,0.0644076919023818
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36815,-0.00617220145439718,0.0033377164935674,-0.0127141257817893,0.000369722872994923,0.0644475468600952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36880,0.0109109327925417,0.00590325151387702,-0.000659440174657223,0.0224813057597407,0.0645827673320878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36765,-0.0141434864622703,0.00765691856467464,-0.0291510468490326,0.000864073924492021,0.0647481020625666
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39836,-0.00447369236266365,0.00242680036737336,-0.00923022108271543,0.000282836357388135,0.0652814109313635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37220,0.0079180690417346,0.00429856548043185,-0.00050711929991182,0.016343257383381,0.0654935069618463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,39579,0.0120051627689791,0.00652008161372609,-0.000774197193924048,0.0247845227318822,0.0656023585620491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,37285,-0.00483839847961351,0.00262994356505575,-0.00999308786712279,0.000316290907895768,0.0658292586529577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39302,0.0114786426624438,0.00624368438326391,-0.000758978728753466,0.0237162640536411,0.0660167057901639
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36877,0.00650399158568343,0.00353911667238567,-0.000432677092192489,0.0134406602635593,0.0661228656747541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,36896,-0.004636570832715,0.00252779432924842,-0.00959104771804191,0.000317906052611898,0.0666417803026173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,36877,0.00555753153189734,0.00304120257167775,-0.000403225508591047,0.0115182885723857,0.0676606564104082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,39860,0.00563570693274656,0.00308519314776053,-0.000411271636864068,0.0116826855023572,0.0677642604701734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36896,-0.0106090607136249,0.00581990416749543,-0.0220160728819159,0.000797951454666145,0.0683425401474927
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36827,-0.0122529361026086,0.00673915322797762,-0.0254616764294447,0.000955804224227525,0.0690609916070812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39720,0.00859171847611343,0.00472643729432909,-0.000672098620771586,0.0178555355729985,0.0691135400828821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37005,-0.0151859801085211,0.00838784085665063,-0.0316261481875564,0.00125418797051412,0.0702449079425026
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37264,0.00334155811456508,0.00185853110470368,-0.000301162850654143,0.0069842790797843,0.0722063931826315
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39401,-0.00552459389496049,0.00307642013085197,-0.0115543773514303,0.00050518956150937,0.0725478884396624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36877,-0.0109146324459502,0.00608028645705899,-0.0228319939017858,0.00100272900988539,0.0726633101519675
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39401,0.00528642293192331,0.00295279714177452,-0.000501059465954758,0.0110739053298014,0.0734235113255133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,39401,0.0113932256640864,0.00638615429012892,-0.00112363674456632,0.0239100880727391,0.0744348647428755
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37277,0.00914203999963967,0.00512891936428471,-0.000910641954358365,0.0191947219536377,0.0746985574265371
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36877,-0.0132630669804263,0.00745678064205077,-0.0278783570388458,0.00135222307799325,0.0753190838729117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36855,-0.0122331451985473,0.00692755665538617,-0.0258111562431042,0.00134486584600962,0.0774416056705947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39401,-0.00539351346993927,0.00305519213243935,-0.0113816900495204,0.000594663109641866,0.0775229444205914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37203,0.00485280529082712,0.00275095319559098,-0.000539062972531197,0.0102446735541854,0.0777472788823581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36896,-0.00789535675120468,0.00448491932596192,-0.01668579863009,0.000895085127680681,0.0783594981424625
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37220,0.00476858896789669,0.00271327604070652,-0.000549432071888083,0.0100866100076815,0.0788551250337669
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,39697,-0.00498896708730701,0.0028401271989793,-0.0105556163973064,0.000577682222692415,0.079005358271597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37215,0.0071756741690732,0.00409838220659885,-0.000857154955860554,0.015208503294007,0.0799937979429035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39793,0.00471367372156116,0.00269579996868338,-0.000570094217058266,0.00999744166018058,0.0803924129327903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36855,-0.00844548189871624,0.00485605702670809,-0.0179633536710641,0.00107238987363162,0.0820295147673654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36855,0.00615489650879165,0.00354211853803072,-0.000787655825748555,0.0130974488433319,0.0822994680505625
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37203,-0.00932604626692081,0.00537927283258493,-0.0198694210187873,0.00121732848494565,0.0829943941970688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39865,-0.00951416534667572,0.0054985692448638,-0.0202913610666088,0.00126303037325733,0.0835962586419642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,39594,0.00488973083474608,0.00282596525632816,-0.000649161067657105,0.0104286227371493,0.0835986263214456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,36877,-0.00705255951972083,0.00408466737654287,-0.0150585075777449,0.000953388538303202,0.0842644473499019
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39302,0.00543869405121577,0.0031506413610665,-0.000736563016474568,0.0116139511189061,0.0843281903247336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39743,0.00435548801744006,0.00252442855251251,-0.000592391945484459,0.00930336798036459,0.0844863495491984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36877,0.00491589783052061,0.00285822516640064,-0.000686223495624633,0.0105180191566659,0.0854720767773905
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,37072,-0.00568455652007036,0.00330597815353968,-0.0121642737010081,0.000795160660867417,0.0855508016286082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37203,0.0111789378574217,0.00650442918316323,-0.00156974334157822,0.0239276190564216,0.0856984988673646
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37267,-0.00423190490030676,0.00246766628020658,-0.00906853080951165,0.000604721008898131,0.0863789433915136
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39557,-0.0115648768147438,0.00674966629768808,-0.0247942227582125,0.0016644691287248,0.0866587601136522
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36827,-0.0152147272437914,0.00890363269993558,-0.0326658473356652,0.0022363928480823,0.0875077771695976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI3,Elafin,39407,0.00870945322765395,0.00510234262088599,-0.00129113830928259,0.0187100447645905,0.0878509687548498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,37203,0.00717716654980268,0.00421840647113287,-0.00109091013361774,0.0154452432332231,0.0888925439106683
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",39836,0.0120184281972642,0.0070701224191072,-0.00183901174418587,0.0258758681387144,0.0891711423281581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36855,-0.0102489183398564,0.00602936921661925,-0.0220664820044302,0.00156864532471728,0.0891863491103401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36862,-0.00639632706731688,0.00376616549689805,-0.0137780114412371,0.000985357306603298,0.0894626497328065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,39675,-0.00572079648031434,0.00337078888591123,-0.0123275426967004,0.000885949736071675,0.0896844981739425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,36896,-0.0172567048634976,0.01016854198394,-0.03718704715202,0.00267363742502468,0.0897077201929024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39764,0.0045378415649373,0.00267566160620699,-0.000706455183228394,0.009782138313103,0.0899111508435424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37257,-0.00307927491536692,0.0018170018420938,-0.00664059852587076,0.000482048695136919,0.0901553887073284
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36880,-0.00532168054606631,0.00314295109935119,-0.0114818647007946,0.000838503608662014,0.0904391624621409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39535,0.00956103552191797,0.00564876847067086,-0.00151055068059692,0.0206326217244329,0.0905538640602575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTN,Titin,36855,0.0111981512632006,0.00662303342864574,-0.00178299425694506,0.0241792967833462,0.0909011130076589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,36855,-0.0105515533109223,0.00624816546981132,-0.0227979576317525,0.00169485100990787,0.0912924496652508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36855,0.00759571384748965,0.00451192250454195,-0.00124765426141257,0.0164390819563919,0.0923069750804962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,37285,0.00314594280457552,0.0018708063199686,-0.000520837582562936,0.00681272319171397,0.0926702188233358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,39401,0.00803128919290528,0.00478450809579443,-0.0013463466748518,0.0174089250606623,0.0932495643290976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36827,-0.0102299525327673,0.00609993876181644,-0.0221858325059275,0.00172592744039293,0.0935551975534401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37215,0.0142159644611195,0.00848081771820399,-0.00240643826656028,0.0308383671887993,0.0937127845280468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,36877,0.00691730881490127,0.00412811550566861,-0.0011737975762092,0.0150084152060118,0.0938292633792555
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36855,0.00656846772212195,0.00392224605916784,-0.00111913455384703,0.0142560699980909,0.0940230632368423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,36877,0.0149803586727367,0.00894696638627803,-0.00255569544436828,0.0325164127898416,0.0940857355616122
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36855,-0.00663617695859419,0.00397496017382493,-0.014427098899291,0.00115474498210267,0.0950433657910073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,39401,0.00694587276946414,0.00416136139141522,-0.00121039555770969,0.015102141096638,0.0951108261205337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39288,-0.0202154026523459,0.012204336753628,-0.0441359026894568,0.00370509738476506,0.0976588672693056
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36896,-0.00963352245783252,0.00582238368238874,-0.0210453944753145,0.00177834955964941,0.0980364864615016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36855,-0.00795531302318062,0.00481603612917391,-0.0173947438363615,0.00148411779000025,0.0985916755431961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39865,0.00424560419837082,0.00257027510291232,-0.000792135003337327,0.00928334340007898,0.0985930587639992
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36795,0.00632197945508724,0.00383346566405825,-0.00119161324646693,0.0138355721566414,0.0991401466448151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36896,0.00499420575075387,0.00303314034727851,-0.000950749329911999,0.0109391608314197,0.0996754585284802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36795,-0.00862794021677958,0.0052595584795384,-0.0189366748366748,0.00168079440311568,0.100939999893582
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37203,0.00833615390184981,0.00509091688746957,-0.00164204319759056,0.0183143510012902,0.101558744862945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39266,0.00740996956036632,0.00453069528133347,-0.00147019319104729,0.0162901323117799,0.101963897643526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37267,-0.00628149313163976,0.00384075951819124,-0.0138093817872946,0.00124639552401508,0.101971515674155
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,39865,-0.00630192900187475,0.00385564193179739,-0.0138589871881976,0.00125512918444812,0.102179979748792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39401,-0.00649477590039526,0.00400448392875591,-0.0143435644007568,0.00135401259996632,0.104850211890903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37267,-0.0210858493019928,0.0130222841548495,-0.0466095262454979,0.0044378276415123,0.105425003786396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36795,-0.0068217545052018,0.00421666542821706,-0.0150864187445072,0.00144290973410365,0.105728392992617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36765,-0.00824711694322613,0.00510385575030379,-0.0182506742138216,0.0017564403273693,0.106149004858695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39302,0.010889592080779,0.00675672229322176,-0.00235358361393568,0.0241327677754936,0.107054674432581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39697,0.00490477627515679,0.00305468656999211,-0.00108240940202774,0.0108919619523413,0.108369418943621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,36877,0.00769837684741739,0.00479652976257956,-0.00170282148723854,0.0170995751820733,0.108520514256266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',36855,0.00664082700885208,0.00414379723692716,-0.00148101557552514,0.0147626695932293,0.109048494650915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36795,-0.00879504175562662,0.00549036640042138,-0.0195561599004525,0.0019660763891993,0.109201183469952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36855,-0.00517965590822456,0.00324131069053084,-0.011532624861665,0.00117331304521589,0.110064445741097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37215,-0.00719651362899421,0.00450892044846102,-0.0160339977079778,0.00164097044998939,0.110498758990968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36827,-0.0113421767674201,0.00711734912743701,-0.0252921810571966,0.00260782752235647,0.111050997278459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37244,0.00641925290311154,0.00405176550118582,-0.00152220747921267,0.0143607132854357,0.113146800499384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36795,-0.00740922146862814,0.00469562092982245,-0.0166126384910801,0.00179419555382385,0.114612979472204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36827,-0.00950690782434985,0.00606599629336665,-0.0213962605593485,0.00238244491064879,0.117081626349303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,36958,0.00437616042646476,0.00279675970339392,-0.00110548859218732,0.00985780944511684,0.117671511927973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39448,-0.0258330387358056,0.0165126189246452,-0.0581977718281102,0.00653169435649907,0.117734044087446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36795,-0.009951602662605,0.00637135940120516,-0.0224394670889671,0.00253626176375711,0.118329488549918
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,39697,-0.0047761369639388,0.00305978768156774,-0.0107733208198116,0.00122104689193396,0.118558508038565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,37257,0.00218869869493564,0.00140431565365797,-0.000563759986233975,0.00494115737610526,0.119126118832261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37005,0.00978351159732895,0.00628864902922822,-0.00254224049995837,0.0221092636946163,0.119793673693965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39817,0.00348344538275474,0.0022422140316405,-0.000911294119260637,0.00787818488477011,0.120305901164724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,39817,-0.00461462093185957,0.00297833249562918,-0.0104521526232928,0.00122291075957363,0.121306025184623
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,39401,-0.011465928021839,0.00742004761127556,-0.0260092213399391,0.00307736529626107,0.122302925268194
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36827,0.00646075671365746,0.00419606824210288,-0.0017635370408642,0.0146850504681791,0.123653803670368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,39603,0.0159195661579547,0.0103413128962527,-0.00434940711870069,0.03618853943461,0.123723254714839
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,37147,-0.0107320889179896,0.0069809928254868,-0.0244148348559438,0.00295065701996449,0.124236357599121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36795,-0.00379285218087851,0.00246978687840068,-0.00863363446254384,0.00104793010078683,0.124636386651972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36795,-0.00811432167963893,0.00530621636084905,-0.0185145057469031,0.00228586238762521,0.126236725652551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39529,-0.00485666929778388,0.00317654892715783,-0.0110827051950132,0.00136936659944547,0.126306015749912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39529,-0.00675202774180454,0.00441885827161524,-0.0154129899541704,0.00190893447056133,0.126532031892462
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36958,-0.00361730481850288,0.00237387168748709,-0.00827009332597758,0.00103548368897182,0.127582912552619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,36941,-0.00530923278825927,0.00350421312343651,-0.0121774905101948,0.00155902493367629,0.129771280827232
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,36877,0.00571434122601917,0.00377236351171622,-0.00167949125694462,0.013108173708983,0.129849692488271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39302,0.00509408785916138,0.00336990648579264,-0.0015109288529922,0.011699104571315,0.130645750275082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,39589,-0.00974180818724611,0.00645408555373186,-0.0223918158725606,0.00290819949806834,0.13121622625064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37005,-0.0108832781893773,0.0072229925602137,-0.0250403436073961,0.00327378722864159,0.131897567736391
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37236,0.00327948543825975,0.00217895548026631,-0.000991267303062212,0.00755023817958171,0.132329113036493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39865,-0.00530850201722872,0.00353269971874029,-0.0122325934659597,0.00161558943150226,0.132942421748672
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,37267,-0.00620221363820549,0.00414266016386307,-0.0143218275593771,0.00191740028296611,0.134375890669853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,36934,0.00823586688372161,0.00550623113552608,-0.0025563461419095,0.0190280799093527,0.13474666134668
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2,Complement C2,39715,0.00338864185074476,0.00227401815514192,-0.00106843373333341,0.00784571743482293,0.136203108637037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37268,0.0105576107438391,0.00710581176456876,-0.00336978031471569,0.0244850018023938,0.137363151438428
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,39564,0.00734824036142907,0.00496703215609877,-0.00238714266452452,0.0170836233873827,0.139052800145459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,37244,-0.00504298076047038,0.00341098459947198,-0.0117285105754355,0.0016425490544947,0.13931007380962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37203,-0.00596881384536158,0.00404203423095109,-0.0138912009380257,0.00195357324730255,0.139783526841849
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,36795,-0.00854980587898081,0.00579388822160591,-0.0199058267933284,0.00280621503536676,0.140059678936592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36855,-0.00516629636946094,0.00350984507011874,-0.0120455927068937,0.0017129999679718,0.141060141584593
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,37220,-0.00321219421236191,0.00218432703528896,-0.00749347520152828,0.00106908677680446,0.141432428900908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,39817,-0.0036043123723249,0.00245270412653667,-0.00841161246033677,0.00120298771568697,0.141709902034549
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39302,0.0054208049822861,0.00370619082370394,-0.00184332903217362,0.0126849389967458,0.143587590434491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39171,-0.0119638947305835,0.00818524895659839,-0.0280069826855163,0.00407919322434936,0.143860160129101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39401,0.00403208767425009,0.00275878463384979,-0.0013751302080955,0.00943930555659569,0.143886175200527
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39594,0.00305308870773552,0.00209365810092369,-0.00105048117007491,0.00715665858554596,0.144790056045037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39860,-0.00376630394029939,0.00259233871707694,-0.0088472878257702,0.00131467994517141,0.146282377684184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36795,0.0114318971543546,0.00788038923737648,-0.0040136657509033,0.0268774600596125,0.146894151398136
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37220,-0.00551561027870477,0.00380864019059115,-0.0129805450522634,0.00194932449485388,0.147589175596674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37202,0.00514979049152321,0.00355907073207432,-0.00182598814334245,0.0121255691263889,0.147934964564878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39668,-0.00771838369808179,0.00537253933558968,-0.0182485607958376,0.00281179339967398,0.150841224193328
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,39401,0.0103878437720191,0.00724831847552664,-0.00381886044001314,0.0245945479840513,0.15183839629151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,39777,0.0157279213943503,0.0109782908840317,-0.00578952873835177,0.0372453715270524,0.151980832584811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39817,0.00629557896955561,0.00439497537597687,-0.00231857276735906,0.0149097307064703,0.152034894848259
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36795,-0.00641918698658812,0.00448279105597693,-0.0152054574563029,0.00236708348312668,0.152178825062279
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37277,-0.00647406093782095,0.00453091099285803,-0.0153546464838227,0.0024065246081808,0.15306626771355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,36877,-0.00502822506849999,0.00352415803601973,-0.0119355748190987,0.00187912468209867,0.153665104251213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,39380,-0.00741586355175968,0.0051981213042517,-0.017604181308093,0.00277245420457366,0.153702928998906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37277,0.00347801259206524,0.00244344339172239,-0.00131113645571064,0.00826716163984112,0.154641674534495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,37182,-0.00792736853111096,0.0056124930876045,-0.0189278549828158,0.00307311792059387,0.157840722576425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39401,0.00796263395807319,0.00563960753993077,-0.00309099682019111,0.0190162647363375,0.157995665938958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36439,-0.014858167830626,0.0105362617753563,-0.0355092409103244,0.00579290524907235,0.158507281478366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36877,0.0053397050685881,0.00380707133188539,-0.00212215474190727,0.0128015648790835,0.160767303215255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36855,-0.00642525833807497,0.00458619274497185,-0.0154141961182198,0.00256367944206986,0.161237802174957
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39594,0.00775355955175192,0.00554598243274782,-0.00311656601643381,0.0186236851199376,0.162117824491958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39302,0.00365129029980988,0.00262321554400787,-0.00149021216644554,0.0087927927660653,0.163968504806892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,39738,-0.00607457481302551,0.00436527907371611,-0.0146305217975091,0.00248137217145807,0.164073294386189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36896,-0.00614714158044446,0.00444073958326406,-0.014850991163642,0.0025567080027531,0.16630231811946
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36896,0.00580082702847899,0.00419314857986776,-0.00241774418806181,0.0140193982450198,0.166564092477451
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36855,-0.00629045466691474,0.00456890324823809,-0.0152455050334614,0.00266459569963191,0.16859857564027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,37220,-0.00358226318105079,0.00260258563195411,-0.00868333101968084,0.00151880465757926,0.168713248919913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39780,-0.00303978647627151,0.0022092417188941,-0.00736990024530395,0.00129032729276093,0.168859225497579
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,36877,-0.00359716587724987,0.00262070043327222,-0.00873373872646342,0.00153940697196368,0.169901274409235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36896,0.00791614113292562,0.00578564835954262,-0.00342372965177791,0.0192560119176292,0.171261323790403
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36896,-0.00904026943222216,0.00660780101636836,-0.0219915594243041,0.00391102055985982,0.171297874974143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39557,0.00455466416284487,0.00333133414483376,-0.0019747507610293,0.011084079086719,0.171576171603197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,37220,-0.00670787506449223,0.0049097679292397,-0.016331020205802,0.00291527007681758,0.171889598327443
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,39302,0.00660322348228271,0.00484417323151048,-0.00289135605147782,0.0160978030160433,0.172862353252379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39680,0.00577729035543552,0.0042457461612913,-0.00254437212069543,0.0140989528315665,0.173620188510934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37203,0.00479514208916483,0.00352810612755837,-0.00211994592084958,0.0117102300991792,0.174129517674135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39627,0.00425399135121044,0.00313765989550521,-0.00189582204397978,0.0104038047464007,0.175187091367445
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39498,-0.00552254941491513,0.00407694755344975,-0.0135133666196766,0.00246826778984638,0.17557115133392
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39508,-0.00523194955217925,0.00386532272934947,-0.0128079821017042,0.00234408299734572,0.175896072324079
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,37224,-0.00309379659238442,0.0022992449863883,-0.0076003167657055,0.00141272358093665,0.178463847790712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36896,0.00716823272630519,0.00535106230656755,-0.0033198493945672,0.0176563148471776,0.180401836378305
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39288,-0.00448514035731101,0.00335947749473842,-0.0110697162469983,0.00209943553237629,0.181872869296074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,39836,-0.00372031633522585,0.00278981168031273,-0.0091883472286388,0.00174771455818711,0.182374743812473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39401,-0.00386850330714053,0.00290167364205358,-0.00955578364556554,0.00181877703128448,0.182486624999023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39401,-0.00667910071149056,0.00501257270247855,-0.0165037432083485,0.0031455417853674,0.182725463280754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36958,0.00326992526102015,0.00245801794469569,-0.00154778991058341,0.00808764043262371,0.18343939433315
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36827,-0.00438177206129408,0.00329459818828085,-0.0108391845103245,0.00207564038773638,0.18354601702299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSND,Barttin,36795,-0.0043077843464922,0.00323930267109433,-0.0106568175818371,0.00204124888885268,0.183591382365642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39401,-0.00504206293684226,0.00380958383477461,-0.0125088472530005,0.00242472137931598,0.185681757373215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,37203,0.0102983826251743,0.00779657754004332,-0.00498290935331056,0.0255796746036593,0.186562351752278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36877,0.00992067669080848,0.00753995179002286,-0.00485762881763632,0.0246989821992533,0.188281800571711
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37203,0.00608615981244947,0.00464623325850198,-0.00302045737421441,0.0151927769991133,0.190247931868193
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36795,-0.00499405662236435,0.0038127462071931,-0.0124670391884628,0.00247892594373412,0.190275969678598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,36546,-0.00883436747839905,0.00678251776183414,-0.022128102291594,0.00445936733479587,0.192762207425191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37215,0.0048570775609428,0.00373540827706816,-0.00246432266211079,0.0121784777839964,0.193527377607296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,36855,-0.00589910654880828,0.00453705773721352,-0.0147917397137468,0.00299352661613022,0.193553671704009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,36877,-0.00833715331751731,0.00641535716311303,-0.0209112533572189,0.00423694672218424,0.193774202005258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36827,-0.00737609123852509,0.00570768098075075,-0.0185631459607965,0.00381096348374638,0.19627295845003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36827,-0.00537150913307067,0.00415966773021828,-0.0135244578842985,0.00278143961815716,0.196611840555647
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,39401,0.00978502852592386,0.00763246646118237,-0.00517460573799358,0.0247446627898413,0.199852278646726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39302,0.00376359400669233,0.00294272755037865,-0.00200415199204983,0.0095313400054345,0.200934767515804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,37203,-0.0055328566704926,0.00433391232173867,-0.0140273248211004,0.0029616114801152,0.201750707272591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,39594,0.00348883196687276,0.00273388572654331,-0.00186958405715213,0.00884724799089764,0.201923444324586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,39680,-0.00920227659614068,0.00721753095356425,-0.0233486372651266,0.00494408407284525,0.202331662513377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39594,0.00565828791066954,0.0044569455473495,-0.00307732536213547,0.0143939011834745,0.204265930255397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36855,-0.00779069026861697,0.00616163695280421,-0.0198674986961132,0.00428611815887927,0.206114030820022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37005,-0.00437590147994079,0.00346926648185405,-0.0111756637843747,0.00242386082449314,0.207211157443668
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39594,-0.004133019227535,0.00328256154132842,-0.0105668398485387,0.00230080139346871,0.208018835764605
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFP,Properdin,37285,0.0028162011917225,0.00223764114983424,-0.0015695754619526,0.00720197784539761,0.208211907727482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,39288,-0.0113681805549243,0.00904912294032209,-0.0291044615179556,0.00636810040810702,0.209035559930935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,38940,0.00340059848782989,0.00270881634625778,-0.00190868155083536,0.00870987852649513,0.209359679130286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,39697,-0.00284683218302578,0.00226874366248432,-0.00729356976149505,0.00159990539544349,0.209567867278984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,36896,-0.00721616963159372,0.00576041491798257,-0.0185065828708395,0.00407424360765211,0.210331192082389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36877,0.00659774413089954,0.00528264415701032,-0.00375623841684068,0.0169517266786398,0.21170681109615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37215,0.00308476494513899,0.00247084612793127,-0.00175809346560629,0.00792762335588427,0.21188269861217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36855,-0.00479823902689655,0.00385130571148303,-0.0123467982214033,0.00275032016761019,0.21283336792065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39302,-0.00769638089359208,0.00618460690364576,-0.0198182104247378,0.00442544863755361,0.213356040060292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,39302,0.00728752967124786,0.00586426563088608,-0.00420643096528885,0.0187814903077846,0.213996847878385
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36896,-0.00340233697106028,0.00274035787549977,-0.00877343840703983,0.00196876446491928,0.214418828236005
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,36880,0.00274757278999458,0.00221721194297034,-0.00159816261822728,0.00709330819821644,0.215293151640889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37268,-0.0033072593461618,0.00267374504734409,-0.00854779963895621,0.00193328094663261,0.216131418737183
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39721,-0.0032209014702317,0.00261087305299874,-0.00833821265410922,0.00189640971364582,0.217351929096767
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37215,-0.00255370731073864,0.00207031283922684,-0.00661152047562325,0.00150410585414596,0.217415231450352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36896,-0.00492995062762786,0.00400951934298035,-0.0127886085398693,0.00292870728461363,0.218883544718601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39668,0.00518747509814185,0.00423736528888551,-0.00311776086807375,0.0134927110643574,0.220886799786175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,39700,0.0052651877120977,0.00430325274564014,-0.00316918766935697,0.0136995630935524,0.221145247581402
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,39775,-0.00480664542852374,0.00393809790692743,-0.0125253173261015,0.00291202646905402,0.222274528158541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,36896,-0.0040371058914879,0.003313294827971,-0.0105311637543111,0.00245695197133526,0.223072564800859
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,39865,-0.00523961324415384,0.00431103801762145,-0.0136892477586919,0.0032100212703842,0.224233473275802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39260,-0.00330334000115076,0.00272144815851935,-0.0086373783918487,0.00203069838954717,0.224836233224343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39302,-0.00462962869619668,0.00381773958122697,-0.0121123982754015,0.00285314088300819,0.225277527138969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36795,-0.0074748195311154,0.00616985896709499,-0.0195677431066216,0.00461810404439077,0.225723769146621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36877,-0.00551514396698426,0.00455509567754697,-0.0144431314949763,0.00341284356100779,0.226008008119596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36855,-0.00370370059297978,0.00306710057190568,-0.00971521771391491,0.00230781652795534,0.227239455617333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39743,-0.00324795360184992,0.00269633599364337,-0.00853277214939093,0.00203686494569109,0.228383259777297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,39668,0.0045687726145758,0.00379795831092211,-0.00287522567483153,0.0120127709039831,0.229011784229927
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,36896,-0.00357852548015588,0.00298255008158599,-0.00942432364006441,0.00226727267975266,0.23023076814806
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39658,0.00364131352549498,0.00304357363276033,-0.00232409079471526,0.00960671784570522,0.231560758851625
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,39302,-0.00546755962848729,0.00457005206791923,-0.014424861681609,0.0034897424246344,0.231563194212709
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37255,0.00282315893948903,0.0023657033017041,-0.00181361953185101,0.00745993741082907,0.232745702097714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36827,0.0071318342731083,0.00598518976314364,-0.00459913766265323,0.0188628062088698,0.23344765789735
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37203,-0.00530626821780111,0.00446178124867868,-0.0140513594652113,0.0034388230296091,0.23435410298432
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37203,-0.00503220428576046,0.00423282355330049,-0.0133285384502294,0.00326412987870849,0.234518739621352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,39373,0.00484202377190464,0.00408000268878618,-0.00315478149811628,0.0128388290419256,0.235336627358003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36827,-0.00512853835919477,0.00432237546986095,-0.0136003942801222,0.0033433175617327,0.235442999645489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36795,-0.00727288654360114,0.00615405354677794,-0.0193348314952859,0.00478905840808362,0.237305112852413
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39680,0.00360532905181974,0.0030512191997391,-0.0023750605796689,0.00958571868330837,0.237381116296808
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,39836,0.00351814129195516,0.00297950124896201,-0.00232168115601038,0.00935796373992069,0.237706935413038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39288,0.00534602726752807,0.00453419768387532,-0.00354100019286755,0.0142330547279237,0.238398074663141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37005,-0.00878148704380627,0.00745334012389388,-0.0233900336866383,0.00582705959902573,0.238740258496763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,37244,0.0178991472244443,0.015209202340884,-0.0119108893636884,0.0477091838125769,0.239271128329429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,37244,0.00414641932564288,0.00353664293534632,-0.00278540082763591,0.0110782394789217,0.241050655530761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,39401,0.00548504961861877,0.00467940749745298,-0.00368658907638907,0.0146566883136266,0.241147762291697
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,39288,0.00344202132658905,0.00293958061095474,-0.00231955667088225,0.00920359932406035,0.241647980892696
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37268,-0.00558635862768408,0.00478109695964214,-0.0149573086685827,0.00378459141321451,0.242655693466522
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39401,-0.0053853488500207,0.00461142208565761,-0.0144237361379096,0.00365303843786821,0.242893978061625
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37005,-0.00969280487556787,0.0083154929498493,-0.0259911710572725,0.00660556130613675,0.243784404303314
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,36877,0.0068498690970908,0.00587927064915669,-0.00467350137525631,0.0183732395694379,0.244004626227108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39401,0.00544295479907429,0.00470284794584283,-0.00377462717477767,0.0146605367729262,0.247137304896016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,36877,0.00670429806170641,0.00579784548748548,-0.00465947909376513,0.0180680752171779,0.247562106739896
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,37268,0.00323737041698997,0.00280155740253073,-0.00225368209197027,0.0087284229259502,0.247881367713324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36795,0.0047730241892586,0.00413708420829025,-0.00333566085899029,0.0128817092375075,0.248637547753037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37267,-0.00248062825176467,0.00215231378755569,-0.00669916327537382,0.00173790677184449,0.249119692820047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,37215,-0.0282461331489124,0.024522747045846,-0.0763107173587705,0.0198184510609458,0.249409923756306
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,37285,0.00231596538123058,0.00202367076165435,-0.00165042931161194,0.00628236007407311,0.25246250931573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37215,-0.00478486975885448,0.00418266487773606,-0.0129828929192172,0.0034131534015082,0.252653943047014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36795,0.00559737265709481,0.00491411725101461,-0.00403429715489383,0.0152290424690835,0.254707858019945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,39860,0.00568115169786853,0.00499641179852845,-0.00411181542724723,0.0154741188229843,0.255535946541502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36877,-0.00609475623054294,0.00537750602737956,-0.0166346680442069,0.004445155583121,0.257075704028689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36827,-0.00844263413183999,0.00745739682179387,-0.023059131902556,0.00617386363887599,0.257606836276945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,36896,-0.00595446448532122,0.00526350070322468,-0.0162709258636416,0.00436199689299916,0.257960355701501
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,37005,-0.018054385480195,0.016013943516372,-0.0494417147722841,0.0133329438118942,0.259586969614337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36795,-0.0087395650069174,0.00775544421185489,-0.023940235662153,0.00646110564831817,0.259808125503948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36877,-0.00391453342888753,0.00347868594927025,-0.0107327578894572,0.00290369103168216,0.26048655832037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,39666,0.00426296417775237,0.00378947487830236,-0.00316440658372026,0.011690334939225,0.26062792962658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39401,-0.00590965483124925,0.00526688222019671,-0.0162327439828348,0.0044134343203363,0.261862582137746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37220,0.00275478187785808,0.00246491793601225,-0.00207645727672592,0.00758602103244209,0.263759769446108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,39288,-0.0147782530637114,0.0132438183785452,-0.0407361370856599,0.0111796309582371,0.264499255222541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,39401,-0.00433754825553318,0.00389038139002272,-0.0119626957799777,0.00328759926891135,0.264892666852703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37277,-0.0029546723790232,0.00265883029025997,-0.00816597974793274,0.00225663498988635,0.266473025684769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,37215,0.0123233033224327,0.0110961137059779,-0.00942507954128389,0.0340716861861494,0.266762131811782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36896,0.00316883778318804,0.00285941851427309,-0.00243562250478722,0.0087732980711633,0.267791338599378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,39302,-0.00400793834771311,0.00361862722345355,-0.0111004477056821,0.00308457101025584,0.268058203124762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36896,0.00690656046501721,0.00624326263833898,-0.0053302343061272,0.0191433552361616,0.268642125015923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37244,0.00695356313043829,0.00629302882379881,-0.00538077336420737,0.019287899625084,0.269195545402991
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37203,-0.0089359096392538,0.00809798550945422,-0.0248079612377841,0.00693614195927647,0.269841642592147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36877,-0.00453745971273471,0.00414497070554326,-0.0126616022955995,0.00358668287013008,0.273672542983522
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,37213,0.00334496969590647,0.00305766060952748,-0.00264804509876739,0.00933798449058033,0.273990635143819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,37244,0.00470962686646264,0.00433902480349719,-0.00379486174839185,0.0132141154813171,0.277759047310425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,37203,0.00551316281612431,0.0050837851084145,-0.0044510559963681,0.0154773816286167,0.278180381041987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,39288,-0.0170248174532862,0.0158020593380733,-0.0479968537559098,0.0139472188493374,0.281327528820913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37215,-0.00576642500792,0.00535961035324749,-0.0162712613002851,0.00473841128444509,0.281989729589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,37005,-0.00533340088589216,0.00499815896173426,-0.0151297924508913,0.00446299067910699,0.285958433132381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39302,0.00444901522093056,0.00420274357156576,-0.00378836217933834,0.0126863926211995,0.289799534623902
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39401,0.00578256484230628,0.00546474185264131,-0.00492832918887068,0.0164934588734832,0.289999484230247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,39401,-0.00536624427279237,0.00507712886453006,-0.0153174168472713,0.00458492830168653,0.290553270802275
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,37285,0.00150172217313644,0.00142092775850442,-0.00128329623353223,0.00428674057980511,0.29059435477036
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36896,0.00786433865445491,0.00744302996833762,-0.00672400008348683,0.0224526773923967,0.290711724601142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36896,-0.00697047521716873,0.00660598434344665,-0.0199182045303242,0.0059772540959867,0.291364457179456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37005,0.0071175322840877,0.00679937070258566,-0.0062092342929802,0.0204442988611556,0.295214400035917
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,37220,-0.00734492194132458,0.00701846029652454,-0.0211011041225127,0.00641126023986353,0.295342389894518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36795,-0.00925808492004657,0.00885035116821008,-0.0266047732097383,0.00808860336964518,0.295548362394997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,37220,-0.00878993540607117,0.00842089176372272,-0.0252948832629677,0.00771501245082537,0.296585355924728
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36877,0.00341357665933164,0.00327177547492297,-0.00299910327151738,0.00982625659018067,0.296809882516685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,39401,-0.0053489899133314,0.00514437824433273,-0.0154319712722235,0.00473399144556075,0.298461162210155
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37203,0.00535979341975743,0.00516911254774526,-0.00477166717382327,0.0154912540133381,0.299806608598074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,39680,0.0034884278568294,0.00336511310101906,-0.00310719382116796,0.0100840495348268,0.29991715203964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37005,-0.00511082082702599,0.00493524475455042,-0.0147839005459448,0.00456225889189283,0.300419061970107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37244,-0.00772326663643073,0.00748672620101604,-0.0223972499904222,0.00695071671756071,0.302280691925973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,39770,0.00330554476495014,0.00320843856731394,-0.00298299482698517,0.00959408435688545,0.302900875587142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37277,-0.00614571319181836,0.00598097502080693,-0.0178684242326,0.00557699784896323,0.304183043864965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36827,-0.00405146813215794,0.0039529018589972,-0.0117991557757925,0.00369621951147657,0.305412898655637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39672,0.00260700030765841,0.00254883952443936,-0.00238872516024275,0.00760272577555956,0.306409300686133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,39266,0.00337014022238364,0.00330351850155519,-0.00310475604066452,0.0098450364854318,0.307665333231048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39668,0.00324936133623814,0.00318564142392622,-0.00299449585465726,0.00949321852713354,0.307743015767597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,39401,0.00290695576274324,0.00285628767873699,-0.00269136808758125,0.00850527961306774,0.308817785170752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,36877,0.007374751470959,0.00727708204777452,-0.00688832934267904,0.0216378322845971,0.310877706081634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,39836,0.00262623132258171,0.00259188210534377,-0.00245385760389207,0.00770632024905549,0.310954859397242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36795,-0.00852208688599198,0.00841117532880115,-0.0250079905304422,0.00796381675845829,0.310990175446836
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36827,-0.00572238910045232,0.00565067468974934,-0.016797711492361,0.00535293329145638,0.311226529890292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37268,0.0029272503206887,0.0028952542850629,-0.00274744807803457,0.00860194871941198,0.312010169645672
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,36827,-0.0051449444150501,0.00512254284456845,-0.0151851283904043,0.00489523956030407,0.315217535733787
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,37203,-0.00337039561259584,0.00335725989390155,-0.00995062500464287,0.00320983377945119,0.31543893298331
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C5,Complement C5,37285,0.00147582679957027,0.00147161283582668,-0.00140853435865003,0.00436018795779056,0.315944800554635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36855,0.00944936479425586,0.00942997807925484,-0.00903339224108361,0.0279321218295953,0.316335272861084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39673,0.00636325557408378,0.0063548537231638,-0.00609225772331727,0.0188187688714848,0.31668642629816
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,37005,-0.00556333035611767,0.00556226924595965,-0.0164653780781986,0.00533871736596325,0.31723660647785
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39594,-0.0021660611635157,0.00216636717599591,-0.00641214082846768,0.00208001850143629,0.317394248777544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36877,-0.00511255569959326,0.00511693599106264,-0.015141750242076,0.00491663884288951,0.317743529980314
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39842,0.00254261028569979,0.00255354223445635,-0.00246233249383466,0.00754755306523424,0.319401815416845
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,39721,0.00371748983279938,0.0037391495379341,-0.00361124326155145,0.0110462229271502,0.320137113065127
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,39673,0.00375467007564855,0.00380030081700383,-0.00369391952567897,0.0112032596769761,0.323171261635949
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37005,0.00658753836358251,0.00667767688959886,-0.00650070834003125,0.0196757850671963,0.323905229870822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,39588,-0.0031675157917714,0.00322579772481081,-0.00949007933240059,0.00315504774885779,0.326148181786761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36795,-0.00476494862280674,0.00486740750986244,-0.0143050673421371,0.00477517009652365,0.327622989596317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,36896,-0.00465698370758298,0.00476202827254297,-0.0139905591217672,0.00467659170660123,0.328121547480302
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37215,0.00236101540588728,0.00241495244362078,-0.00237229138360946,0.00709432219538402,0.328257557143037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39288,0.00323883413012975,0.00331558454638561,-0.00325971158078603,0.00973737984104554,0.328657933478142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36877,-0.00641588188317246,0.00659448311444902,-0.0193410687874925,0.00650930502114763,0.330612848058327
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,36855,0.00481126818013878,0.00498558441424514,-0.00496047727178169,0.0145830136320592,0.334544764940898
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,39401,-0.00459939179089151,0.00476652665594047,-0.0139417840365348,0.00474300045475181,0.33459202756561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36855,-0.00604396434120747,0.00626743182076291,-0.0183281307099028,0.00624020202748783,0.33489110744216
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,37244,0.00327827828003428,0.00340511852840676,-0.00339575403564297,0.00995231059571154,0.33569033011204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,39401,0.00576137517231251,0.00598937283736473,-0.00597779558892235,0.0175005459335474,0.336098244356492
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,39493,0.00355813691737682,0.00370258367975642,-0.00369892709494577,0.0108152009296994,0.33657327741853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36827,0.00440343967618098,0.00458619959665985,-0.00458551153327232,0.0133923908856343,0.336997614944134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36855,0.00373264675610711,0.00390476706501783,-0.00392069669132783,0.0113859902035421,0.339130199950829
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,39371,0.00349795735562786,0.00366159465296362,-0.00367876816418084,0.0106746828754366,0.339435927142869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36795,0.00531565506256259,0.00556735090336739,-0.0055963527080375,0.0162276628331627,0.339701376192026
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,36896,-0.00528083091270974,0.00553798748039705,-0.016135286374288,0.00557362454886848,0.340321570967464
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,36855,-0.00558723451723104,0.00588693614212041,-0.017125629355787,0.00595116032132497,0.342592291310308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36877,0.00339318730551274,0.00357837934160356,-0.00362043620403024,0.0104068108150557,0.343021352799969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,36998,-0.00896796015852691,0.00948089973581556,-0.0275505236407254,0.00961460332367159,0.344218221527227
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,39401,0.00283879061711029,0.00302397017639771,-0.00308819092862921,0.0087657721628498,0.347867147362874
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36855,0.00359907334195069,0.00384209528482903,-0.00393143341631421,0.0111295801002156,0.348905839239891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36896,-0.00842176721786899,0.00901868665102989,-0.0260983930538876,0.0092548586181496,0.350417636539004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,39799,-0.00379498201416161,0.00407335327191449,-0.011778754427114,0.00418879039879078,0.351526159368492
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39401,0.0108212321973728,0.011662237856368,-0.0120367540011084,0.0336792183958541,0.353480896812411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39302,0.00270699466906863,0.00291945676585951,-0.00301514059201601,0.00842912993015327,0.353823973424879
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36855,-0.00457301938002177,0.00493244955420358,-0.0142406205062608,0.00509458174621725,0.353876531203359
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39668,-0.00424346223869301,0.0045889756694845,-0.0132378545508826,0.00475093007349661,0.355131963253446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36958,-0.00335218502679676,0.00363241014501529,-0.0104717089110267,0.00376733885743321,0.356100180383592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,36795,-0.0103201155482526,0.0112007803212503,-0.0322736449779033,0.0116334138813981,0.356872019598392
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,36958,0.008301132520844,0.00906839072659833,-0.00947291330328874,0.0260751783449767,0.360002717204248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36972,-0.00450873383020778,0.00493033144719851,-0.0141721834667169,0.0051547158063013,0.360476776118943
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36877,-0.00371986318219466,0.00406832978691844,-0.0116937895645548,0.00425406320016548,0.360551729687183
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,37005,-0.00370408847667008,0.00407725802185187,-0.0116955141994997,0.00428733724615959,0.363643777765705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,36827,-0.00564662605796646,0.00621729106669518,-0.017832516548689,0.00653926443275609,0.363782449240814
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36877,-0.00425462333524221,0.00468762841704779,-0.0134423750326559,0.00493312836217145,0.364091537922395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36795,0.00698353477606393,0.00771064809853728,-0.00812933549706915,0.022096405049197,0.365111477746203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,39401,-0.00282009919292535,0.00311589758437634,-0.00892725845830298,0.00328706007245227,0.365443394308084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,36877,-0.00516561891682786,0.00571589456124739,-0.0163687722568727,0.00603753442321702,0.366155912196984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39817,0.00616069548051037,0.00682658780516565,-0.00721941661761431,0.019540807578635,0.366828278889171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,39302,-0.00278016084897311,0.00308954582484879,-0.00883567066567673,0.00327534896773051,0.368208422378322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,39529,-0.0108754624924243,0.0120948936633079,-0.0345814540725078,0.0128305290876593,0.368571665554173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,36896,-0.00301743665329346,0.00336064419901274,-0.00960429928335843,0.00356942597677151,0.369269055277472
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36880,0.00543358161053005,0.00607555973480577,-0.00647451546968927,0.0173416786907494,0.371159571685866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36877,0.00557146306528408,0.00623487205926134,-0.00664888617086814,0.0177918123014363,0.371554064133106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39557,-0.00330335246368072,0.00369913346616793,-0.0105536540573699,0.00394694913000841,0.371867058425175
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36827,-0.00277881760121595,0.00312387563744144,-0.00890161385060117,0.00334397864816926,0.373728532269227
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,36896,-0.00254328979890768,0.00286528181887058,-0.00815924216389401,0.00307266256607866,0.374759999510219
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39302,0.00402515279936935,0.0045403051361299,-0.00487384526744526,0.012924150866184,0.375341520674771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,37133,-0.00242890476176704,0.00274772443828977,-0.00781444466081498,0.00295663513728091,0.376728656552333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,36855,-0.00343477480175692,0.00390303126795684,-0.0110847160869523,0.00421516648343848,0.378860692500906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,39594,0.0157261362277506,0.0179289578562435,-0.0194146211704866,0.0508668936259878,0.380426109280185
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36896,0.00234802437121073,0.0026877127088375,-0.00291989253811076,0.00761594128053222,0.382344405232575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37203,-0.00483146449012722,0.00554223543936754,-0.0156942459512876,0.00603131697103315,0.383358419616151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,39714,0.0126146186250252,0.0144929716589591,-0.0157916058265347,0.0410208430765851,0.384097433953998
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,39302,-0.00375663065949874,0.00432753769577269,-0.0122386045432132,0.00472534322421573,0.385366339290911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39860,-0.00189070520145424,0.00218148912068438,-0.00616642387799562,0.00238501347508715,0.386117246623301
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36795,-0.00341277606583666,0.00393772952448417,-0.0111307259338256,0.00430517380215232,0.3861300131137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,39865,0.00699497361970692,0.00808271716911316,-0.00884715203175486,0.0228370992711687,0.386819342713152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36855,-0.00598235127168499,0.00693944149816982,-0.0195836566080978,0.00761895406472787,0.388659598640312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37244,0.00965143418445593,0.0112008589747788,-0.0123022494061105,0.0316051177750223,0.388885065766476
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,36862,0.0055714007387932,0.00647938989787112,-0.00712820346103419,0.0182710049386206,0.389879305243499
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36880,0.00216249348374012,0.00251841369731943,-0.00277359736300596,0.00709858433048619,0.390536837236456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39770,-0.00245194538259421,0.00285670713675119,-0.00805109137062654,0.00314720060543813,0.390733257450487
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36855,0.00336720557309625,0.00395566044283211,-0.00438588889485469,0.0111203000410472,0.394653251785729
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,37244,0.00508867118516507,0.0059914409401051,-0.00665455305744093,0.0168318954277711,0.395716536579134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,37244,0.00662669008920656,0.00780459651374828,-0.00867031907774006,0.0219236992561532,0.395854582333808
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39721,-0.00295077722852121,0.00347722606276017,-0.00976614031153114,0.00386458585448872,0.396116202657744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36880,0.0075304306851793,0.00887980100216403,-0.00987397927906219,0.0249348406494208,0.396431017880664
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,39251,0.00355597019439233,0.00419896918087761,-0.00467400940012779,0.0117859497889124,0.397082191811572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37189,0.00295638567661272,0.00349778728334915,-0.00389927739875163,0.00981204875197706,0.398005437929968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37244,0.00282303724083465,0.00334258706578779,-0.00372843340810941,0.00937450788977871,0.398367985394203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36877,-0.00297994585921895,0.00353433147990735,-0.00990723555983735,0.00394734384139946,0.399164121068828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,39817,0.00269692480914857,0.00319875336150596,-0.00357263177940311,0.00896648139770025,0.39917539233024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36896,0.00312695777658356,0.00371898390849048,-0.00416225068405777,0.0104161662372249,0.40046996911096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36877,0.00394709907699539,0.00469448718160788,-0.00525409579895606,0.0131482939529468,0.400478503987544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37203,-0.00418401673586821,0.00498724142041389,-0.0139590099198794,0.00559097644814301,0.401515711848981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39594,-0.00307779065285257,0.00368231015712051,-0.0102951185608088,0.00413953725510362,0.403262421142909
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37244,0.00191844835326313,0.00231168204244241,-0.00261244844992399,0.00644934515645026,0.406614180596376
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37005,-0.00528761750080616,0.00637438402123572,-0.0177814101824282,0.00720617518081585,0.406830747406444
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39721,0.00624792920366039,0.00755364376549383,-0.00855721257670752,0.0210530709840283,0.408169535467145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39860,-0.00555322292067411,0.00671818991066864,-0.0187208751455846,0.00761442930423642,0.408478916792082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36896,0.00302821204342015,0.00366521941888191,-0.0041556180175884,0.0102120421044287,0.408704568193131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,36795,0.00435021782601553,0.00526552034762377,-0.00597020205532706,0.0146706377073581,0.408722591410985
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36827,0.00439067495504627,0.0053178460057668,-0.00603230321625665,0.0148136531263492,0.409018343577038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37203,-0.00610459950635463,0.00742222614384175,-0.0206521627482845,0.0084429637355752,0.410820995846805
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,39228,-0.00239303669195358,0.0029187563392855,-0.00811379911695316,0.00332772573304601,0.412295917250892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36827,-0.00525298237833368,0.00640885580404282,-0.0178143397542576,0.00730837499759025,0.412433954283634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36795,-0.00254631647225982,0.00312110530904048,-0.00866368287797917,0.00357104993345952,0.414607789805356
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39401,0.00330505445232103,0.00405466659551088,-0.0046420920748803,0.0112522009795224,0.415014052429789
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,36855,0.0059525865246658,0.0073239245530545,-0.00840230559932102,0.0203074786486526,0.416371063313723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,36827,-0.00608896832270938,0.00750360870437525,-0.0207960413832849,0.0086181047378661,0.417109563876664
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36877,0.00789395021525265,0.00972894822678928,-0.0111747883092543,0.0269626887397597,0.417157820007199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37244,0.00218757636624124,0.00269682119622186,-0.0030981931783536,0.00747334591083609,0.417283345115944
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,39401,-0.00243035077861196,0.00300111434425606,-0.00831253489335383,0.00345183333612991,0.418058264440014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37244,-0.0026215112914844,0.00324160915957755,-0.00897506524425639,0.00373204266128759,0.418698204584108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36795,0.00726004300690178,0.00897774516825093,-0.01033633752287,0.0248564235366736,0.418719232190704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36827,-0.00412364247083167,0.00511034107913296,-0.0141399109859323,0.00589262604426893,0.419726693266416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,39337,-0.00362642600423799,0.00450954180241658,-0.0124651279369745,0.00521227592849851,0.421312719196447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36877,0.0039979436218614,0.00497797886153577,-0.00575889494674871,0.0137547821904715,0.421916648350891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36827,0.00310125870516462,0.00386369908892934,-0.00447159150913689,0.0106741089194661,0.422182698317556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36877,0.00413870994192304,0.0051584777159376,-0.00597190638131466,0.0142493262651607,0.4223869962804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39720,0.00690958355086105,0.00861551252201648,-0.00997682099229126,0.0237959880940134,0.422568834405193
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36827,-0.00562336934099125,0.0070540358359256,-0.0194492795794054,0.00820254089742293,0.425358375200152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,39594,0.00321802707321124,0.00404430863192311,-0.00470881784535805,0.0111448719917805,0.426222643329084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36877,0.00653366027695212,0.00821796952421194,-0.00957355999050328,0.0226408805444075,0.426601489576803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,37244,0.00224538665965674,0.00282502438471774,-0.00329166113439003,0.00778243445370351,0.426732148775785
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39401,-0.00497122063078423,0.00625917786148387,-0.0172392092392926,0.00729676797772415,0.427074250775729
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36855,-0.00432005960467085,0.00544522332725039,-0.0149926973260816,0.00635257811673992,0.427578612036969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36795,-0.0063667244580414,0.00803241294112029,-0.0221102538226372,0.00937680490655437,0.428008470465679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36855,-0.00475581373007805,0.00603418299089572,-0.0165828123922337,0.00707118493207756,0.430626022434364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37005,0.00397380219609128,0.0050434156576463,-0.00591129249289546,0.013858896885078,0.430758390011197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37203,0.00742654383456198,0.00943859187939323,-0.0110730962490488,0.0259261839181727,0.431396816103382
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,36920,0.00628491159008332,0.0080201319535685,-0.00943454703891093,0.0220043702190776,0.433264463058454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37244,0.00691685627860214,0.00884148800653121,-0.010412460214199,0.0242461727714033,0.434041480463488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37020,0.00315874938269866,0.00405024351616061,-0.00477972790897614,0.0110972266743735,0.435468928858208
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36775,-0.0035868353519136,0.00460116526219562,-0.012605119265817,0.00543144856198981,0.43567046826526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,39401,-0.00293345287203873,0.00377269403374883,-0.0103279331781864,0.00446102743410898,0.436847023107582
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,37267,-0.00677733291328136,0.00871865941759288,-0.0238659053717634,0.0103112395452007,0.436973932879998
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36896,-0.00234134367995837,0.00301985718345255,-0.00826026375952538,0.00357757639960863,0.438167003694103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36877,-0.00581477187009773,0.00754239937555746,-0.0205978746461903,0.00896833090599489,0.440753778273091
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37203,-0.00313281113354863,0.00406994991216213,-0.0111099129613864,0.00484429069428914,0.441466613997309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39798,0.00458957981604133,0.00599019272790822,-0.00715119793065878,0.0163303575627414,0.44357916842308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,36795,0.00530589485955834,0.00694732362416004,-0.00831085944379534,0.018922649162912,0.445040768809121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,39673,-0.00246321867989459,0.00323929562087075,-0.00881223809680126,0.00388580073701207,0.447016108097368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37244,-0.00383677136989339,0.00504702872621646,-0.0137289476732777,0.00605540493349088,0.447146051863253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39673,0.00239686972367084,0.00315605875312407,-0.00378900543245234,0.00858274487979402,0.447594562983429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39269,0.00374137151485116,0.00493240142295818,-0.00592613527414688,0.0134088783038492,0.448145718228254
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,36929,0.010384028275541,0.0137415359840595,-0.0165493822532156,0.0373174388042976,0.449862362336947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,37203,-0.00248609748803929,0.00330692018734311,-0.00896766105523178,0.0039954660791532,0.45219280668094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,39401,-0.00352758058062582,0.0047002706023494,-0.0127401109612306,0.005684949799979,0.452961464607099
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39302,0.0057518331095705,0.00766499205045127,-0.00927155130931398,0.020775217528455,0.453023451827461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,39836,-0.00311081490129637,0.00416496614740381,-0.0112741485502078,0.0050525187476151,0.45513467320351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37203,-0.00352851153683424,0.00472849984553125,-0.0127963712340755,0.005739348160407,0.455546349004534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36880,0.00236148515086061,0.00317667203260572,-0.0038647920330466,0.00858776233476782,0.457263025059516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39743,0.00240210701283896,0.0032316801631652,-0.00393198610696482,0.00873620013264274,0.457311225447825
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37005,-0.00489497402136161,0.00659186822971764,-0.0178150357516082,0.00802508770888496,0.457750693032801
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,36827,0.00445304920950757,0.00601563359127384,-0.00733759262938915,0.0162436910484043,0.459164091733332
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,37082,0.00224184052634721,0.00302979613711832,-0.00369655990240471,0.00818024095509912,0.459354912255362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39029,-0.00268152443068352,0.00364091789602739,-0.00981772350689721,0.00445467464553016,0.461439795282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36877,0.00506923282205598,0.00688825643616395,-0.00843174979282537,0.0185702154369373,0.461790247068809
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,39401,-0.00763673701970138,0.0103987822639927,-0.0280183502571271,0.0127448762177243,0.462723606164264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36877,-0.00205402521360094,0.00280149442260624,-0.00754495428190917,0.00343690385470729,0.463456297209454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39401,0.00437749634037969,0.00597137305355312,-0.00732639484458443,0.0160813875253438,0.463520471807908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,36795,-0.00654515154430228,0.00893176705637234,-0.0240514149747921,0.0109611118861875,0.463696934116651
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37005,0.0032880143480444,0.00448757428156544,-0.00550763124382387,0.0120836599399127,0.463758747208891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39521,-0.00212891550062037,0.00290909046592608,-0.00783073281383547,0.00357290181259474,0.464292555728753
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36827,0.00329574430264461,0.004507696883175,-0.00553934158837839,0.0121308301936676,0.464708643208011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39617,0.00243218968845319,0.00332930235216144,-0.00409324292178323,0.00895762229868961,0.465070822951552
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36827,-0.00212452516905536,0.00291996548010906,-0.00784765751006911,0.0035986071719584,0.466880364775049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39288,-0.00401924008584444,0.0055687373652654,-0.0149339653217646,0.00689548515007575,0.470458703514565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,39721,0.00148604297016886,0.00208361281659526,-0.00259783815035785,0.00556992409069558,0.475729437933598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36958,0.00193851757307872,0.0027270309216498,-0.00340646303335489,0.00728349817951233,0.477188113457676
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37005,-0.00370961150759034,0.00524706975367724,-0.0139938682247977,0.00657464520961705,0.479586922583109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,36827,0.00505970828149129,0.00716780621842236,-0.00898919190661654,0.0191086084695991,0.480267011322489
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,39673,0.00435169865174721,0.00616707301321481,-0.00773576445415383,0.0164391617576482,0.480425941975
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39673,-0.00416243343261458,0.00590687163820605,-0.0157399018434984,0.00741503497826927,0.481021978155979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36855,-0.00352758172910447,0.00501653437094121,-0.0133599890961492,0.00630482563794031,0.481949336159618
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36795,-0.00177709324899012,0.00253833155879615,-0.00675222310423057,0.00319803660625033,0.483875644985258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,39557,0.00237773208108311,0.00340246024344075,-0.00429108999606075,0.00904655415822697,0.484670323340699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37244,-0.00242955875109124,0.00347871339960194,-0.00924783701431104,0.00438871951212857,0.484934661379888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,36877,0.00236219207793585,0.0034047192271113,-0.0043110576072023,0.00903544176307399,0.487820413812529
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36827,0.00213481150907028,0.0030968054702438,-0.00393492721260755,0.00820455023074812,0.490609553123906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,39557,0.00367167618655052,0.00537610637922663,-0.00686549231673367,0.0142088446898347,0.494640955092724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36880,0.00515358475398199,0.00754816582795164,-0.00964082026880323,0.0199479897767672,0.494770735955907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,37005,0.00189052295671574,0.00277248171418134,-0.0035435412030797,0.00732458711651117,0.495321572199854
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,36827,-0.00321525293513722,0.00472415617080067,-0.0124745990299065,0.0060440931596321,0.496137817875408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,36855,0.00388016522327062,0.00572528076038081,-0.00734138506707577,0.015101715513617,0.497958213449274
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36855,-0.00304136435272258,0.00450288803937245,-0.0118670249098926,0.00578429620444742,0.499417635516411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37005,-0.00478690302774356,0.00709034202353068,-0.0186839733938637,0.00911016733837657,0.499605012517252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36855,-0.00319067207186304,0.00473369729757749,-0.0124687187751149,0.00608737463138884,0.500301801524665
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37285,-0.00121389892262454,0.00180365014873283,-0.00474905321414088,0.00232125536889181,0.500943929915251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,39236,0.00297762311318129,0.00443371567025553,-0.00571245960051955,0.0116677058268821,0.501857132834238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36896,-0.00622207755439164,0.00926534456218813,-0.0243821528962804,0.0119379977874971,0.501886557076854
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39401,0.00540673029852598,0.00807562713172436,-0.0104214988796538,0.0212349594767057,0.503178793743134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37203,0.00293278651471827,0.00438431209048179,-0.00566046518262603,0.0115260382120626,0.503553359640344
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39594,0.00167488789002004,0.00251246649848875,-0.00324954644701791,0.00659932222705799,0.505017679255197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36827,-0.00531637694972915,0.00803458477148324,-0.0210641631018363,0.010431409202378,0.5081838622903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39836,0.00374876262741416,0.00574386347835241,-0.00750920979015657,0.0150067350449849,0.513987951975723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37244,-0.00249047561196708,0.00381776329283645,-0.00997329166592651,0.00499234044199236,0.514193756037844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,39668,0.00241220507230889,0.00369868637346607,-0.00483722021968461,0.00966163036430238,0.514295276553365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,37285,-0.00114507633918194,0.00176428040595876,-0.00460306593486111,0.00231291325649722,0.516328099712369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,39706,0.00313056288802046,0.0048369211466437,-0.00634980255940119,0.0126109283354421,0.517497501921748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36827,-0.00333256401068272,0.00523851932900725,-0.0136000618955369,0.0069349338741715,0.524679941786191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,36877,0.0049268677528381,0.00774694335316907,-0.0102571412193733,0.0201108767250495,0.524803439087366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,39401,0.00773617706794108,0.0121731220676866,-0.0161231421847246,0.0315954963206068,0.525103261857638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36827,-0.00647529587096942,0.0102054683647089,-0.0264780138657989,0.0135274221238601,0.525770478665698
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39680,-0.00169103814798304,0.00266646133084618,-0.00691730235644155,0.00353522606047547,0.52596721735579
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,36827,-0.00555918592834038,0.00877479010729467,-0.0227577745386379,0.0116394026819572,0.526391840262119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36877,0.00235156788243734,0.00372607985834187,-0.00495154863991272,0.0096546844047874,0.52797939925751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,36737,-0.00208237411347698,0.00332502242349421,-0.00859941806352562,0.00443466983657167,0.531146531218287
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,36795,-0.00482803252608397,0.00771064561342514,-0.0199408979283973,0.0102848328762293,0.531226606336217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,37186,0.00303433400560727,0.00486686240421897,-0.00650471630666191,0.0125733843178765,0.5329875552858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36795,-0.00223599572729877,0.00360067394163184,-0.00929331665289717,0.00482132519829963,0.53461472992383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36855,-0.00266013921592864,0.00429648513476489,-0.0110812500800678,0.00576097164821053,0.535832932024852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36827,-0.0069838852551952,0.0112862755585147,-0.029104985349884,0.0151372148394936,0.536062615055724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36855,-0.00236666581391127,0.00383415535456573,-0.00988161030886009,0.00514827868103755,0.537074907205453
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,36877,-0.00289250689430325,0.00472780345261878,-0.0121590016614361,0.00637398787282956,0.540675632551243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,39666,-0.0111137333936919,0.018205602478875,-0.0467967142522869,0.0245692474649031,0.541568044976081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,36880,0.00172414668625925,0.00283058299944605,-0.00382379599265502,0.00727208936517351,0.542459751361582
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,39680,0.00447178454482902,0.00737974039153073,-0.00999250662257121,0.0189360757122293,0.544553873056511
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37244,0.0040773495507171,0.0068071319833424,-0.00926462913663401,0.0174193282380682,0.549195023641883
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36855,-0.00324965969532412,0.00544433642455432,-0.0139205590874506,0.00742123969680234,0.550592482664637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36880,0.00490490516092698,0.00823399164879817,-0.0112337184707174,0.0210435287925714,0.551392801622468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39695,0.00135264276215448,0.00227126638013992,-0.00309903934291977,0.00580432486722872,0.551487320237712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39401,0.00246580438755014,0.00415657812985981,-0.00568108874697509,0.0106126975220754,0.553036266311366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39288,0.00311929007172129,0.00526565478688379,-0.00720139331057094,0.0134399734540135,0.55360210533799
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39288,0.00265047682141376,0.00447677879227896,-0.00612400961145301,0.0114249632542805,0.553825792353641
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39680,0.000998576076088134,0.00169198060115347,-0.00231770590217267,0.00431485805434894,0.555077234150866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39182,0.00206698787172138,0.00351110982108859,-0.00481478737761226,0.00894876312105501,0.556071689914158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,39826,0.0034106515708581,0.00579534321037063,-0.00794822112146833,0.0147695242631845,0.556194396044648
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,37203,0.00337056967232425,0.00573065471070519,-0.00786151356065793,0.0146026529053064,0.556431602302116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,36855,0.00218128761685659,0.00372385787472789,-0.00511747381761008,0.00948004905132326,0.558046866463892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39302,-0.00183929714722306,0.00314876591531368,-0.00801087834123788,0.00433228404679176,0.559139566299384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39848,0.00202044132961608,0.00346282270099372,-0.00476669116433161,0.00880757382356376,0.559587476720942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,37244,0.00121518837757372,0.0020919075908871,-0.00288495050056498,0.00531532725571243,0.561317872583339
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37244,0.00196874174194444,0.0034091888823856,-0.00471326846753134,0.00865075195142022,0.563624296598545
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,36795,-0.0022749857125168,0.00394578594127777,-0.0100087261574212,0.00545875473238763,0.564246182392344
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,37005,-0.00198149773966409,0.00344106897619505,-0.00872599293300639,0.00476299745367821,0.564734649270332
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39401,-0.00251723860964168,0.00439306546253875,-0.0111276469162176,0.00609316969693426,0.566651119282587
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,39223,-0.00369951249108191,0.00649872257562308,-0.0164370087393031,0.00903798375713933,0.569182843569632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36795,0.00349501541529734,0.00614929329667415,-0.00855759944618399,0.0155476302767787,0.569800072043261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,36795,-0.00335437001588267,0.00590307013979304,-0.014924387489877,0.00821564745811168,0.569880792304092
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39817,-0.00147606677510825,0.00259914097583908,-0.00657038308775284,0.00361824953753634,0.570107044014133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,36896,-0.00209812190866779,0.00370216057372556,-0.00935435663316988,0.0051581128158343,0.570908044743601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,39401,-0.00292858305369333,0.00517395610752803,-0.0130695370244483,0.00721237091706161,0.571385674788707
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39401,0.00205714396472079,0.0036354600193368,-0.00506835767317933,0.00918264560262092,0.571500386546129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37244,-0.00417082865093622,0.00737660059567057,-0.0186289658184505,0.0102873085165781,0.571802105988608
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,36896,-0.00468546400587275,0.00849421324810786,-0.0213341219721642,0.0119631939604187,0.581227375188918
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36827,-0.00258814367133367,0.0047037041146546,-0.0118074037360567,0.00663111639338935,0.582167526799428
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,36877,-0.00245560331682567,0.00448067207536349,-0.0112377205845381,0.00632651395088678,0.583671415042539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39798,-0.00242938466635331,0.00444533431024603,-0.0111422399144355,0.0062834705817289,0.584728474666946
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36896,-0.0026480724733734,0.00486060713575199,-0.0121748624594473,0.00687871751270051,0.585898458669645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,36765,0.00186203003011218,0.00342064179417724,-0.00484242788647521,0.00856648794669957,0.586209312935569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39673,-0.0043638458350143,0.00802946108949163,-0.0201015895704179,0.0113738979003893,0.586807505536325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,39638,-0.00412931272708354,0.00759972864072172,-0.0190247808628981,0.010766155408731,0.58689650523515
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39614,-0.00175952294413268,0.00323862523364682,-0.00810722840208045,0.0045881825138151,0.586935658391264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37005,-0.00358034916310933,0.0065961319103084,-0.0165087677073138,0.00934806938109513,0.587279976993671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39302,0.00202181440369641,0.00374483591983923,-0.00531806399918848,0.0093616928065813,0.589277928671244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39865,0.00177655463739111,0.0033062122838647,-0.00470362143898371,0.00825673071376593,0.591041393237507
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39288,-0.00161906490035334,0.00301594968582941,-0.00753032628457898,0.00429219648387229,0.591389895192513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,39401,-0.00365758842886528,0.00684659029977016,-0.0170769054164148,0.00976172855868424,0.593196676024707
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36896,0.00312467378157061,0.00585612806209316,-0.00835333722013198,0.0146026847832732,0.593645857796532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36877,-0.00331802480554231,0.0062386329880939,-0.0155457454622064,0.00890969585112174,0.594838094285358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36836,0.00426986121034595,0.00807133165991274,-0.011549948843083,0.0200896712637749,0.596803604016377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,39720,-0.00145055405401758,0.00278066798612051,-0.00690066330681377,0.00399955519877861,0.601916670068668
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36985,-0.00273042722735079,0.0052614687403207,-0.0130429059583794,0.00758205150367779,0.603805945878576
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37220,0.00191793613415342,0.00373016767572418,-0.00539319251026597,0.0092290647785728,0.607142427972603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36877,0.0038642318676605,0.00757972655793465,-0.0109920321858914,0.0187204959212124,0.610192161982339
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,37203,-0.00540080245287645,0.0106297455758802,-0.0262351037816017,0.0154334988758488,0.611402913648883
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,36896,-0.0014326531553831,0.0028210366517728,-0.00696188499285779,0.00409657868209158,0.611569696859643
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,37220,-0.00182685924569479,0.00361159206917506,-0.00890557970127791,0.00525186120988833,0.612982858802581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39288,-0.00180453482967542,0.00357978058103478,-0.00882090476850359,0.00521183510915275,0.614204696780118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36958,-0.00177355622817896,0.00352258841830728,-0.00867782952806124,0.00513071707170331,0.614634624606839
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39302,-0.00237849133914779,0.00472872350115575,-0.0116467894014131,0.00688980672311748,0.61497985853519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36877,-0.00197623869370181,0.00393898754960401,-0.00969665429092567,0.00574417690352204,0.615878362328592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39668,0.00161653555689332,0.00323552126602374,-0.00472508612451321,0.00795815723829985,0.61734866366713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39673,-0.00265476168967078,0.00532009336819471,-0.0130821446913324,0.00777262131199085,0.617781677916676
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,39401,0.00284151952650706,0.00570569831910721,-0.00834164917894308,0.0140246882319572,0.618480988819077
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36896,0.00188386685752626,0.00379225387125357,-0.00554895073013074,0.00931668444518326,0.619361693933291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36795,0.00286394268498831,0.00576837192887825,-0.00844206629561306,0.0141699516655897,0.619556724745968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,39720,0.00391742853495129,0.00791861951083838,-0.0116030657062919,0.0194379227761945,0.620810956393646
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,39636,0.00125193461200084,0.00253107508505141,-0.00370897255469992,0.0062128417787016,0.620871293711573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39668,0.00168767858158692,0.00341519946577403,-0.00500611237133018,0.00838146953450402,0.621195170404086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39302,0.00255280070297702,0.00520377213828396,-0.00764659268805953,0.0127521940940136,0.623739454934748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39302,0.00323797126933199,0.00664676615020734,-0.00978969038507439,0.0162656329237384,0.62615904206542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36896,0.00214494272261786,0.00440789087432877,-0.00649452339106653,0.0107844088363023,0.626539870063363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,37203,-0.00130193767934742,0.00268267652264638,-0.00655998366373432,0.00395610830503949,0.627462332921657
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,36880,-0.000835160330254428,0.00172880905059541,-0.00422362606942144,0.00255330540891258,0.629044077795831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39574,-0.00167634516866988,0.00347488910188484,-0.00848712780836416,0.0051344374710244,0.629516549838017
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36827,-0.00261737874278522,0.00545950510679477,-0.013318008752103,0.00808325126653252,0.631650193539764
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,39594,-0.00146867720330863,0.00306626173578705,-0.00747855020545125,0.00454119579883399,0.631959708761752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37244,0.00124115892589672,0.0025977835536511,-0.00385049683925944,0.00633281469105289,0.632817367733215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39288,0.00404225705029683,0.00846167897168382,-0.0125426337342035,0.0206271478347971,0.632861005484247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39594,-0.00141466475254225,0.0029651012666161,-0.0072262632351098,0.0043969337300253,0.633293953925251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36827,-0.00346539780134824,0.00727934200191493,-0.0177329081251015,0.010802112522405,0.634040216338179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,37005,0.00242919797378263,0.0051413679264831,-0.00764788316212424,0.0125062791096895,0.636591439460408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36896,0.00135106298205192,0.0028690552321489,-0.00427228527295992,0.00697441123706376,0.637713836246324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,39401,-0.00649893892386968,0.0138491051600334,-0.0336431850375351,0.0206453071897957,0.63888482109577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,39680,0.00159029839818529,0.00339618106739608,-0.00506621649391102,0.00824681329028161,0.639604562504203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36855,-0.00176749501832992,0.0037833243177422,-0.00918281068110463,0.00564782064444479,0.640378638840539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,39401,0.00270359855211563,0.0057893580939012,-0.00864354331193072,0.014050740416162,0.640510339655354
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36877,0.00231337540220298,0.00496170551189996,-0.00741156740112094,0.0120383182055269,0.641047220605163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36896,-0.000908274361277451,0.00195093723986589,-0.00473211135141461,0.0029155626288597,0.641539718205378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37005,-0.00138585728633553,0.0029776265772506,-0.0072220053777467,0.00445029080507565,0.641635942278688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36880,-0.00210067096043963,0.0045389471861041,-0.0109970074452037,0.00679566552432441,0.643508168979003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36855,-0.0030032336507541,0.00651610102258967,-0.0157747916550299,0.00976832435352165,0.644882173082196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39490,-0.00138189154345047,0.00306594922983412,-0.00739115203392534,0.0046273689470244,0.652195994311308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39288,0.00237661898255745,0.00529197763506935,-0.00799565718217848,0.0127488951472934,0.653366942730248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36855,-0.00384137522272291,0.00859680469712823,-0.0206911124290942,0.0130083619836484,0.654999797346197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,37005,-0.0018056230541521,0.00405566373730606,-0.00975472397927197,0.00614347787096777,0.656175153393042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36877,-0.00161832825877858,0.00364642823394929,-0.00876532759731919,0.00552867107976203,0.65718595781389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39668,-0.00128790750434107,0.00290670921493177,-0.00698505756560734,0.0044092425569252,0.657713240910126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36896,0.00384225066466535,0.00870444075349774,-0.0132184532121902,0.0209029545415209,0.658921573331587
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36855,-0.00169489955058252,0.00385052620448567,-0.00924193091137442,0.00585213181020939,0.659818780803362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36795,-0.00283695424708762,0.00644976536543542,-0.015478494363341,0.0098045858691658,0.660050298145776
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,36896,-0.00323917443236904,0.00739424613833795,-0.0177318968635114,0.0112535479987733,0.661345051359534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37005,-0.00278951560831495,0.00637131619468098,-0.0152772953498897,0.00969826413325978,0.661521012395249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39482,-0.00248317847692913,0.00567875736696912,-0.0136135429161886,0.00864718596233034,0.661917987413286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37005,-0.00328453876448269,0.00761163516672586,-0.0182033436912654,0.0116342661623,0.666100641589623
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39673,-0.00191017951970763,0.00444667445038864,-0.0106256614424694,0.00680530240305411,0.667510786524812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39401,0.00138429192087526,0.00322279823316454,-0.00493239261612724,0.00770097645787775,0.667542754622512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,39507,0.00196087085943363,0.00458190714375266,-0.00701966714232157,0.0109414088611888,0.668686469877777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,36896,0.0018024670047871,0.0042221161252805,-0.00647288060076268,0.0100778146103369,0.669451343593411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36855,-0.00208089381557528,0.00489858916412772,-0.0116821285772656,0.00752034094611505,0.670993508411014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36855,-0.00208750112725204,0.00492283425131106,-0.0117362562598217,0.00756125400531764,0.671540328930546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37203,0.00243029992519836,0.00576242650096602,-0.00886405601669503,0.0137246558670918,0.673214736331601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,36877,-0.000917885259350276,0.00218998159786631,-0.00521024919116825,0.0033744786724677,0.675128619290097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36877,0.00142890926176869,0.00341811009371132,-0.0052705865219055,0.00812840504544287,0.675924229099338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36896,0.00294549411043669,0.00706950330712635,-0.010910732371531,0.0168017205924043,0.676942785958844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,39797,0.00153119042626991,0.00370048246103252,-0.00572175519735383,0.00878413604989366,0.679039851578535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36855,0.00205351798649307,0.00499986308283592,-0.00774621365586533,0.0118532496288515,0.681288412880467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,39810,-0.00105976000504267,0.00259160927388786,-0.00613931418186288,0.00401979417177754,0.682604104803219
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36896,-0.00132006622746672,0.00323520199201021,-0.00766106213180673,0.00502092967687328,0.683256817618572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36896,-0.00124743005261298,0.00307512565299033,-0.00727467633247403,0.00477981622724807,0.685005168632807
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36855,0.00162880216490673,0.00405026150339774,-0.00630971038175285,0.00956731471156631,0.68758215874818
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,39288,-0.00341279124290899,0.00852198697884511,-0.0201158857214454,0.0132903032356274,0.688816688045395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37183,-0.0015773290898121,0.00395551160043605,-0.00933013182666676,0.00617547364704255,0.690070988235687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39599,0.00102262652245141,0.00257049584650735,-0.00401554533670301,0.00606079838160582,0.690759130866448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36827,-0.00130753589147877,0.00328674076395719,-0.00774954778883486,0.00513447600587732,0.690768372587251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36827,-0.00321560649417639,0.00826567570639396,-0.0194163308787085,0.0129851178903558,0.69725938688765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,37267,-0.0029264329874024,0.00762837524827529,-0.017878048474022,0.0120251824992172,0.7012627306813
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,37005,0.00217673579118204,0.00569779532608293,-0.00899094304794049,0.0133444146303046,0.702444371374948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36896,0.0013835650945116,0.00363303459001556,-0.0057371827019189,0.00850431289094211,0.703336311001065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37277,-0.000895506264865135,0.00239688127535111,-0.00559339356455332,0.00380238103482305,0.708698082736495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39529,0.00083398415454421,0.00223305124606018,-0.00354279628773374,0.00521076459682216,0.708801553936408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,36877,-0.00241060344008195,0.00650968171244885,-0.0151695795964817,0.0103483727163178,0.711157181958346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36827,0.00206496789276376,0.005586627481393,-0.00888482197076651,0.013014757756294,0.711666528410953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39643,0.00125530929593969,0.00340977427033333,-0.00542784827391364,0.00793846686579303,0.712766131041939
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37215,-0.00519524752187911,0.0141156954655098,-0.0328620106342784,0.0224715155905202,0.712843591444206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,37203,0.00139500277784432,0.00384619960765429,-0.0061435484531581,0.00893355400884673,0.716837428887793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,39680,0.00157730173135908,0.00436096720066061,-0.00697019398193572,0.0101247974446539,0.717591358070187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37277,-0.000885975203920927,0.00248792473790494,-0.00576230769021462,0.00399035728237276,0.72176368971911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36795,-0.00142494400851567,0.00403604017896056,-0.00933558275927836,0.00648569474224702,0.724052990224681
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,39288,0.00176371804451732,0.00499903929985139,-0.0080343989831914,0.011561835072226,0.724234657959281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,36880,-0.00241337274803688,0.00687293534401347,-0.0158843260223033,0.0110575805262295,0.725487885319621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,36655,0.00131677334165804,0.00378342309713066,-0.00609873592871804,0.00873228261203413,0.727817701752406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36855,0.00217407884883841,0.0062515800034733,-0.0100790179579693,0.0144271756556461,0.728022534160838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37203,-0.00148983047325176,0.00428537218611316,-0.00988915995803356,0.00690949901153004,0.728104883553558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36877,-0.00279705701380575,0.00812342446834786,-0.0187189689717676,0.0131248549441561,0.730611253322202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39288,0.00115820516351014,0.00338483517938586,-0.00547607178808615,0.00779248211510643,0.732224039974933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36877,-0.00109258770959924,0.00325682442125177,-0.00747596357525271,0.00529078815605423,0.737271155986386
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39557,0.00328900513403914,0.00984526631030228,-0.0160077168341533,0.0225857271022316,0.738331428804174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,37215,0.00197462175294808,0.00593909469183859,-0.00966600384305555,0.0136152473489517,0.739533131733036
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,36855,0.0011923299416036,0.00364013845456526,-0.00594234142934432,0.00832700131255152,0.743256670362924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,39302,-0.00215423825727693,0.00668326635064364,-0.0152534403045385,0.0109449637899846,0.747204689992721
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36877,0.00206680375796542,0.00643768331810031,-0.0105510555455112,0.014684663061442,0.748179357920097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39809,0.000933549789713151,0.00291313764496253,-0.00477619999441341,0.00664329957383971,0.748622363414492
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36519,-0.00145750979564359,0.00472661382905093,-0.0107216729005834,0.00780665330929623,0.757811693514722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39401,0.000900766114946324,0.00294346966888794,-0.00486843443607404,0.00666996666596668,0.759592087523367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39860,0.000852022053110995,0.00279002904919564,-0.00461643488331245,0.00632047898953444,0.760079911040478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39860,0.000799927629691213,0.00263095933657968,-0.00435675267000497,0.00595660792938739,0.761098257244319
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37215,-0.0024600524733349,0.00810636176078192,-0.0183485215244675,0.0134284165777977,0.761535036258553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37005,-0.00131367917441175,0.00435892049546588,-0.00985716334552487,0.00722980499670136,0.763131659397076
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39302,-0.00143999869478306,0.00477954943006755,-0.0108079155777154,0.00792791818814933,0.763202487938763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39630,-0.00113931475407756,0.00379844784317996,-0.00858427252671027,0.00630564301855515,0.764225207488437
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37005,-0.00115126320626639,0.0038714570740517,-0.00873931907140772,0.00643679265887493,0.766187163290974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37268,-0.000840920031170603,0.00282987637737591,-0.00638747773082738,0.00470563766848617,0.766350589521663
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37268,-0.000734593850977918,0.00247672935560785,-0.0055889833879693,0.00411979568601347,0.766777761468537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,36877,-0.00173407964368736,0.00584678595748776,-0.0131937801203634,0.00972562083298866,0.766786707704409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36855,0.00113892734949527,0.00385602985208723,-0.00641889116059571,0.00869674585958624,0.76772155053442
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,36958,0.00106218673773397,0.00360221417381626,-0.00599815304294591,0.00812252651841385,0.76809747229617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36855,-0.00140042037857534,0.00475291503970101,-0.0107161338563893,0.00791529309923864,0.768270154297265
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39689,-0.00137268288109242,0.00469900358582937,-0.010582729909318,0.00783736414713316,0.770197084415119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39594,-0.00123563262777048,0.00426816888954792,-0.00960124365128439,0.00712997839574344,0.772203000577093
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,36827,-0.00179172399520153,0.00623643346129923,-0.014015133579348,0.010431685588945,0.773887623316264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36795,-0.00137140687626963,0.00483949416537241,-0.0108568154403995,0.00811400168786029,0.77689151536682
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,39401,-0.000741546609153117,0.00263103608158439,-0.00589837732905853,0.00441528411075229,0.778065462619214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,39573,0.0014250788994819,0.00506462941418116,-0.00850159475231317,0.011351752551277,0.778423649613628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,36795,-0.00124397552948174,0.00442703516247019,-0.00992096444792331,0.00743301338895984,0.7787185933427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,36896,-0.00124787307265963,0.00451721236324724,-0.0101016093046242,0.00760586315930497,0.782361598938104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36896,-0.000697042762193296,0.00252399758989997,-0.00564407803839725,0.00424999251401065,0.782424812975692
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,37277,0.000681990712801178,0.0024806307270188,-0.00418004551215568,0.00554402693775803,0.783377067716004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39842,-0.0014749321537182,0.00536551494489901,-0.0119913414457203,0.00904147713828387,0.783403480033432
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,39302,-0.00139041793199287,0.00507703223944204,-0.0113414011212993,0.00856056525731353,0.784192562649591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39401,0.00162982993862999,0.00595590632494734,-0.0100437464582668,0.0133034063355268,0.784357736056908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36795,0.00144794636907768,0.0054132633157769,-0.00916204972984504,0.0120579424680004,0.789102923184141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,36827,-0.001227371758322,0.00461049547473317,-0.010263942888799,0.00780919937215501,0.790079750607846
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36877,0.0012674583173364,0.00486000707288641,-0.00825815554552096,0.0107930721801938,0.794255872758183
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39288,-0.0012211949126217,0.00474189094877919,-0.0105153011722289,0.00807291134698552,0.79677053258754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36976,-0.00160623755353338,0.00625272927051318,-0.0138615869237392,0.0106491118166724,0.797270938375736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,37203,-0.00122314592999994,0.00483430001546658,-0.0106983739603144,0.00825208210031456,0.80026123713832
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,39508,0.00160873825235374,0.00649993116762018,-0.0111311268361818,0.0143486033408893,0.804523909146841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37203,0.00143927689844726,0.00589902938863054,-0.0101228207032686,0.0130013745001631,0.807245897851886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36277,-0.00121526810913889,0.00500263379957624,-0.0110204303563083,0.00858989413803054,0.808067000902387
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36880,-0.00606850460542595,0.0250158609276589,-0.0550995920236374,0.0429625828127855,0.808329733016202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36827,-0.00115552012797384,0.00476956379924752,-0.010503865174499,0.00819282491855128,0.808575129498331
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36880,0.00062141260645672,0.00258108807467445,-0.0044375200199052,0.00568034523281864,0.809747974427211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36795,-0.00326119983505304,0.0139417674551887,-0.0305870640472228,0.0240646643771167,0.815054040512128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37005,0.00088814460217192,0.00381873186402033,-0.00659656985130793,0.00837285905565177,0.81609444497798
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37203,-0.000925395297401391,0.00400783984987555,-0.00878076140315747,0.00692997080835468,0.81739892378856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,39654,0.00276858946877444,0.0120045395843743,-0.0207603081165993,0.0262974870541482,0.817606378654799
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,36877,-0.000916356828703354,0.00403814926384356,-0.00883112938583674,0.00699841572843003,0.820485662543941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,36795,-0.00155967637908824,0.00691953860344177,-0.0151219720418341,0.0120026192836576,0.821670281039523
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37005,-0.0018292648832936,0.00814862434257031,-0.0178005685947314,0.0141420388281442,0.82238142640454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,36877,0.00104689299794742,0.00467453737190994,-0.00811520025099606,0.0102089862468909,0.822794671336752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39383,-0.000727895648090323,0.00326084628313422,-0.0071191543630334,0.00566336306685275,0.823364947042914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37203,-0.00079549251029208,0.00364742083646817,-0.0079444373497697,0.00635345232918554,0.82735666322379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36827,-0.002025249917124,0.00933199899606892,-0.0203159679494191,0.0162654681151711,0.828194544873352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,39401,0.0018765396943685,0.0086797893384851,-0.0151358474090623,0.0188889267977993,0.828837453377666
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37215,-0.00352301470945375,0.0164551299188942,-0.0357750693504863,0.0287290399315788,0.830473699994027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36877,0.000843922582454073,0.00397569950700146,-0.00694844845126878,0.00863629361617693,0.831899555846002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36855,-0.00120534995115068,0.00570481322704696,-0.0123867838761627,0.00997608397386137,0.832667039164938
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39865,0.00083840166925674,0.00402646601047761,-0.00705347171127937,0.00873027504979285,0.835057725754696
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,36855,0.00221939396870229,0.0106865292866937,-0.0187262034332173,0.0231649913706219,0.835480951845843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,39401,-0.00103205251076391,0.00500697182770964,-0.0108457172930748,0.00878161227154699,0.836697461896532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39810,-0.000920682340306849,0.00450438442771899,-0.00974927581863607,0.00790791113802237,0.838045938399829
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39401,0.000701414416908714,0.00344712622566371,-0.00605495298539216,0.00745778181920958,0.838764088371962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37244,0.000568958256269154,0.0028779383475147,-0.00507180090485965,0.00620971741739796,0.843285552917461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,36827,-0.000894702274439828,0.00454917351950186,-0.00981108237266346,0.00802167782378381,0.84408606304207
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36855,-0.000638681860458786,0.00325469422173027,-0.00701788253505011,0.00574051881413254,0.844430038902567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,39401,-0.000889812944272831,0.00454208932368796,-0.00979230801870123,0.00801268213015557,0.844687957756233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,39594,0.000353916463308931,0.00181639298680063,-0.0032062137908203,0.00391404671743816,0.845516216947861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,36827,-0.00079944852176249,0.00412361561865297,-0.0088817351343223,0.00728283809079732,0.846280110909922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,36827,0.000705970501269693,0.00367335416588499,-0.00649380366386488,0.00790574466640426,0.847598826732186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,36704,-0.000804177048500477,0.004214208117665,-0.00906402495912388,0.00745567086212292,0.848665571616287
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37203,-0.000669428246788756,0.00352108211018904,-0.00757074918275927,0.00623189268918176,0.849217964513557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39673,-0.000442729314179754,0.00234933357569447,-0.00504742312254091,0.0041619644941814,0.850527192525822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_A,,37244,-0.000588961523577657,0.0031264866531284,-0.00671687536370933,0.00553895231655401,0.850583145053411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,36855,0.00085291443878058,0.00460781752858858,-0.00817840791725304,0.00988423679481419,0.85315222825864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36827,0.00104798284783577,0.00569979215947219,-0.0101236097847297,0.0122195754804013,0.854123536527712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,36855,-0.00086396087633301,0.0047294947156001,-0.0101337705189092,0.00840584876624319,0.855055811198635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37268,0.000682976003492434,0.00379281704989657,-0.00675094541430485,0.00811689742128971,0.857099623945736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37005,-0.00101234829769714,0.00567346088003938,-0.0121323316225743,0.01010763502718,0.858383518122166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39401,0.000588787316381827,0.00330099067466789,-0.00588115440596724,0.0070587290387309,0.85843720471438
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,39302,-0.000747100173560903,0.00429410218541247,-0.00916354045696935,0.00766934010984754,0.861881214230835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36896,0.00184097160710279,0.010612548874313,-0.0189596241865508,0.0226415674007564,0.862283755746054
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37005,0.000733192974933073,0.00423053250692725,-0.00755865073864433,0.00902503668851048,0.862410546327374
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36855,-0.00191948534536521,0.0112059651633574,-0.0238831770655457,0.0200442063748153,0.863997317461028
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36795,-0.000965700500241809,0.00577683571806072,-0.0122882985076408,0.0103568975071572,0.867240689786569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39302,-0.000836920701679153,0.00504844214188532,-0.0107318672997744,0.00905802589641608,0.86833382083241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37268,0.000428286763062953,0.00258815027325803,-0.00464448777252279,0.00550106129864869,0.868568789996034
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36896,-0.00143654290734729,0.00876265333479492,-0.0186113434435453,0.0157382576288508,0.869781501359914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39860,-0.000357888976601005,0.00218655612966983,-0.00464353899075388,0.00392776103755187,0.869987481575396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,39129,-0.00039943854415441,0.00244744367834188,-0.0051964281537045,0.00439755106539568,0.870358063982384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,37267,0.000700778894153046,0.00430516559178504,-0.00773734566574563,0.00913890345405173,0.87069702827443
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36880,-0.000640916320154218,0.00394989241172777,-0.00838270544714066,0.00710087280683222,0.87110227939603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,36877,-0.0011068742762396,0.00682308748693805,-0.0144801257506382,0.012266377198159,0.871131317312258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36855,0.000717856967355357,0.00450145883656909,-0.00810500235232006,0.00954071628703077,0.87329943847654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39401,-0.000996400515733678,0.00633702766190846,-0.0134169747330743,0.0114241737016069,0.875061940238084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,39826,0.000311425522232359,0.00200408805006285,-0.00361658705589082,0.00423943810035554,0.876511787989768
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39401,0.00116295927672998,0.00751191733165963,-0.0135603986933229,0.0158863172467828,0.876968987557624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36827,0.00109869219143674,0.00724374190394067,-0.013099041940287,0.0152964263231605,0.879445892860056
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39401,-0.00084421509694768,0.00562464654648696,-0.0118685223280621,0.0101800921341668,0.880693888516792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39630,0.00040232450980889,0.00273109504471281,-0.00495062177782822,0.005755270797446,0.88288722921535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,36896,0.000576797306385583,0.00394420864354952,-0.00715385163497147,0.00830744624774264,0.883734944411309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36880,-0.000985657493352519,0.00681193841148609,-0.0143370567798653,0.0123657417931602,0.884953455481355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39401,0.000819461877175969,0.00577116393686352,-0.0104920194390765,0.0121309431934285,0.887087786539454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39697,-0.000432771080924099,0.00317976911301546,-0.0066651185424344,0.0057995763805862,0.891742837496416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,39557,0.00186464927356325,0.0139281687762069,-0.0254345615278023,0.0291638600749288,0.893502245536727
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37220,-0.000320650851898566,0.00245551908587577,-0.00513346826021507,0.00449216655641794,0.896106576745977
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,36896,0.000605622484762656,0.00467003963185605,-0.0085476551936752,0.00975890016320051,0.896819617520755
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39302,-0.00067076197731482,0.0054962546658955,-0.01144342112247,0.0101018971678404,0.90286906338732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,36896,-0.000554197391512159,0.00454238168695595,-0.00945726549794581,0.00834887071492149,0.902896221787384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39860,0.00034170307933893,0.00282756283044676,-0.00520032006833671,0.00588372622701457,0.903813573335117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37285,-0.000214526474142491,0.00179356437359524,-0.00372991264638917,0.00330085969810418,0.904794665108341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36877,-0.00116733008899787,0.0100378638801348,-0.0208415432940622,0.0185068831160664,0.907422380977955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,39401,-0.00056099169017249,0.00483899854912124,-0.0100454288464501,0.00892344546610515,0.907708438257157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,39401,0.000490096486229995,0.00431221813530999,-0.00796185105897758,0.00894204403143757,0.909514347281974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36795,0.000616396116173236,0.0054536166224577,-0.0100726924638439,0.0113054846961903,0.910012329516298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,36877,0.000649968454866356,0.00583358677141781,-0.0107838616171126,0.0120837985268453,0.91128634875499
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39288,0.000303274990671177,0.0028841261363975,-0.00534961223666792,0.00595616221801027,0.916255640741708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39594,0.000231082785983362,0.00224820550936678,-0.00417540001237552,0.00463756558434224,0.918134573451384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,36795,0.000527193200356163,0.00513032387900345,-0.0095282416024906,0.0105826280032029,0.918154872430094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,37244,-0.000378851249268011,0.00370611770125949,-0.0076428419437366,0.00688513944520058,0.91858103646824
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37244,-0.000351177619216518,0.00345201680805954,-0.00711713056301322,0.00641477532458018,0.918971604934166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36998,-0.000961541846358847,0.00960943426814724,-0.0197960330119274,0.0178729493192097,0.920296412574778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,39288,0.00097415356150476,0.00975369806980135,-0.0181430946553059,0.0200914017783154,0.920444620403553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36827,-0.000548211519230797,0.00575613979525955,-0.0118302455179395,0.0107338224794779,0.924126116986997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37215,-0.000948659762227202,0.00999975210735646,-0.0205481738926459,0.0186508543681915,0.924420836948491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,36896,-0.000152337529455481,0.00161022722222909,-0.00330838288502449,0.00300370782611353,0.924629054012669
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,39743,-0.000368377686007618,0.00401136909701323,-0.00823066111615354,0.0074939057441383,0.926831560362768
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36795,0.000451038274317464,0.00511839955788082,-0.00958102485912895,0.0104831014077639,0.929781902962716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,36896,-0.000543716946316448,0.00617681471222693,-0.0126502737822812,0.0115628398896483,0.929857793926248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37268,-0.00028450287429983,0.00329043275651496,-0.00673375107706914,0.00616474532846948,0.931099130393831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,39860,0.000330017828034068,0.00394189459619697,-0.007396095580512,0.00805613123658014,0.933279616041986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37005,-0.000450891748174119,0.00575397872990003,-0.0117286900587782,0.0108269065624299,0.93754150482225
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39594,0.00025323714065816,0.00327326690407928,-0.00616236599133724,0.00666884027265355,0.938333961231999
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39685,0.000416048177422259,0.00550126087826154,-0.0103664231439704,0.0111985194988149,0.939716186149203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38883,-0.000211523941876613,0.00279747769229171,-0.00569458021876836,0.00527153233501514,0.939728494917186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,37005,-0.000629390014772437,0.00852793054668095,-0.0173441338862671,0.0160853538567222,0.941167968316644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36880,-0.000266169726202369,0.00383599196674103,-0.00778471398101479,0.00725237452861005,0.944682278599562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36855,0.000602523482175594,0.00969893700196386,-0.0184073930416736,0.0196124400060248,0.950466130456891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36827,0.000427000776649415,0.00698473439128733,-0.0132630786302737,0.0141170801835726,0.951253887152073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39372,0.000236950082476293,0.00395195144521654,-0.00750887475014813,0.00798277491510072,0.952190064024291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39288,-0.000415889481672734,0.0071740723156274,-0.0144770712203024,0.013645292256957,0.953772330804694
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36855,-0.000250214198469498,0.00449110715403713,-0.00905278422038228,0.00855235582344328,0.955571096382118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,37005,-0.000316110527316252,0.00577430393664913,-0.0116337462431485,0.011001525188516,0.956342966487935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36880,0.000214746952146384,0.00400008824733532,-0.00762542601263084,0.00805491991692361,0.957186516389199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,36896,-0.000164830889425508,0.00310266124460309,-0.00624604692884757,0.00591638514999655,0.95763261012524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,39269,-0.000181329618723501,0.00345126463314231,-0.00694580829968242,0.00658314906223542,0.958099064630009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,36896,0.000317809354756853,0.0061270575800357,-0.0116912235021131,0.0123268422116268,0.958633219267245
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36795,-0.000230145852751552,0.00473167728437804,-0.0095042333301325,0.0090439416246294,0.961207436783892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,37005,0.000107139634090185,0.0022042766970038,-0.00421324269203726,0.00442752196021763,0.961234547021137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39544,-0.000175764925790431,0.00378234370648498,-0.007589158590501,0.00723762873892014,0.962936359954685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39817,0.000205397109880478,0.0044641334960887,-0.00854430454245338,0.00895509876221433,0.963302439664688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37220,-0.00011348334486285,0.00259434295563363,-0.00519839553790476,0.00497142884817906,0.965110223634802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,39680,0.000113169114265355,0.00261613070323604,-0.00501444706407728,0.00524078529260799,0.965496254750885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39288,-0.000465853494183601,0.0115710531864637,-0.0231451177396524,0.0222134107512852,0.967886164912125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,39597,9.25154077541692e-05,0.00237454302231004,-0.0045615889159735,0.00474661973148184,0.968921695644974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37277,0.000123033755565534,0.00337623626264482,-0.00649438931921831,0.00674045683034937,0.970931186812841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37005,-0.000162780953055427,0.00512843482716295,-0.0102145132142948,0.00988895130818395,0.974679188322855
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,38989,6.42192574251574e-05,0.00203614335385119,-0.00392662171612317,0.00405506023097349,0.974839584372908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,36827,-0.000170164054022034,0.00565441093579005,-0.0112528094881705,0.0109124813801265,0.975992519207314
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,37011,9.83263359500468e-05,0.0034941000299037,-0.0067501097226612,0.00694676239456129,0.977550379353322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37005,0.00014055532874784,0.00505941712127431,-0.00977590222894981,0.0100570128864455,0.97783729497279
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39817,-0.000305390328303322,0.012406449884599,-0.0246220321021174,0.0240112514455107,0.980362004703102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39302,0.000182298896298157,0.00818647429565094,-0.0158631907231777,0.016227788515774,0.982234220267641
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39799,-5.28796654409227e-05,0.00244897480016466,-0.00485287027376366,0.00474711094288181,0.982773228879895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36855,8.28923983033435e-05,0.0045012273612621,-0.00873951322977038,0.00890529802637707,0.985307661925267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36877,8.60315053664117e-05,0.00496272737424786,-0.0096409141481594,0.00981297715889222,0.986169207330151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37005,-5.36437249961541e-05,0.00614002626465301,-0.0120880952037161,0.0119808077537237,0.993029322748609
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,37267,5.04874341560681e-05,0.00758173603702131,-0.0148097151984057,0.0149106900667178,0.994686956239435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,36795,-1.33273792373273e-05,0.00579749048119321,-0.011376408722376,0.0113497539639014,0.998165845157042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,36795,-8.39748405960453e-06,0.00700046327196044,-0.0137293054971021,0.0137125105289828,0.999042907373868
